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ABSTRACT 
Human systemic fungal infections are increasing, and causing high morbidity and 
mortality. Treatment is challenging because fungi share many metabolic pathways with 
mammals. Current antifungals are losing effectiveness due to drug resistance. In 
immunocompromised patients Aspergillus fumigatus causes systemic aspergillosis, the most 
important airborne fungal disease. Mortality from aspergillosis exceeds 50% even with 
aggressive treatment. We need novel antifungal drug targets. Fungal cell wall components are 
promising targets for antifungal therapy as they are essential for fungi and absent from humans. 
The sugar galactofuranose (Galf) is a 5-memberd ring form of galactose that is found in 
the cell walls of many fungi, but not in mammals. I used molecular biology and microscopy 
techniques to characterize Galf biosynthesis enzymes in the model species A. nidulans. I studied 
three enzymes that catalyze sequential steps in Galf biosynthesis:  UgmA, UgtA and UgeA. 
UDP-galactopyranose mutase (UgmA) creates UDP-galactofuranose (UDP-Galf) from UDP 
galactopyranose (UDP-Galp) in the cytoplasm. The UDP-Galf transporter (UgtA) moves 
UDP-Galf into membrane bound organelles for incorporation into cell wall compartments. 
Upstream of UgmA, UDP-glucose/galactose epimerase (UgeA) interconverts UDP-glucose into 
UDP-Galp, the UgmA substrate. Neither UgmA nor UgtA has a human counterpart; UgeA is in 
the Leloir galactose metabolism pathway that found in many organisms from bacteria to humans. 
 None of UgeA, UgmA and UgtA is essential for viability of A. nidulans, but deleting any 
one of them substantially reduces colony growth and sporulation (Figure i). Wild type and Galf 
defective strains (ugeA∆, ugmA∆ and ugtA∆) were quantified for colony growth, cell 
morphometry, spore formation and germination, as well as wall architecture. The abundance of 
these proteins was regulated using the alcA promoter. Galf content was assessed by 
immunolocalization in the Galf defective strains, showing that those strains lacked 
immunodetectable Galf. Gene products were localized with fluorescent protein tags; both UgmA 
and UgeA were cytoplasmic, whereas UgtA was Golgi localized. Wall surfaces were imaged and 
force-probed using transmission electron microscopy and atomic force microscopy. Overall, Galf 
deletion strains had aberrant wall maturation, and poorly consolidated surfaces. Our results 
indicate that Galf is necessary for abundant sporulation, wild type growth and full maturation of 
Aspergillus cell wall.  
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Figure i: Colony morphology of wild type and Galf-defective strains: wild type strain has 
large abundantly sporulating colonies, whereas Galf-defective strains (ugeA∆, ugmA∆, and 
ugtA∆) have compact colonies with reduced sporulation. 
Galf deletion strains were assessed for sensitivity to antifungal agents in clinical use. 
They were significantly more sensitive to caspofungin and amphotericin B that target cell wall 
synthesis and cell membrane chemistry, respectively. Thus, anti-Galf drugs (once created) may 
be useful in combination with existing antifungal drugs. In summary, Galf biosynthesis pathway 
appears to be promising as an antifungal drug development target. 
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Chapter 1 
General introduction 
1.1. Biology of fungi 
Fungi are a diverse group of organisms. Most fungi are microscopic, but some fungi are 
macroscopic, particularly the fruiting bodies of mushrooms. Fungi are common in the 
environment and have several key roles in the functioning of ecosystems (Newbound et al., 
2010). The estimated number of fungal species is at least 1.5 million, although only 72,000 have 
been formally described (Hawksworth, 2001). Many fungi play key roles in recycling of 
nutrients through decomposition of dead plant biomass and bioremediation (Barr and Aust, 
1994). Some species form symbiotic relationships with plants (Rodriguez and Redman, 2008) 
which are essential for their survival in terrestrial environments. Some fungi are food sources for 
humans or animals and others are used in industrial fermentation processes to produce useful 
biochemicals (Bennett, 1998).  However, some fungi are harmful for plants, animals and humans 
(Monk and Goffeau, 2008; Cannon et al., 2009).  
Fungi are eukaryotic, heterotrophic microorganisms. Fungi and animals are in 
neighbouring kingdoms in the domain Eukarya. An important difference between these groups is 
that fungal cells are supported externally by a strong and flexible cell wall, whereas animal cells 
are not. Regarding their growth form, fungi can be multicellular (filamentous), unicellular 
(yeasts) or dimorphic (able to switch between unicellular and multicellular forms) (Osiewacz, 
2002). Yeasts are oval or round cells that undergo cytokinesis after each mitosis, whereas 
filamentous fungi do not. Budding yeasts produce a daughter cell as an outgrowth from a 
localized site (Herskowitz, 1988).  Filamentous fungi (moulds) are composed of long tubular 
cells called hyphae that exhibit tip localized growth (Kaminskyj and Heath, 1996). Hyphae may 
be divided by cross walls (septa), although certain fungal groups are aseptate. Major groups of 
septate fungi are the Ascomycetes (e.g. Aspergillus and Candida) and the Basidiomycetes (e.g. 
Cryptococcus). The major aseptate group of filamentous fungi is the Zygoycetes (e.g. Rhizopus). 
Hyphae of septate filamentous fungi can be uninucleate or multinucleate. In Aspergillus, 
the nuclei are typically haploid, except before sexual reproduction or during parasexual cycle. 
Most filamentous fungi produce specialized cells for dispersal, called spores. Fungal spores 
contain one or more nuclei and mitochondria, have limited nutrient reserves, and in many species 
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they can survive long periods of dorminancy. Many spores are dispersed by air. Some fungi 
produce both sexual spores (conidiospores, products of meiosis) and asexual spores (ascospores, 
products of mitosis) spores (Taylor et al., 1999). For many filamentous fungi including 
Aspergillus the predominant life cycle stage is asexual (Wearing, 2010). In addition, most 
filamentous fungi can produce colonies from hyphal fragments. Filamentous fungi acquire 
nutrients during vegetative growth, forming mycelial colonies that produce spores for dispersal, 
as well as being able to regrow from fragments if a colony is physically damaged. 
  
1.2. Aspergillus nidulans as a model system 
Aspergillus is a genus of filamentous fungi that has more than 200 species. Aspergillus 
has diverse ecological roles. Its habitat includes soil, dust, and living or dead plant materials 
(Latge and Steinbach, 2009). The genus Aspergillus includes human and plant pathogens as well 
as beneficial species used to produce foodstuffs and industrial enzymes. For example, A. 
fumigatus is a deadly pathogen of immunocompromised patients; A. flavus is an agriculturally 
important toxin producer; A. niger and A. oryzae are used in industrial processes (Kapoor et al., 
1999). As discussed below Aspergillus nidulans is used as an experimental model species.   
Aspergillus hyphae are septate and their cells are multinucleate. Aspergillus nidulans 
hyphae are ~2-3 µm in diameter, and for wild type cells the basal cell length is ~40 µm. Apical 
cells are usually much longer than 40 µm and have many evenly spaced nuclei (Figure 1). 
Aspergillus nidulans reproduces asexually to form conidiophores that produce long chains of 
spherical uninucleated spores. Figure 2 shows the stages of the asexual reproduction in A. 
nidulans. The asexual life cycle takes ~2-3 days to be completed (Adams et al., 1998) depending 
on genetic background, nutrition, and temperature.   
Aspergillus nidulans has many advantages that make it an excellent experimental model 
system including: 
1. It is safe to deal with in a biosafety level 1 facility, whereas in Canada most Aspergillus 
species must be handled in a biosafety level 2 cabinet (de Aguirre et al., 2004). 
2. It possesses a tractable well-characterized sexual cycle and thus a well-developed 
genetics system. Aspergillus nidulans is the asexual stage of the sexual fungus 
Emericella nidulans. The A. nidulans sexual cycle is well studied and readily induced 
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so this species is easily manipulated using classical and molecular genetics (Todd et 
al., 2007).  
3. It has many similarities with the pathogenic species A. fumigatus. Analysis of cell wall 
sugars of A. fumigatus and A. nidulans showed that both fungi have overall similar 
wall sugar composition (Guest and Momany, 2000). 
4. The genome of A. nidulans was sequenced in 2005 (Galagan et al., 2005) and the 
sequence was updated in 2008 (Wortman et al., 2009). There are several extensively 
curated comparative databases of many Aspergillus species and easy-to-use 
web-based tools for accessing, analyzing and exploring these data. Together these 
resources facilitate and accelerate Aspergillus research (Rokas et al., 2007; Arnaud et 
al., 2010).  
5. Studies in A. nidulans contributes significantly to understanding fundamental biological 
principles and are relevant for biotechnology and industrial applications, as well as 
human, animal and plant fungal pathogenesis (Tsitsigiannis and Keller, 2006; 
Panagiotou et al., 2009). 
 
1.3. Human fungal pathogens including Aspergillus 
Many fungi degrade plants and plant products.  However, about 300 to 400 fungi are 
reported to be pathogenic to humans, where they cause a wide variety of diseases (Person et al., 
2010; Moran et al., 2011). Fungi can cause superficial infections of skin and mucous membranes 
of healthy individuals, as well as subcutaneous infections that can be painful and disfiguring. 
Fungi can also penetrate tissues or into the blood system of immunocompromised patients to 
cause invasive fungal infections which are associated with high morbidity and mortality (Menzin 
et al., 2009). Systemic infections can be acquired by environmental exposure or by wounding.  
Fungal infections cause a variety of symptoms depending on the species, type of infection 
and the affected area of the body. People at risk for fungal infections include: 1) people with 
weak immune systems, 2) very young and very old people, 3) diabetic patients, 4) patients taking 
steroid medication or antibacterial antibiotics for extended periods of time, and 5) patients on 
chemotherapy (Ringden et al., 1991; Perlroth et al., 2007). The most common systemic human 
fungal pathogens are species of Candida, Aspergillus, and Cryptococcus (Richardson, 2005). 
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Although Candida infections have recently shown a slight decrease in North America, 
Aspergillus infections are increasing (Erjavec et al., 2009).  
  Several species of Aspergillus are opportunistic human pathogens that can cause a 
systemic disease named aspergillosis. In 1939, aspergillosis was described as “being so rare as to 
be of little practical importance” (reviewed in Latgé and Steinbach, 2009). Much has changed in 
the past 70 years. Aspergillus fumigatus become one of the most common fungal pathogens 
(Lass-Florl, 2009). A. fumigatus is regarded as the most important airborne pathogenic 
filamentous fungus in developed countries (Latgé, 2001). Other Aspergillus species can also 
cause human infections, particularly A. flavus, A. terreus, and A. niger, but also to a lesser extent 
A. nidulans (Mirhendi et al., 2007). 
The lungs are the most common site of Aspergillus infection, which can be acquired by 
inhaling spores that reach the lungs to cause localized non-invasive infection called a pulmonary 
aspergilloma that can develop in a preexisting cavity (Thornton, 2010), Aspergillomas can also 
form in the brain, kidneys or other organs. Aspergillus species can produce allergic conditions 
such as allergic sinusitis (Walsh et al., 2008). Aspergillomas and allergic conditions are usually 
associated with low morbidity, and are seldom life-threatening (Riscili and Wood, 2009). 
Invasive aspergillosis happens when Aspergillus reaches the blood and spreads into other organs. 
Central nervous system aspergillosis has been reported in organ transplantation patients 
(Nadkarni, 2010). Despite aggressive treatment, invasive aspergillosis is still associated with 
high morbidity and mortality (Menzin et al., 2009).  Overall, the increase in the number of 
immunocompromised patients has led to increase in the incidence of the life threatening fungal 
infections, particularly including invasive aspergillosis. Treatment of these infections is 
problematic with the current antifungal therapies. 
 
1.4. Antifungal drugs and their targets  
The ideal antifungal agent should have a broad spectrum of activity, low host toxicity, 
flexible routes of administration, and reasonable cost (Chapman et al., 2008). It is recommended 
that an antifungal drug target be present in a broad spectrum of fungal pathogens, be essential for 
fungal cell viability or pathogenicity, but not be found in human cells to avoid toxicity problems 
(Carrillo-Muñoz et al., 2006). Finding such a universal target appears to be unrealistic due to the 
underlying physiological similarities between humans and fungi (Aimanianda and Latgé, 2010). 
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Invasive fungal infections are often difficult to diagnose because their symptoms can be 
non-specific, and may resemble bacteria or viral infections. Following diagnosis, there are only 
about two dozen antifungal drugs, which limit therapeutic options. Antifungal drugs can be 
grouped into the following classes according to their targets.  Cell membrane targeting 
antifungals either bind directly to ergosterol (polyenes) or inhibit ergosterol biosynthesis (azoles, 
allylamines and morpholines). Cell wall targeting antifungals (echinocandins) inhibit wall 
synthesis. Other agents, including flucytosine and griseofulvin, target nucleic acid biosynthesis 
and mitosis respectively (Carrillo-Muñoz et al., 2006; Cannon et al., 2009). No single class of 
antifungal is effective against all invasive mycoses, and some are highly selective. Each class of 
drug has a specific mode of action (summarized in table 1) and a distinct role in the treatment of 
particular fungal pathogens (Chen and Sorrell, 2007). 
 
1.4.1. Polyenes 
  The polyenes irreversibly bind to ergosterol (Figure 3). Ergosterol is the sterol 
component of the fungal cell membrane (Figure 3a). It is chemically similar to human 
cholesterol (Figure 3b), and this similarity causes toxicity reactions in human treatment. The 
structure of polyenes (Figure 3c) allows them to bind to ergosterol, resulting in formation of 
pores in the membrane (Figure 3d) and so leakage of ions and small molecules that leads to cell 
death (Bolard, 1986). In addition, polyenes can cause oxidative damage to fungal cell, shown by 
in vitro studies (Brajtburg et al., 1990). 
 
1.4.1.1. Nystatin 
Nystatin was the first polyene drug to be used clinically. It is active against Candida and 
Aspergillus. However, nystatin can only be used topically due to problems with its solubilization 
in injectable solvents, as well as its human toxicity (Carrillo-Munoz et al., 1999). Nystatin is the 
most common antifungal agent prescribed in dentistry (Martinez-Beneyto et al. 2010). Recent 
developments include trials with nystatin formulations (Nystatin-Intralipid) that can be used 
intravenously to treat certain systemic fungal infections (Semis et al., 2010). 
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1.4.1.2. Amphotericin B 
Amphotericin B (AmB) is a polyene developed shortly after nystatin, that was essentially 
the only available antifungal drug until the late 1980s. AmB is still one of the most effective 
drugs for treating systemic mycoses. AmB has a broad spectrum of activity, and is used 
successfully to treat various yeast and mould infections (Gallis et al., 1990). Resistance to AmB 
is rare, apart from a few species that are intrinsically resistant, including Aspergillus terreus and 
Candida glabrata (Walsh et al., 2003; Rezusta et al., 2008). Unfortunately, AmB clinical use is 
hindered by its kidney toxicity and by the requirement for intravenous administration.  
Three lipid-based formulations of amphotericin B have been developed in order to 
minimize toxicities associated with AmB. These include amphotericin B lipid complex (ABLC), 
amphotericin B colloidal dispersion (ABCD), and liposomal amphotericin B (L-AmB) Their 
development has substantially reduced, but did not eliminate the toxicity completely (Adler-
Moore and Proffitt, 2008). 
 
1.4.2. Azole antifungal agents 
Azoles are the most widely used as well as the best-studied class of antifungal drugs 
(Sheehan et al., 1999). In addition, azoles are abundantly used in the environment as agricultural 
pesticides for plant fungal diseases (Verweij et al., 2009). Azoles act by inhibiting the fungal 
cytochrome P450 enzyme (also known as 14α-sterol demethylase or lanosterol demethylase) 
(Figure 3). This depletes cellular ergosterol and causes accumulation of toxic sterol intermediates 
(Sheehan et al., 1999). There are two groups of azoles in clinical use: imidazoles and triazoles. 
Azoles are generally fungistatic against yeast, although some triazoles have fungicidal activity 
against moulds (Francois, 2006).  
 
1.4.2.1. Imidazoles 
The imidazoles have a five membered ring that includes two nitrogen atoms. The 
imidazoles in clinical use include ketoconazole, miconazole, clotrimazole, and econazole.  
Except for ketoconazole, imidazoles can only be applied topically due to their human toxicity, so 
their use is limited to treating superficial mycoses (Zhang et al., 2007). 
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1.4.2.2. Triazoles 
 The triazoles have a five membered ring with three nitrogen atoms. There are two 
generations of triazoles: the first generation (fluconazole and itraconazole), and the 
extended-spectrum second generation (voriconazole and posaconazole), which have a more 
extensive range. Triazoles have greater affinity for fungal compared with mammalian 
cytochrome P450 enzymes, so their safety profile is significantly improved for systemic use. 
Fluconazole is active against yeast but not against Aspergillus and other moulds (Koltin, 1997), 
so it is mainly used for treating oral candidiasis. However, development of fluconazole-resistant 
Candida strains has become a major issue in treatment of many patients (Tumbarello et al., 
2009). Voriconazole and posaconazole have broad-spectrum activity against yeasts and moulds, 
including Aspergillus. Voriconazole is currently the drug of choice for the management of 
invasive aspergillosis. Posaconazole is the only azole drug with activity against zygomycete 
fungi. In general, the triazoles are relatively safe, even when used for prolonged periods, 
although they can cause liver toxicity (Spanakis et al., 2006). 
 
1.4.3. Allylamines 
The allylamines inhibit an early stage of ergosterol biosynthesis by binding the enzyme 
squalene epoxidase (Figure 4).  Terbinafine is the only allylamine in clinical use. As it 
accumulates in hair, nail and skin, topical and oral preparations of terbinafine are widely used to 
treat nail and skin infections such as tinea pedis. Terbinafine displays a primary fungicidal action 
against dermatophytes and filamentous fungi (Petranyi et al., 1987). There are also new reports 
of its value in certain invasive mould infections in combination with either a triazole or AmB 
formulation (Yu et al., 2008). Terbinafine is generally well tolerated, but may cause 
gastrointestinal upset and transient elevation of liver enzymes. 
 
1.4.4. Morpholines 
There is only one morpholine used clinically, amorolfine. It blocks two enzymes in 
ergosterol biosynthesis. These are the sterol C8-C7 isomerase and the C-14 sterol reductase 
(Figure 4), which result in ergosterol depletion. Amorolfine is active against dermatophytes and 
yeasts, but it can only be applied topically (Gauwerky et al., 2009). 
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1.4.5. Echinocandins 
The echinocandins are the newest class of antifungals. These compounds target the cell 
wall by inhibiting β -1,3-glucan synthase. Caspofungin (Cancidas®) was the first echinocandin 
approved. Caspofungin was first used clinically in 2001, followed shortly by micafungin 
(Mycamine®) and anidulafungin (Eraxis®) (Morrison, 2006). Echinocandins are fungistatic rather 
than fungicidal in vitro against Aspergillus species, but have strong efficacy in vivo. 
Echinocandins show good activity against Candida and Aspergillus, but they are not effective 
against Cryptococcus neoformans or non-Aspergillus moulds. Echinocandins are fungicidal 
against most ascomycete yeasts, but are fungistatic against most moulds (Bowman, 2002). 
Because echinocandin action is specific to fungal cell walls, human toxicity associated with 
echinocandins is limited (Gauwerky et al., 2009). However, all echinocandins require injection, 
as there are no oral preparations available (Kauffman and Carver, 2008).  
 
1.4.6. Flucytosine 
Flucytosine (5-fluorocytosine; 5-FC) is a fluorinated analogue of the nucleotide base cytosine. It 
was synthesized in 1957 as a potential antitumor agent, but it was also used in 1968 for treatment 
of human candidiasis and cryptococcosis (Vermes et al., 2000). 5-FC is imported into cells by 
the action of the enzyme cytosine permease. In the cell, 5-FC is converted into the metabolically 
active nucleoside analogue 5-fluorouracil, which inhibits RNA and DNA synthesis. 5-FC should 
not be administered as a single agent because of rapid development of resistance (Barchiesi et 
al., 2000). Also, 5-FC should be used with caution in patients with renal insufficiency. 5-FC has 
very limited spectrum of activity (Candida species, Cryptococcus neoformans, some moulds). Its 
role is clinically limited to use in combination with AmB for treating cryptococcal meningitis 
(Patel, 1998). 
 
1.4.7. Griseofulvin 
  Griseofulvin is an oral antifungal agent that was first used to treat superficial fungal 
infections of hair, nail and skin (Bedford et al., 1960). Griseofulvin has been the treatment of 
choice for the skin infection tinea capitis (ringworm) for more than 40 years (Gupta et al., 2008). 
Griseofulvin binds to microtubules where it acts mainly by inhibiting mitosis. Notably, the 
griseofulvin concentration required to inhibit the growth of fungal cells is much lower than that 
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required to inhibit the mammalian cells due to its higher affinity for fungal tubulin (Panda et al., 
2005). Griseofulvin has recently been shown to inhibit proliferation of various types of cancer 
cells and to inhibit tumor growth (Rathinasamy et al., 2010). 
 In summary, AmB was one of the first therapeutic agents for treatment of fungal 
infection, but its use is limited due to human toxicity. Although azoles are less toxic, they are not 
effective against all fungi. In addition, the extensive use of azoles in agriculture as well as 
medicine has led to the development of resistance, as well as to the development of cross-
resistant strains. Recent significant advances in antifungal therapy include: the development of 
lipid formulation of AmB, and the broad-spectrum triazoles (voriconazole and posaconazole). 
The newest class of antifungals, the echinocandins have relatively low human toxicity, however 
they are not active against Cryptococcus and Zygomycetes and also require injection. Overall, 
our current selection of antifungal drugs is insufficient given that each has limitations and that 
patient populations are increasing.  
 
1.5. Problems associated with antifungal therapy 
 Despite the availability of effective antifungal agents including echinocandins and 
second-generation triazoles, therapy failure is a clinical problem with all invasive fungal 
infections. Therapy failure was reported in 40–70% of patients with invasive aspergillosis (Nucci 
and Perfect, 2008). Management of fungal infections is limited by problems of drug safety, 
fungal resistance and restricted effectiveness profiles (Chapman et al., 2008). 
 
1.5.1. Toxicity and adverse reactions 
 Polyenes are the most toxic antifungal drugs. Amphotericin B toxicity results from the 
chemical similarity between ergosterol in fungal cell and cholesterol in mammalian cell. The 
major effect of AmB toxicity is nephrotoxicity, which is observed in approximately one third of 
patients. Other adverse effects of AmB include headache, chills, fever and intestinal problems 
(Worth et al., 2008).  Recently-developed lipid-based formulations of amphotericin B are less 
toxic.  
Azole drugs have relatively minor adverse effects, for example rashes are associated with 
fluconazole, gastrointestinal symptoms are observed with itraconazole, and eye symptoms are 
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reported in patients who receive voriconazole (Herbrecht et al., 2002; Chapman et al., 2008). 
Two relatively common adverse effects are associated with 5-FC: bone marrow suppression and 
hepatic dysfunction (Smith, 2008). In contrast, the echinocandins have a low frequency of 
toxicity. The most common adverse effects reported with echinocandin use are infusion reactions 
and elevations of liver enzyme levels (Denning, 2003). 
 
1.5.2. Emerging resistance 
Intrinsic and acquired antifungal resistance is a growing clinical problem with many 
fungal pathogens. Antifungal drug resistance can be caused by: 1) mutation or overexpression of 
the drug target, 2) biofilm formation, 3) drug efflux by upregulation of the efflux pumps, 
4) stress-related tolerance that enhances short-term survival, or 5) modification of chromosomal 
ploidy (Monk and Goffeau, 2008; Marie and White, 2009). The extensive prophylactic use of 
fungistatic azole derivatives, especially fluconazole, is associated with the emergence of resistant 
fungal pathogens (Canuto and Rodero, 2002). Furthermore the use of azoles in agriculture has 
led to development of cross-resistance to related azoles that are used as drugs. This was recently 
found in A. fumigatus clinical isolates (Verweij et al. 2009). Resistance to azoles is an important 
factor in treatment failure. Some filamentous fungi can cause infections that are unresponsive to 
current therapies and so can be lethal. Antifungal drug resistance also has striking economic 
consequences. For example, a conservative estimate of the annual cost of evolution of resistance 
in the United States is US$33 billion (Cowen, 2008). 
 
1.5.3. Low efficacy 
A narrow spectrum of activity against some fungal pathogens is related to some classes of 
antifungals. 5-FC is active against yeasts such as Candida and Cryptococcus but has limited 
activity against moulds. Terbinafine is the drug of choice for treatment of dermatophyte 
infections but it has limited activity against invasive fungal infections. Echinocandins are 
effective against Candida and Aspergillus species, but not against C. neoformans or 
non-Aspergillus moulds (Denning and Hope, 2010).  
Overall, numerous problems are associated with current antifungal therapies. The main 
problems are host toxicity, narrow activity spectra, and evolved resistance. Collectively these 
lead to high economic costs for treatment of fungal infections, as well as to increase in the 
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mortality rate. The problems associated with current antifungal drugs demand the development 
of new antifungal therapeutics. 
 
1.6. The fungal cell wall as target for antifungal drugs 
An ideal antifungal drug target should be widely distributed amongst fungal species, 
important for fungal cell viability or pathogenicity, but not found in humans (Carrillo-Muñoz et 
al., 2006). Although these general criteria may seem overly optimistic, fungal cell wall 
components can potentially fulfill at least some of them (Aimanianda and Latgé, 2010). The 
fungal wall functions include: 1) environment sensing and protection from certain environmental 
stressors, 2) adhesion to and penetration of host tissues, and 3) mediating secretion of 
pathogenicity factors and hydrolytic enzymes. Disruption of the cell wall renders the fungus 
susceptible to lysis or death (Aimanianda and Latge, 2010).  
 The fungal cell wall is a three-dimensional mesh work composed of several types of 
polysaccharide and glycoprotein. Despite decades of effort to characterize the composition and 
architecture of fungal cell walls (Bowman and Free, 2006), many details remain poorly 
understood. In part, this is because analysis of biologically distinctive carbohydrates is hampered 
by their similar chemistry. In filamentous fungi, the polysaccharides form about 90 % of the cell 
wall, which consists mainly of glucans, chitin and galactomannan (Gastebois et al., 2009). 
 Glucans are the major fungal cell wall polysaccharides, constituting about 50-60 % of the 
wall dry weight. Amongst these, β-1,3-glucan predominates, with β-1,6-glucans and 
α-1,3-glucans also present in lower amounts.  Chitin, a β-1,4 polymer of N-acetylglucosamine, 
accounts for 10-20 % of fungal cell wall mass. In Aspergillus cell walls, galactomannan (GM) 
accounts for 20-25 % of the polysaccharides (Gastebois et al., 2009). The composition of 
filamentous fungi wall polysaccharides is summarized in table 2.  
Galactomannans (GMs) are branched polymers composed of a linear core of α-mannans 
with short side chains of β-1,5-galactofuranose (Galf). GMs are found in many fungi including 
Aspergillus (Latge et al., 2005). As well as being a part of the fungal cell wall, GM is the major 
antigen found in the bodies of patients suffering from aspergillosis (Leitao, 2003). The 
immunodominant epitope in the GM molecule is galactofuranose. This has been the basis of the 
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development of a monoclonal antibody that detects GM presence in the biological fluids of 
patients with invasive aspergillosis (Mennink-Kersten et al., 2004). 
The cell wall is about one quarter of fungal cell biomass (Gastebois et al., 2009), and 
about one third of the fungal genome (~ 4000 genes) is involved in cell wall biosynthesis and 
maintenance (de-Groot et al., 2009). Fungal genomes typically have suites of genes with partially 
redundant and overlapping functions that encode synthetic enzymes for wall formation and 
others for its maintenance (Latge, 2007). As a result of the fungal cell wall complexity and its 
ability to be remodeled as growth conditions change, walls are dynamic structures that display 
ongoing changes in cell wall composition during growth and development, as well as in response 
to changing environmental conditions (Momany et al., 2004). The composition of the cell wall 
can be different between genera, between species of the same genus (Latge, 2007), and between 
disseminated growth and biofilms (Gastebois et al., 2009).  
Due to the above mentioned reasons, development of compounds targeting the cell wall is 
challenging (Aimanianda and Latge, 2010). To date only the echinocandins are used clinically to 
target the fungal cell wall; these block β-1, 3-glucan synthesis (Kamigiri et al., 2004). In contrast, 
although inhibitors of chitin (Nikkomycin Z and Calcofluor White, CFW) and mannan 
(Pradimicin) synthesis have been identified, they are not clinically effective (Kim et al., 2002).  
Due to the importance of cell wall components for fungal growth and host invasion, and the lack 
of conservation with animal cell components, the cell wall could be extremely rich source of 
potential antifungal targets (Aimanianda and Latgé, 2010). However, each potential target 
pathway must be investigated individually, because of the adaptability of the fungal wall to 
respond to environmental stressors such as wall-targeting compounds.  
The research presented in this thesis provides a comprehensive study of the biological 
roles of three sequential enzymes in the Galf biosynthesis pathway. As will be discussed, this 
pathway appears to be a chink in the fungal armour that could be used as a drug development 
target. 
 
 
 
 
Amira El-Ganiny PhD thesis May 2011 
13 
 
1.7. Galf biosynthesis as a potential drug target 
Galf is the 5-membered ring form of galactose that is found in several pathogenic 
microorganisms but not in humans (Figure 5). Galf is usually found in glycoconjugates that are 
essential for survival or virulence of many pathogenic microorganisms including bacteria, 
protozoa and some fungi (Weston et al., 1998; Beverley et al., 2005; Kleczka et al., 2007; 
Schmalhorst et al., 2008; Lamarre et al., 2009). Galf is a major carbohydrate in A. fumigatus 
walls, said to account for about 5% of the total wall dry weight of (Lamarre et al., 2009). Galf is 
reported from four different molecules in A. fumigatus: galactomannans, glycoproteins, several 
sphingolipids and lipophosphogalactomannan (Latge, 2009). Research into Galf roles in fungal 
cell wall structure and function has been hampered in part by analytical factors.  
Galf is absent from higher eukaryotes including humans, but is required for survival or 
virulence in many types of pathogenic microorganism. Thus the Galf biosynthesis pathway 
(Figure 5) is thought to be a promising drug target (Pedersen and Turco, 2003; Scherman et al., 
2003; Urbaniak et al., 2006; Dureau et al., 2010). Enzymes in the Galf pathway have been well 
studied in prokaryotes (Weston et al., 1998; Mikusova et al., 2006). These include 
UDP-galactopyranose mutase (UGM) that catalyzes the inter-conversion between UDP-Galp and 
UDP-Galf (Weston et al., 1998) and galactofuranosyl transferase(s) that transfer Galf moieties 
from UDP-Galf to glycoconjugate molecules (Belanova et al., 2008).  
In eukaryotes Galf biosynthesis and incorporation in the cell wall is a multistep process 
that can be summarized in the following steps (Figure 5).  
1) The synthesis of UDP-galactopyranose (UDP-Galp) from UDP-glucose, upstream of 
UDP-Galf biosynthesis. This step is catalyzed by the enzyme UDP-glucose/galactose 
epimerase (Singh et al., 2007).  
2) The synthesis of UDP-Galf from UDP-Galp, catalyzed by UDP-galactopyranose mutase, an 
enzyme located in the cytoplasm (Kleczka et al., 2007). These are the 5-member and 
6-member ring forms of galactose, respectively, that interconvert spontaneously in 
solution unless conjugated at carbon 1, such as with UDP. 
3) Transport of UDP-Galf into a membrane bound organelle (Golgi or endoplasmic reticulum) by 
the action of a UDP-Galf transporter (Engel et al., 2009).  
4) Incorporation of Galf into glycoconjugates by the action of galactofuranosyl transferase(s). 
These have not yet been identified in fungi. 
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1.7.1. UDP-glucose-4-epimerase  
UDP-glucose/galactose 4-epimerase (named UGE, GalE, Gal10 in various systems) 
catalyzes the synthesis of UDP-galactopyranose from UDP-glucose. This is a step in the Leloir 
pathway of galactose metabolism that is highly conserved in species ranging from bacteria to 
humans (Allard et al., 2001; Holden et al., 2003). In Saccharomyces cerevisiae, galactose 
metabolism enzymes are encoded by GAL1 (galactokinase), GAL7 (galactose-1-phosphate 
uridylyltransferase), and GAL10 (a combined mutarotase and UDP-glucose/galactose-4-
epimerase) (Holden et al., 2003). The GAL10 enzyme dual-activity is restricted to S. cerevisiae 
and a few other yeasts including Kluyveromyces fragilis, Schizosacchromyces pombe and 
Candida albicans (Scott and Timson, 2007, Brahma et al., 2009). The crystal structure of 
ScGal10 shows an N-terminal epimerase domain and a C-terminal mutarotase domain joined by 
a short linker (Thoden and Holden, 2005). In most organisms, UGE is encoded by a gene distinct 
from that encoding the mutarotase (Singh et al., 2007).  
UGE interconverts UDP-galactopyranose (UDP-Galp) and UDP-glucopyranose 
(UDP-Glc). This may be the only source of providing galactose to the cell if it is not present in 
the environment (Singh et al., 2007). In some organisms including Trypanosoma species, hexose 
transporters are unable to uptake galactose directly from the media. Instead the parasite must 
generate galactose via UGE (MacRae et al., 2006). Human GalE not only contributes to Leloir 
pathway galactose metabolism, but can also interconvert UDP-N-acetylglucosamine and 
UDP-N-acetylgalactosamine which are important for glycosylation of some macromolecules in 
humans (Schulz et al., 2005).  
Fungi including C. neoformans, S. pombe and some Aspergillus species have two genes 
that both encode functional UDP-glucose/galactose epimerases (Moyrand, 2008; Suzuki et al., 
2009), whereas other organisms (e.g. C. albicans) have only one (Singh et al., 2007).  
Arabidopsis thaliana has five genes encoding UDP-glucose/UDP-galactose 4-epimerases (named 
UGE1 to UGE5), that function in different metabolic situations (Barber et al., 2006).  
Loss of GalE activity in humans causes a metabolic disorder called galactosemia (Openo 
et al., 2006). Epimerase deficiency galactosemia (galactosemia type III) can be benign or with 
symptoms that can be controlled by restricting lactose or galactose in the diet (Wohlers et al., 
1999). Mutations of GalE in S. cerevisiae cause galactose sensitivity: the mutants cease growth 
in response to trace quantities of galactose, even in the presence of other carbon sources 
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(Wasilenko and Fridovich-Keil, 2006). CaGAL10 (C. albicans glucose ̸ galactose-4-epimerase) 
was found to be essential for growth on galactose. Even if CaGAL10Δ cells are grown on glucose 
they show some phenotypic defects. CaGAL10 was found to be important for cell wall integrity 
and resistance to stress, which can affect cell permeability and sensitivity to antibiotics (Singh et 
al., 2007). Cryptococcus neoformans epimerases UGE1 and UGE2 have distinct roles in C. 
neoformans physiology. UGE1 is essential for capsule formation and virulence, whereas UGE2 
was necessary for the cells to utilize galactose as a carbon source at 30ºC but is not required for 
virulence (Moyrand et al., 2008). In the protozoan, Trypanosoma. brucei, galactose metabolism 
mediated by UDP-glucose-4-epimerase is essential for parasite growth and survival (Roper et al., 
2002).  
UDP-glucose/galactose epimerase is well characterized both structurally and kinetically 
(Holden et al., 2003). Epimerases from E. coli (Thoden et al., 1996), S. cerevisiae (Thoden and 
Holden, 2005) and human sources (Thoden et al., 2000) have been cloned and sequenced, and 
their X-ray crystallographic structures are solved (Thoden and Holden, 2005). Epimerases from 
E. coli, yeast and human are functional as dimers. Understanding the structure of UGE from 
different organisms could help in designing inhibitors that are selective for UGEs from 
microorganisms. 
Some inhibitors of UGE were discovered from a directed library screen (Winans and 
Bertozzi, 2002). Inhibitors for TbGalE have been tested in vivo, and display some selectivity 
between human and Trypanosoma enzymes (Urbaniak et al., 2006). Although UgeA is highly 
conserved amongst diverse organisms, it may be possible to find compounds that selectively 
inhibit its function in specific organisms. 
In summary, UDP-glucose/galactose-4-epimerase catalyzes a step in galactose 
metabolism that is highly conserved. UgeA activity is encoded by single gene in some organisms 
or multiple genes in others. UDP-glucose/galactose 4-epimerase appears to have distinct roles in 
different systems. For example UGE is essential for survival of the protozoan Trypanosoma. 
However its deletion only causes galactose sensitivity in yeast, and leads to metabolic disorder in 
human. Despite the crystal structure of different UGE(s) have been solved, few specific 
inhibitors are reported in the literature. More work could be done to find inhibitors that are 
selective for UGE in specific types of pathogenic microorganism. 
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1.7.2. UDP-galactopyranose mutase  
 UDP-galactopyranose mutase (UGM, also called GLF in some species) is the key 
enzyme in the Galf biosynthesis pathway. UGM was first identified in E. coli (Nassau et al., 
1996), followed shortly thereafter by its identification in Klebsiella pneumoniae and 
Mycobacterium tuberculosis (Köplin, 1997; Weston et al., 1998). UGM has also been identified 
in eukaryotes including A. fumigatus, C. neoformans and L. major (Bakker et al., 2005; Beverley 
et al., 2005; Schmalhorst et al., 2008). There is only about 15% - 20% amino acid sequence 
identity between the prokaryotic and the eukaryotic UGMs, which is restricted to its active site. 
In contrast, eukaryotic UGMs are more closely related to each other than to prokaryotes. For 
example, A. fumigatus and L. major UGM share 51 % amino acid sequence identity (Beverley et 
al., 2005).  
The genes encoding UGM (ugm or glf) have been studied in several microorganisms. 
Those genes have consistently been shown to be important for survival, growth, and ̸ or 
pathogenicity. Deletion of glf from M. smegmatis showed that it was essential for growth and 
survival (Pan et al., 2001). Targeted replacement of GLF in L. major (the causative agent of 
leishmaniasis) caused attenuation of virulence (Kleczka et al., 2007). Deletion of glf-1 from the 
nematode Caenorhabditis elegans caused a significant late embryonic and larval lethality due to 
defective surface coat formation (Novelli et al., 2009).  
Aspergillus species including A. fumigatus and A. nidulans contain only a single copy of 
the gene encoding UGM. However, Damveld et al (2008) reported that A. niger has two genes 
that encode putative UDP-galactopyranose mutase (ugmA & ugmB). Deletion of A. niger ugmA 
impaired the colony growth and produced a Calcofluor-sensitive phenotype, whereas deletion of 
ugmB did not create any observable changes in phenotype (Damveld et al., 2008). 
Schmalhorst et al. (2008) reported that deletion of A. fumigatus glfA led to hyphae with 
thinner cell walls, as well as reduced colony growth, attenuated virulence, and increased 
susceptibility to antifungals. Lamarre et al (2009) created an A. fumigatus strain that lacked 
AfUGM1, another name for AfglfA. Their mutant lacked Galf, had reduced growth and a hyper 
adhesive phenotype but it was as pathogenic as the wild type strain. Disparities between 
Schmalhorst et al (2008) and Lamarre et al (2009) results particularly regarding the 
pathogenicity of the deletion strains must be resolved.  
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UGM overexpression in M. bovis increases resistance to isoniazid, an important drug 
used to treat tuberculosis (Richards and Lowary, 2009). Because UGM is essential for survival in 
bacteria and for virulence of protozoa and fungi, it is thought to be good target for antimicrobial 
therapy. 
 Rational drug design of UGM inhibitors requires understanding its structure and catalytic 
mechanism. The first crystal structure of UGM was reported in 2001 from E. coli (Sanders et al., 
2001a; Sanders et al., 2001b), followed by the crystal structure in M. tuberculosis and K. 
pneumonia (Beis et al., 2005). While many studies have been done on the prokaryotic UGM, 
little is known about eukaryotic UGM. Preliminary mechanistic studies of UGMs from A. 
fumigatus and T. cruzi were reported last year (Oppenheimer et al., 2010). Future work in this 
field should include a high-resolution crystal structure of UGM alone and bound to substrate, 
which will guide further efforts to design inhibitors. Several groups have designed inhibitors for 
UGM that mimic its substrate. Some of these inhibitors are active against mycobacteria 
(Scherman et al., 2003; Soltero-Higgin et al., 2004; Dykhuizen et al., 2008). Synthetic UDP-
furanoses are reported to be active against L. donovani (Dureau et al., 2010). 
Taken together, UGM is a key enzyme in Galf biosynthesis, since it catalyzes the 
interconversion of UDP-Galp and UDP-Galf. UGM has been found in many microorganisms, but 
it is absent from mammals. Deletion of the gene encoding UGM showed that it is essential for 
survival of bacteria and for virulence of protozoa and the growth of fungi. Importantly, 
Aspergillus fumigatus has only one UGM encoding gene. Several inhibitors of bacterial UGM 
have been reported, but no inhibitor has been developed that is effective against fungal UGM. 
 
1.7.3 UDP-Galf transporter  
The cell surface glycoconjugates are fundamental components of many organisms 
including fungi (Pinto et al., 2008). Approximately 80% of secreted proteins are covalently 
linked to a sugar (Caffaro and Hirschberg, 2006). Glycosylation of these compounds depends on 
a sugar donor that is typically a nucleoside diphosphate sugar (NDP-sugar), although a few are 
nucleoside monophosphate sugars (Handford et al., 2006). Many nucleotide sugars are 
synthesized in the cytosol, then translocated to the lumen of Golgi or ER by the action of the 
nucleotide-sugar transporters (NSTs) (Handford et al., 2006). NSTs translocate cytosolic 
nucleotide-sugars to the endomembrane system using luminal UMP as an antiporter substrate, 
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where the entrance of NDP-sugar is coupled to the exit of NMP (Reyes and Orellana, 2008; 
Sesma et al., 2009). 
NSTs are transporter proteins, typically with 6–10 transmembrane domains. They occur 
in all eukaryotes and are frequently located in the membrane of the Golgi apparatus, an organelle 
in the endomembrane system where the biosynthesis of glycoconjugates and polysaccharides 
occurs (Reyes and Orellana, 2008). NSTs are structurally conserved and can be identified from 
genome databases; however their substrate specificity cannot be predicted from the sequence 
(Berninsone and Hirschberg, 2000). A large number of NSTs have been identified; many of them 
are able to transport multiple substrates, although a few have been shown to be monospecific 
(Handford et al., 2006). 
UDP-Galf is an NDP-sugar that is synthesized in the cytosol and then translocated into 
the organelles of the secretory pathway prior to incorporation into glycoconjugates. A transporter 
for UDP-Galf has been identified in the genome of A. fumigatus, and named GlfB (Engel et al., 
2009). A. fumigatus GlfB was found to be localized in Golgi. In vitro transport assays established 
binding of UDP-Galf to GlfB and excluded transport of several other nucleotide sugars, which 
indicates that GlfB is specific for UDP-Galf transportation (Engel et al., 2009). 
In summary, the UDP-Galf transporter actively translocates the nucleotide sugar 
UDP-Galf from cytosol into Golgi equivalent in fungi. It was recently characterized in 
Aspergillus fumigatus. To our knowledge this is the only studied UDP-Galf transporter till now. 
 
1.7.4. Galactofuranosyl transferases  
 For production of Galf-containing glycoconjugates, additional processing steps are 
required to conjugate Galf subunits to other cell wall components and to each other (Chen and 
Okayama, 1988). These glycosylation steps take place in one or more compartments of the 
endomembrane system, and involve enzymes called galactofuranosyl transferases. In general, 
glycosyltransferases are specific enzymes that catalyze the transfer of monosaccharides to 
proteins, lipids or carbohydrates to produce glycoconjugates. Glycoconjugates are often vital for 
survival or virulence of many organisms (Breton et al., 2001, Deshpande et al., 2008). Many 
glycosyltransferases have been identified in fungi including glucan synthases, chitin synthases, 
and mannosyltransferses (Klutts et al., 2006). 
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Galactofuranosyl transferases were first characterized in prokaryotes. A bifunctional 
galactofuranosyl transferase (WbbO) was identified in Klebsiella pneumoniae. WbbO can 
transfer both Galp and Galf residues to form galactan molecules (Guan et al., 2001).  Two 
galactofuranosyl transferases were identified in Mycobacterium, GlfT1 (Rv3782) and GlfT2 
(Rv3808c) (Belanova et al., 2008). GlfT1 initiates the first step of galactan synthesis, whereas 
GlfT2 is a bifunctional enzyme responsible for the majority of galactan polymerization  
(Szczepina et al., 2010). GlfT2 was identified as essential for growth of Mycobacterium (Pan et 
al., 2001). GlfT1 was identified by its sequence similarity to GlfT2 and its location within the 
“possible galactan biosynthetic gene cluster” (Mikusova et al., 2006). A putative E. coli 
galactofuranosyl transferase, WbbI was partially characterized in vitro (Wing et al., 2006). 
In eukaryotes, sequence analysis of parasitic protozoa shows that there are at least six 
putative UDP-Galf transferases in the Leishmania genome and more than 20 related genes in 
Trypanosoma cruzi (Zhang et al., 2004;  Wing et al., 2006). However, to date only one 
galactofuranosyl transferase has been identified and characterized in the Leishmania, LPG1 
(Novozhilova and Bovin, 2010). Beverly et al (2005) note that no candidate UDP-Galf 
transferases have so far been reported in fungi. Deshpande et al (2008) tried to identify a putative 
Galf transferase in filamentous fungi using homology searches and applying hidden Markov 
model (HMM) techniques, but could not find any possible hits. However Galf transferases 
should exist given the number of Galf containing glycoconjugates reported in fungi (Latge, 
2009). 
Synthetic UDP-furanoses were identified recently as potent drugs against 
Mycobacterium. These synthetic furanoses are inhibitors for GlfT1 (Peltier et al., 2010). More 
research needs to be done to understand the structure of galactofuranosyl transferases and hence 
design inhibitors for them. In summary galactofuranosyl transferases are a specific type of 
glycosyl transferases that incorporates Galf residues into glycoconjugates. They have been 
identified in bacteria and protozoa but not in fungi. 
 
1.8. Assessment of antifungal drugs efficiency 
Antifungal susceptibility testing (AFST) is an in vitro method used to assess the response 
of a fungus to a drug or drug combination. AFST was less well developed and utilized than 
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antibacterial testing (Lass-Flörl, 2006). The requirement for accurate and predictive 
susceptibility testing of fungi did not become a major issue until the start of the AIDS era, which 
caused dramatic increase in the incidence of fungal infections (Johnson, 2008). Recently, AFST 
has been standardized for both yeasts and filamentous fungi. Two international standard 
methodologies are available: the Clinical and Laboratory Standards Institute (CLSI) method 
(Espinel-Ingroff et al., 2005), and European Committee for Antimicrobial Susceptibility Testing 
(EUCAST) method (Lass-Flörl, 2006). Both of these methods are broth-microdilution based 
assays and both have good inter- and intra-laboratory reproducibility (Lass- Flörl et al., 2010).  
Broth dilution methods use the minimum inhibitory concentrations (MICs) of antifungal 
drugs as an endpoint to define an appropriate dose. MIC is defined as the lowest concentration of 
the drug that inhibits the growth of fungi within a defined period of time. MIC is expressed as 
mg/L and must be observed visually (Subcommittee on Antifungal Susceptibility Testing 
(AFST) of EUCAST, 2008).  
Assessment of in vitro activity of echinocandins against Aspergillus spp. is complicated 
because of the phenomena of trailing endpoints and the fact that MIC values are usually higher 
than the allowed treatment doses, which makes MICs for Aspergillus poorly reproducible. In 
order to deal with these difficulties, the minimum effective concentration (MEC) is used as an 
end point for echinocandins, since it generates more consistent susceptibility results than MIC.  
MEC is defined as the lowest drug concentration at which short, stubby, highly branched hyphae 
are observed by microscopic examination (Espinel-Ingroff et al., 2007).  
Besides broth-microdilution methods, agar-based testing methods can be used for AFST, 
including agar diffusion, disc diffusion and E-test (Lass-Florl et al., 2010). Disc-based methods 
are convenient, simple and economical, with easy to read end points. A CLSI reference method 
(M 44A) was established for AFST in Candida	  species (Pfaller et al., 2005). Recently a 
disc-based assay for susceptibility testing of dermatophytes has been developed (Nweze et al., 
2010). 
 Several studies have compared the results of AFST using disc diffusion and standardized 
broth microdilution method (Espinel-Ingroff et al., 2007; Messer et al., 2007; Maida et al., 2008). 
These studies tried to correlate inhibition zone diameter with MIC values and they suggest that 
the agar-based methods hold promise as simple and reliable method for AFST, once they are 
standardized. The CLSI has proposed a standardized disc diffusion method for mould 
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susceptibility testing (M51-P, under development) (Espinel-Ingroff et al., 2009). Overall, AFST 
is a method to predict the response of fungi to certain drugs. The broth-based AFST have been 
standardized for yeast and mould. The disc-based methods are easy and economical, but they are 
waiting for standardization. 
 
1.9. Towards more effective antifungal therapy (drug combination)  
The high rate of mortality from mould infections and the relatively limited number of 
effective antifungal drugs have produced pressing needs for new therapeutic options. This has 
led to the use of drug combination, especially to treat intractable infections (Kontoyiannis and 
Lewis, 2004). There are several possible benefits for using two or more antifungal drugs, instead 
of monotherapy. Combination therapy may achieve fungicidal activity that is not possible with 
only one agent. Drug combinations may be effective at lower drug dosages, thus reducing toxic 
side-effects while also increasing efficacy. Combination therapies may delay or possibly prevent 
the emergence of drug-resistant mutants. In addition, combination therapy may provide broader 
spectrum coverage for seriously ill patients (Wirk and Wingard, 2008).  
 When two drugs are used together, drug interaction can be classified as synergistic, 
additive/indifferent or antagonistic on the basis of the fractional inhibitory concentration (FIC) 
index. The FIC index is the sum of the FICs for each drug. The combined FIC is defined as the 
MIC of each drug when used in combination divided by the MIC of the drug when used alone 
(Te Dorsthorst et al., 2002). In case of synergism, the combined effect of two drugs is greater 
than the sum of the individual effects. Additive interaction means the effect of two drugs is equal 
to the sum of the effect of them when taken separately. In case of antagonism the combined 
effect is less than the sum of the effects produced by each drug separately (Kontoyiannis and 
Lewis, 2003). 
Numerous in vitro investigations of various combinations of antifungal agents and trials 
in animal models of fungal infection have been performed (Johnson and Perfect, 2010). 
However, most of these antifungal combinations have not been evaluated in large clinical trials, 
in part because of the time and expense involved (Marr, 2004, Ashley and Johnson, 2011). To 
date, it has been shown that toxicity of amphotericin B can be reduced in combination with 
echinocandins (Caillot et al., 2007; Mihu et al., 2010). Also, use of flucytosine in combination 
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with many other drugs helps in preventing the rapid development of resistance (Johnson et al., 
2004).  
A problem with combination therapy is lack of generality of effect: combinations that 
prove successful with certain infections may not be broadly effective in improve the therapeutic 
outcome in others. For example, combination therapy  can successfully treat cryptococcal 
meningitis where  5-FC used in combination with polyenes or azoles (Van et al., 1997). 
However, the same combinations don’t work as well in treatment of invasive candidiasis, 
aspergillosis and zygomycoses (Chen et al., 2010). Additional clinical trials should be performed 
to support the use of combination therapy for different fungal infections, but again these are 
extremely expensive. 
Recently there is a new trend toward developing methods to exploit chemosensitization to 
antifungal drugs (Kim et al., 2008). The chemicals used for chemosensitization do not have 
antifungal activity but can augment the efficacy and lower dosage of antifungals. HSP90 
inhibitors, calcineurin inhibitors and fungal efflux pump inhibitors are examples of chemicals 
that are used in combination with antifungals to give better outcome (Onyewu et al., 2003; 
Cernicka et al., 2007; Cowen, 2008). 
Overall, there are several trials to apply the idea of combination therapy in management 
of fungal infections. Combination therapy has been used successfully for treatment of 
cryptococcal infections. Several in vitro and in vivo studies tested different combination of 
antifungal drugs towards various infections. However, they should be tested clinically before 
approval. 
 
1.10. Summary 
Life threatening fungal infections, including invasive aspergillosis, have increased 
dramatically in the last three decades, in part because the susceptible population is growing, and 
also as resistant fungal pathogen strains develop. Despite new and combination drug treatments, 
systemic fungal infections are associated with high morbidity and mortality. We are in critical 
need of new and validated targets for developing novel types of antifungal drug. Some cell wall 
components are promising targets for new drug development, since the cell wall is essential for 
fungi and it is not found in humans. Galactofuranose is a component of the fungal cell wall that 
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is important for normal growth in culture, and also plays a role in virulence in some fungal 
diseases. 
Synthesis of Galf-containing compounds for the cell wall is a multi-step process. 
UDP-galactopyranose mutase (UGM), the UDP-Galf transporter (UGT) and galactofuranosyl 
transferases are enzymes that catalyze sequential steps in Galf biosynthesis. 
UDP-glucose/galactose-4-epimerase catalyzes the upstream step from UGM, and hence 
contributes to Galf biosynthesis. Galf biosynthesis enzymes are well studied in bacteria, and 
inhibitors of these enzymes show potent activity against Mycobacterium. None of these 
inhibitors is yet used clinically. The enzymes involved in Galf biosynthesis in fungi are under 
investigation by many groups. 
In our lab we are studying Galf biosynthesis enzymes in a safe and experimentally 
tractable model fungus, Aspergillus nidulans, which is closely related to the pathogen species 
A. fumigatus. During my research, I characterized the biological function of Galf biosynthesis 
enzymes in A. nidulans using gene deletion strategy, and by controlling gene expression with an 
inducible promoter to compare the effects of gene repression and induction. Phenotype 
characterization of the Galf-defective strains in comparison to wild type strain used fluorescence 
microscopy, SEM, TEM, and AFM. Gene product localization used GFP tagging, and Galf 
localization used immunofluorescence microscopy. To assess whether Galf-targeting compounds 
(if and when created and validated) might be useful for combination therapy, I assessed the 
sensitivity of the Galf-defective strains to commercially available antifungal drugs.  
 
1.11. Outline and objectives 
My thesis has seven chapters in total. The first chapter is the general introduction. 
Chapters 2-6 contain 5 manuscripts which discuss biological roles of UgmA (chapter 2), UgeA 
(chapter 3), and UgtA (chapter 4). Chapter 5 describes the cell wall surface characteristics of 
Galf deletion strains. Chapter 6 discusses how changing the level of expression of ugmA alters 
antifungal drug sensitivity and morphogenesis. My roles and those of the other authors in these 
manuscripts are described on the first page of each chapter. Finally, in chapter 7, I discuss my 
research results in terms of its importance to understanding fungal growth, development and 
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pathogenicity, and whether Galf should continue to be considered as an anti-fungal drug 
development target. 
There general objectives for my research work are 
1. Exploring the biological roles of Galf biosynthesis enzymes in the model filamentous 
fungi Aspergillus nidulans  
 Hypothesis: the strains that have a defect in Galf-biosynthesis enzymes will lack Galf 
which will result in a wall defect causing impaired growth 
2. Assessing the sensitivity of Galf-defective strains to available antifungal drugs 
 Hypothesis: deletion strains will have a wall defect that will make them  more sensitive 
to wall-targeting agents 
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Table 1: Antifungal drug classes and their targets in fungal cell 
 
Class Target Examples 
Polyenes  Cell membrane ergosterol Amphotericin B 
Azoles Ergosterol biosynthesis, lanosterol demethylase  Fluconazole, 
voriconazole 
Allylamines Ergosterol biosynthesis, squalene epoxidase Terbinafine 
Morpholines Ergosterol biosynthesis, sterol C8-C7 isomerase 
and the C-14 sterol reductase 
Amorofine 
Echinocandins Cell wall, β-1, 3-glucan synthesis Caspofungin, 
micafungin 
Fluorinated 
pyrimidines 
 RNA/DNA synthesis Flucytosine 
Others Mitosis Griseofulvin 
 
 
 
 
Table 2: Typical polysaccharide composition of filamentous ascomycete cell walls. 
 
Cell wall polymer % composition 
Glucans  50-60% 
Chitin  10-20% 
Galactomannans  20-25 % 
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Figure 1. Germination and growth of wild type Aspergillus nidulans hyphae grown at 28°C (not 
to scale), from Kaminskyj SGW and Hamer JE 1998 Genetics 148: 669-680, Fig 1 (reproduced 
with author's permission).  
A conidium (a) germinates (b), and nuclei migrate into the germ tube as it grows (c). The first 
septum is deposited at the base of the germ tube when the germling has eight or more nuclei (d). 
Hyphae are tubular, ~ 3 µm in diameter, apical cells are variable in length and usually much 
longer than 40 µm. Apical cells contain many nuclei (circles) that are evenly spaced along the 
length of the cell (e). 
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Figure 2. The asexual life cycle in Aspergillus nidulans. a-c) Germination and hyphal growth in 
A. nidulans leads to the formation of a vegetative colony. d) At the onset of spore development, a 
stalk forms. e) the stalk swells at its tip to form a vesicle. The vesicle produces two layers of 
specialized cells, f) metulae, and g) phialides. In wild type A. nidulans, each metula produces a 
pair of phialides. h) The mature conidiophore produces chains of uninucleate spores. 
 
 
 
Amira El-Ganiny PhD thesis May 2011 
45 
 
 
 
 
Figure 3. Target of polyene drugs. Structures of a) ergosterol, and b) cholesterol, which are 
found in fungi and mammals, respectively. c) Polyene drugs such as amphotericin B can span a 
membrane phospholipid bilayer. d) When polyenes are associated with cell membranes, they 
bind to sterols, and form transmembrane hydrophilic pores (part d was taken from 
www.biology.ed.ac.uk). 
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Figure 4. Antifungal drugs that target ergosterol biosynthesis. Allylamines, azoles and 
morpholines inhibite ergosterol biosynthesis at different steps. allylamines targets an early step 
in ergosterol biosynthesis by inhibiting the enzyme squalene epoxidase (ERG1). Azoles bind 
C14 α -demethylase (ERG11) while morpholines inhibit to enzymes C14 sterol reductase 
(ERG24) and C8 sterol isomerase (ERG 25).  
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Figure 5. The galactofuranose (Galf) biosynthesis pathway in Aspergillus nidulans, showing the 
steps of Galf biosynthesis starting from UDP-glucose until the insertion of the Galf-containing 
glycoconjugates in the cell wall. Enzymes are colored brown and the intermediates are colored 
blue.  
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Chapter 2 
Characterization of Aspergillus nidulans UDP-galactopyranose mutase, UgmA 
This chapter studies the biological roles of the key enzyme in Galf biosynthesis pathway, 
UDP-galactopyranose mutase, UgmA. The manuscript has been published as “Aspergillus 
nidulans UDP-galactopyranose mutase, encoded by ugmA plays key roles in colony growth, 
hyphal morphogensis, and conidiation”. In Fungal Genetics and Biology Journal, 45: 1533-1542. 
El-Ganiny, Sanders and Kaminskyj, 2008. 
The objectives for the research work in this chapter were 
1) To identify A. nidulans UDP- galactopyranose mutase (AnUgmA). 
2) To determine whether UgmA is essential for viability of A. nidulans.  
3) To quantify the effect of ugmA deletion on sporulation, colony and hyphal morphogenesis. 
4) To examine the effect of ugmA deletion on Galf localization and on the cell wall 
ultrastructure. 
5) To investigate whether A. fumigatus glfA can complement the defects caused by ugmA 
deletion (homology of function). 
The starting point of this project was the identification of Aspergillus nidulans ugmA, this 
part was done by Eshwari Addala, a former Ph.D. student that was working with my 
co-supervisor Dr. David Sanders. I performed all the experiments including: designing primers 
for gene deletion, deletion of ugmA, confirming the deletion of ugmA, characterization of ugmA∆ 
strains using confocal, SEM and TEM, Immunolocalization of Galf in wild type and ugmA∆ 
strains, complementing ugmA∆ strain defects using AfglfA sequence and finally mating ugmA∆ 
strain with swoA strain. My supervisor Dr. Kaminskyj did the statistical analysis of the data and 
the editing of the final figures. I wrote the first manuscript of the paper which edited by my 
supervisor Dr. Kaminskyj prior to accepting it for publication. 
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Abstract 
 
Growing resistance to current anti-fungal drugs is spurring investigation of new targets, 
including those in fungal wall metabolism. Galactofuranose (Galf) is found in the cell walls of 
many fungi including Aspergillus fumigatus, which is currently the most prevalent opportunistic 
fungal pathogen in developed countries, and A. nidulans, a closely-related, tractable model 
system. UDP-galactopyranose mutase (UGM) converts UDP-galactopyranose into UDP-Galf 
prior to incorporation into the fungal wall. We deleted the single-copy UGM sequence 
(AN3112.4, which we call ugmA) from an A. nidulans nkuA∆ strain, creating ugmA∆. Haploid 
ugmA∆ strains were able to complete their asexual life cycle, showing that ugmA is not essential. 
However, ugmA∆ strains had compact colonial growth, which was associated with substantially 
delayed and abnormal conidiation. Compared to a wildtype morphology strain, ugmA∆ strains 
had aberrant hyphal morphology, producing wide, uneven, highly-branched hyphae, with thick, 
relatively electron-dense walls as visualized by transmission electron microscopy. These effects 
were partially remediated by growth on high osmolarity medium, or on medium containing 
10 µg/mL Calcofluor, consistent with Galf being important in cell wall structure and/or function. 
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1. Introduction 
 
In the last decades there has been an increase in the incidence of fungal infections due to 
 immunocompromising conditions such as AIDS and organ transplantation, and perhaps also to 
overuse of broad-spectrum antibiotics (Loeffler and Stevens, 2003; Garcia-Ruiz et al., 2004). 
Mortality in patients with systemic fungal infections is high even with aggressive therapy 
(Randhawa and Sharma, 2004). Aspergillus fumigatus is the most common opportunistic fungal 
pathogen in industrialized countries, due to their relatively large populations at risk (Arathoon, 
2001). Aspergillus fumigatus is common in the environment (where it contributes to recycling), 
has air-dispersed spores that are readily inhaled, and has a growth optimum near 37 ºC. 
Treatment of fungal infections is limited by problems of drug safety, effectiveness and fungal 
resistance. Polyene antifungals lack target specificity and have a high toxicity to humans; azoles 
are fungistatic, not fungicidal; echinocandins have a narrow spectrum of activity; and apart from 
polyenes, there is emerging antifungal drug resistance (Carrillo-Munoz et al., 2006; Chamilos 
and Kontoyiannis, 2005). An anti-fungal drug target should be found in a broad spectrum of 
fungal pathogens, be important for infectivity, and not be found in humans. Fungal cell wall 
components, including chitin, β1-3 glucans, and galactofuranose (Notermans et al., 1998; Leitao 
et al., 2003) are obvious drug targets (Tawara et al., 2000; Pederson and Turco, 2003, 
Schmalhorst et al., 2008).  
Genetic and biochemical studies of Galf biosynthesis in prokaryotes show that UDP-Galf 
(the five-membered ring form, Fig. 1) is formed from UDP-Galp (the six-membered ring form) 
by UDP-galactopyranose mutase (UGM) (Nassau et al., 1996, Weston et al., 1998). UDP-Galf is 
the precursor to Galf residues found in the cell walls of many microorganisms. The gene 
encoding UGM has been identified in prokaryotes (Stevenson et al., 1996; Nassau et al., 1996; 
Koplin et al., 1997; Pan et al., 2001) and its crystal structure has been solved (Sanders et al., 
2001).  
Galactofuranose (Galf) is an essential component of the bacterial cell wall (Whitfield et 
al., 1991; Nassau et al., 1996; Pan et al., 2001), and is important or essential for pathogencity of 
Leishmania major (Spath et al., 2000; Kleczka et al., 2007), which causes leishmaniasis. Beta-
linked Galf chains are the immunodominant epitope in Aspergillus spp (Bennet et al., 1984; 
Leitao et al., 2003). In A. niger, ugmA contributes to cell wall integrity (Damveld et al., 2008). In 
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A. fumigatus, the ugmA homologue glfA contributes to wildtype wall structure (Schmalhorst et 
al., 2008). Galf has been shown to be attached to linear mannan chains in the A. fumigatus cell 
wall, which are GPI-anchored to the cell membrane (Costachel et al., 2005, Schmalhorst et al., 
2008). Aspergillus fumigatus and A. nidulans hyphal walls have similar galactose content (Guest 
and Momany, 2000). The Galf monoclonal antibody EBA2 has been used for diagnosis of 
aspergillosis and to monitor therapy effectiveness (Stynen et al, 1992, Wallis et al., 2001, 
Maertens et al. 2007). 
Beverly et al. (2005) identified eukaryotic UGM genes in protozoa (L. major and 
Trypanosoma cruzi) and the fungus (Cryptococcus neoformans). Beverly et al. (2005) found that 
eukaryote UGM amino acid sequences are closely related to each other but distantly related to 
prokaryote UGMs. Aspergillus fumigatus and L. major UGM shared 51 % sequence identity, but 
were less than 20 % identical to their prokaryotic orthologues, with the region of 
identity/similarity confined to the catalytic site (Bakker et al. 2005). Eukaryote UGMs have four 
major insertions, which are thought to form loops that are important for protein regulation and 
interaction.  
BLAST analysis with default parameters using A. fumigatus UGM (Afu3g12690, named 
AfglfA by Schmalhorst et al., 2008) at www.broad.mit.edu/annotation/fungi/aspergillus/ showed 
a strong sequence alignment (98 % identity) to one locus in A. nidulans, AN3112.4, which we 
named ugmA. We are using A. nidulans as a safe and experimentally-tractable system for 
studying UGM function in vivo, in parallel with crystallization studies of A. fumigatus glfA. This 
study focuses on the effects of UgmA deletion in A. nidulans. We found that ugmA was not 
essential, but its deletion resulted in compact colonial growth, reduced sporulation, and hyphal 
morphological abnormalities, all of which can be attributed to wall defects. 
 
2. Materials and methods 
 
Biological materials and primers are given in Table 1. Chemicals were reagent grade and 
were purchased from VWR (www.vwrcanlab.ca) or Sigma (www.sigmaaldrich.com) unless 
stated otherwise. Vinoflow was purchased from Gusmer Enterprises (www.thewinelab.com). 
Water was 18 MΩ deionized, and sterilized as appropriate. Aspergillus nidulans strains were 
grown in complete media CM with nutritional supplements as required (Kaminskyj, 2001). 
Amira El-Ganiny PhD thesis May 2011 
53 
 
Statistical analysis used Statview SE+Graphics v1.02. Values are presented as mean ± standard 
error of the mean. Images were prepared with Adobe Photoshop 7.0. 
 
2.1. Gene knockout 
Aspergillus nidulans strain A1149 was used for AN3112 (ugmA) gene deletion, following 
the procedures described in Nayak et al. (2006) and Szewczyk et al. (2007), with A. fumigatus 
pyrG as the selectable marker (Fig. 2A-F). Experiments using A. fumigatus pyroA selection (not 
shown) gave comparable results. A1149 was also transformed to pyrimidine prototrophy as 
described in Yang et al. (2008), creating AAE1, a wildtype phenotype pyrG+, nkuA∆ strain used 
for phenotype comparison. Following transformation, putative ugmA∆ colonies were able to 
conidiate on selective media. These conidia were inoculated onto selective and non-selective 
media to assess whether ugmA was essential (Osmani et al., 2006). Spores were also grown on 
selective media to examine hyphal and colony morphology under different growth conditions, 
and to generate mycelium for genomic DNA extraction, as described in Yang et al. (2008). PCR 
comparing A1149 genomic DNA with that from three ugmA∆ deletion strains used the primers 
described in Fig. 2 and Table 1. 
 
2.2. Microscopical methods 
 
2.2.1. Confocal Microscopy 
Aspergillus nidulans wildtype and ugmA∆ strains were grown at 28 ºC, then samples 
were fixed and stained with Calcofluor to visualize walls and Hoechst 33258 to visualize nuclei, 
as described in Kaminskyj and Hamer (1998). Confocal imaging used a Zeiss META510 
confocal microscope with a 63 X, 1.2 N. A. multi-immersion objective, a 405 nm diode at 20 % 
power, and a 420-480 nm emission filter. Fluorescence and transmitted light images were 
collected simultaneously.  
For morphometry, hyphal width was measured at septa (50 per strain), and basal cell 
length was measured between adjacent septa (50 per strain) as previously described in 
Kaminskyj and Hamer (1998). Total hyphal length per germling was measured using Zeiss LSM 
software, by adding the lengths of all branches (30 germlings per strain). The number of tips per 
germling was counted.  
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For immunofluorescence microscopy, samples were prepared as described in Kaminskyj 
and Heath (1995). EBA2 monoclonal antibody originally raised against A. fumigatus 
galactomannan, which contains Galf (Wallis et al., 2001), was eluted from a BioRad Platelia 
ELISA kit using TBS, and concentrated with a 10 kDa Microcon centrifugal concentration 
column (Millipore). EBA2 binding was localized using FITC-conjugated goat-anti-rat IgG 
(Sigma) that had been affinity purified against lyophilized ugmA∆ mycelium as described in 
Kaminskyj and Heath. Confocal imaging used 488 nm excitation, 5–10 % power from an argon 
multispectral laser operated at 5.9 A, with emission controlled by a BP505-530 filter. 
 
2.2.2. Electron microscopy 
For scanning electron microscopy (SEM), AAE1 and ugmA∆ strains were grown on 
dialysis tubing overlying selective media for 3 d at 28 ºC. Isolated colonies were fixed at 100 % 
relative humidity over 4 % aqueous OsO4 for 2 h, frozen to -80 ºC, and lyophilized overnight. 
Samples were mounted on SEM stubs, gold sputter coated for 6 min, and examined with 
scanning electron microscope JEOL model JSM840A. The accelerating voltage was 20 kV. The 
beam current for sample examination was 1.5 nA, and for image acquisition was 50 pA. 
For transmission electron microscopy (TEM), AAE1 and ugmA∆ strains were grown on 
dialysis tubing overlying selective media (CM, CM + 1 molar sucrose, or CM + 10 µg/mL 
Calcofluor) for 16 h at 28 ºC. Samples were prepared and imaged as described in Kaminskyj 
(2000). 
 
3. Results 
 
3.1. UDP-galactopyranose mutase deletion 
To test whether ugmA was essential, we deleted the AN3112.4 coding sequence in the 
nkuAΔ strain A1149 (Fig. 2A-F). The knockout construct was generated using fusion PCR: the 
selectable marker A. fumigatus pyrG was flanked by predicted 5’ and 3’ untranslated regions for 
AN3112. The deletion cassette was transformed into A1149 protoplasts as described in Nayak et 
al. (2006) and Szewczyk et al. (2007). Transformants were selected on CM lacking pyrimidines, 
containing 1 M sucrose as osmoticum. Conidia produced by these primary transformants were 
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able to germinate and formed sporulating colonies when streaked on growth medium lacking 
exogenous pyrimidines, indicating that A. nidulans ugmA is not essential.  
Ectopic integration of the knockout construct could potentially have contributed to the 
ugmA∆ phenotype. Morphometric characterization of three randomly-chosen putative ugmA∆ 
phenotype colonies are given in Table 2. Deletion experiments using A. fumigatus pyroA as a 
selectable marker (not shown) gave comparable results regarding the phenotype of colonies 
produced by conidia from primary transformants. We interpret a high level of phenotype 
consistency at the colony and cellular level between multiple transformants from independent 
experiments, as being evidence of lack interference from ectopic integrants. Additional 
confirmatory studies are presented below.  
Genomic DNA was extracted from A1149 and ugmA∆ strains, and used as template for 
PCR to test for the presence and location of AN3112 and AfpyrG. AN3112 is predicted to be 1.9 
kb, and AfpyrG is predicted to be 0.9 kb. The 5’ and 3’ flanking regions were 1 kb and 1.1 kb 
respectively. PCR using P1 and P6 (to span AN3112 plus the 5’ and 3’ flanking regions) 
amplified a ~ 4 kb band from the A1149 parental strain, and a ~ 3 kb band with ugmAΔ strains 
(Fig 2G) consistent with replacement of AN3112 with AfpyrG. PCR using P1 and P8 (targeted to 
a flanking region and the middle of AfpyrG), produced bands of the 1.6 kb in ugmAΔ strains, and 
did not amplify a band for A1149 (Fig 2H). PCR using P21 and P23 (designed to amplify ugmA) 
gave no band with any of the ugmAΔ strains, and 1.9 kb band with A1149 (Fig. 2I). Additional 
studies re genetic segregation following mating, and complementation of the ugmA∆ defect with 
the A. fumigatus homologue are presented below. Three knockout strains, ugmA∆1, ugmA∆2, 
and ugmA∆3, gave comparable results in all studies. We designated ugmA∆1 as AAE2. 
Protoplasts were generated from A. nidulans AAE2 germlings, transformed with pET22b 
containing AfglfA (which encodes functional A. fumigatus UGM: Bakker et al., 2005), and 
incubated at 37 ºC for 3 d. The following data are presented in Supplemental figure 1. In addition 
to many ugmA∆ phenotype colonies that showed compact colony growth and limited sporulation, 
a putative ugmA∆:AfglfA colony was generated that had wildtype growth and abundant 
conidiation (arrow in Suppl. Figure Aa). We named this strain AAE3. PCR of AAE3 genomic 
DNA using primers designed to amplify AfglfA showed a band comparable in size to the pET22b 
control (Suppl Fig Ab). Light microscopy of AAE3 revealed wildtype hyphal morphology 
(Suppl. Fig Ac), morphometry (Suppl. Fig Ad), and nuclear distribution unlike AAE2 (Fig. 4A, 
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and Table 2). Young AAE3 conidiophores had abundant metulae and synchronous phialide 
development (Suppl. Fig. Ac) unlike AAE2 (Fig. 3H). 
AAE2 was mated to AOZ1 to determine whether the ugmA∆ defect segregated 
independently, and to create additional strains for future studies (Suppl. Fig. B). Independent 
assortment of the ugmA∆ phenotype following mating is evidence that the ugmA∆ knockout 
construct underwent homologous rather than ectopic integration. AAE2 mating efficiency is 
poor, matings with at least three other A. nidulans strains were not successful. Cleistothecium 
maturation was delayed (no outcrossed cleistothecia containing viable spores were isolated until 
three months), consistent with the suggestion by Adams et al. (1998) that mutations affecting 
conidiation also compromise sexual development. Both AOZ1 and AAE2 have reduced 
conidiation (Suppl. Fig. Ba). AOZ1 contains swoA1, which can be complemented by a protein 
O-mannosyl transferase (Shaw and Momany, 2002). Amongst 140 progeny from this cross were 
43 with wildtype colony growth and sporulation, and equal numbers of green- and white-spored 
strains, consistent with independent assortment of ugmA and swoA. As expected, there were also 
[ugmA∆, swoA1] progeny, with severe growth defects at permissive conditions (e. g. arrowheads 
in Suppl. Fig Ba).  
Genomic DNA was prepared from six randomly-selected progeny that showed the 
ugmA∆ phenotype under the growth conditions shown in Suppl. Figure 2a. PCR with primers 
nkuAF and nkuAR, expected to amplify an band of 1981 bp in nkuA+ strains, amplified this 
band in three of these ugmA∆ progeny, as well as in wildtype strain A28 (Suppl. Fig. Bb). This is 
evidence that ugmA segregates independently of nkuA.  
The phenotype consistency for multiple strains from independent knockout experiments 
using pyrG and pyroA as selectable markers; rescue of the ugmA∆ phenotype by AfglfA; and 
independent segregation of ugmA with nkuA and swoA is strong evidence that the AAE2 
phenotype discussed below is due to the deletion of ugmA, and that ugmA encodes A. nidulans 
UGM. 
 
3.2. Colony growth and sporulation 
To characterize the effect of ugmA∆ on colony growth, AAE1 and AAE2 strains were 
grown for 3 d on CM lacking exogenous pyrimidines. AAE1 colonies had a wildtype phenotype, 
with a broad fringe of submerged hyphae extending into the growth medium (arrows in Fig. 3A), 
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whereas AAE2 colonies had a compact colonial morphology with little penetration of the 
medium. The AAE2 colonies also had reduced sporulation: the centres of AAE1 colonies had 
strong green pigmentation (Fig. 3A) whereas AAE2 colonies were pale (Fig. 3B). After 3 d 
growth at 28 ºC, isolated AAE1 colonies were about 50 % larger in diameter than those of 
AAE2, 6.0±0.8 mm vs 4.4±0.6 mm, respectively, even without considering the submerged 
hyphae at the AAE1 colony margins (arrows in Fig. 3A). Viewed from above at 50 x, the AAE1 
colonies were sporulating abundantly at 3 d (Fig. 3C), with closely spaced conidiophores bearing 
pigmented conidia, whereas AAE2 conidiophores that produced pigmented spores were widely 
separated (e. g., arrows in Fig. 3D).  
The number of spores produced per colony was estimated for AAE1 and AAE2 strains. 
After 3 d, individual AAE1 colonies had produced an average of 1.0 ± 0.4 x 108 spores, 
compared to 2.2 ± 0.7 x 105 spores for AAE2 colonies. Thus, AAE2 had suffered a 500-fold 
reduction in sporulation compared to AAE1.  
Viability of AAE1 and AAE2 spores was determined by plating similar numbers of 
conidia (~ 250, 125, or 60 per plate) and counting the number of colonies formed after 2 d 
incubation at 28 ºC. Plates inoculated with ~ 60 spores each produced 49 AAE1 and 48 AAE2 
colonies, with comparable results for the higher inoculation densities, suggesting that spore 
viability was not compromised by ugmA∆. 
Conidiation in AAE1 and AAE2 was examined using SEM (Fig. 3E-H). By 3 d, AAE1 
produced long chains of conidia (Fig. 3E, G), whereas AAE2 colonies (Fig. 3F, H) had relatively 
few conidiophores (arrows in Fig. 3F) with at most short chains of conidia (s in Fig. 3H), despite 
abundant sterile hyphae (Fig. 3F). Often, formation of metulae and phialides in AAE2 was 
arrested or aberrant. 
 
3.3. Hyphal morphology and wall composition 
The effect of ugmA∆ on hyphal morphogenesis is shown in Fig. 4. Unlike AAE1, which 
had a wildtype phenotype (Fig. 4 inset), AAE2 strains stained with Calcofluor (Fig. 4A) had 
wide, highly branched hyphae. The AAE2 and AAE1 hyphae in Fig. 4A were stained with the 
same solution of Calcofluor and Hoechst 33258, and imaged with the same confocal settings. 
Lateral walls, but few nuclei, were visible in the AAE2 hyphae, whereas the converse was true 
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for AAE1. We interpret this as meaning the AAE2 hyphal walls were relatively thicker than 
those of AAE1.  
AAE1 and three ugmA∆ strains including AAE2 were compared by cell morphometry for 
hyphal width, basal cell length, total hyphal length per germling, and total tips per germling 
(Table 2A). Relative branching was quantified using the hyphal growth index described by 
Trinci (1974), as the total hyphal length of a germling divided by the number of tips for that 
germling. Compared to AAE1, all three ugmA∆ strains had more than two-fold lower hyphal 
growth index (Table 2A), indicating at least double the branching frequency. 
Galf can be immunolocalized with a monoclonal antibody, EBA2 (Wallis et al., 2001). 
We used EBA2 to compare Galf content and distribution in AAE1 and AAE2 strains. EBA2 
binding in AAE1 localized to mature conidia and phialides (Fig. 4B), and hyphae (Fig. 4B and 
C), but not to conidiophores and metulae (Fig. 4B and data not shown). Control AAE1 samples 
where EBA2 was omitted did not bind the FITC-conjugated secondary antibody. In contrast to 
AAE1, the spore and hyphal walls of the AAE2 strain did not bind EBA2 (Fig. 4D–G). Thus, 
AAE2 is depleted for Galf in its walls, consistent with the expected function of the ugmA gene 
product. 
Hyphal morphogenesis defects and branching abnormalities in the ugmA∆ strains in 
Table 2A suggested that ugmA deletion had impaired fungal wall formation and/or maturation. 
The growth morphology of AAE2 was assessed on CM containing sucrose and/or Calcofluor 
(Table 2B). Wildtype morphology strain A28, AAE1, and the three ugmA∆ strains for which data 
are provided in Table 2A were replica-plated on CM with or without sucrose or Calcofluor to 
assess colony phenotype at 2 d (Fig. 5A–E). Unexpectedly, the colony morphology of A28 and 
AAE1 strains differed on most media. AAE2 hyphae growing at the edges of the colonies were 
examined using transmitted light microscopy, directly on the plates to avoid damage from 
mounting on a microscope slide (Fig. 5F–O). Colonies of AAE1 and the three ugmA∆ strains 
grew differently on these media (Fig. 5A–E), consistent with Fig. 3A and B. Their hyphal 
morphologies also differed, consistent with Fig. 4A and described quantitatively in Table 2B. 
AAE1 hyphae had wildtype morphology when grown on CM (Fig. 5F), whereas AAE2 
hyphae had profuse apical branching (Fig. 5K). AAE1 hyphal morphology on CM containing 1 
M sucrose was wildtype (Fig. 5G), substantially similar to Fig. 5F, whereas AAE2 grown on 1 M 
sucrose had a partially remediated hyphal phenotype (Fig. 5L) with reduced but still apical 
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branching. AAE1 hyphae grown on CM containing 10 µg/mL Calcofluor had a beaded 
morphology (Fig. 5H), whereas AAE2 hyphae grown on this medium had a partially remediated 
hyphal phenotype (Fig. 5M), reminiscent of AAE2 growth on 1 M sucrose (Fig. 5L). Like 10 
µg/mL Calcofluor, AAE1 hyphae grown on CM containing 30 µg/mL Calcofluor had a beaded 
morphology (Fig. 5I), whereas AAE2 hyphae grown on this medium were highly branched (Fig. 
5N). AAE1 hyphae grown on 30 µg/mL Calcofluor plus 1 M sucrose had a wildtype phenotype 
(Fig. 5J). Many AAE2 hyphae had a wildtype phenotype this medium, however, bursting was 
frequent (e.g., arrow in Fig. 5O), despite being examined directly on the Petri plate, suggesting 
that their walls were fragile.  
The effect of growth on CM containing 1 M sucrose or 10 µg/mL Calcofluor on the 
ugmA∆ strains was quantified morphometrically (Table 2B). AAE1 strains were slightly affected 
by growth on these media particularly regarding hyphal extension. For the ugmA∆ strains, 
growth on amended medium significantly reduced hyphal width, and had comparable relative 
effects on growth and branching (shown as hyphal growth index). 
 
3.4. Hyphal wall ultrastructure 
Relative hyphal wall thickness was inferred for wildtype AAE1 and ugmA∆ strain AAE2 
using Calcofluor and Hoechst 33258 dual-stained samples (Fig. 4A). The same dye 
concentrations and imaging conditions were used for both strains. Lateral walls of AAE2 hyphae 
(Fig. 4A) stained brightly, but not those of AAE1 (inset). For the AAE2 hyphae, hyphal wall 
staining obscured visualization of all but a few nuclei (arrows in Fig. 4A), unlike AAE1 hyphae 
(arrows in Fig. 4A inset). For both strains, wall staining was evident at septa and in spore walls. 
We interpret this difference to mean that the lateral walls of the AAE2 hyphae are thicker than 
those of wildtype.  
Transverse TEM sections of AAE1 and AAE2 hyphae (that is, with well resolved cell 
membrane bi-layers) were used to compare hyphal diameter and wall thickness. Hyphal 
diameters imaged with TEM (Fig. 6) were consistent with Calcofluor-stained samples imaged 
with fluorescence microscopy (Fig. 4A and Table 2). Both AAE1 and AAE2 hyphae imaged by 
TEM had abundant, well-preserved cytoplasmic organelles, suggesting that the hyphae were 
likely to have been growing at the time of fixation. The AAE2 walls grown on CM (Fig. 6A–D) 
were significantly thicker than those of AAE1 (Fig. 6E and F), or of AAE2 grown on 1 M 
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sucrose (Fig. 6G and H) or 10 µg/mL Calcofluor (Fig. 6I and J). Wall thicknesses in transverse 
TEM sections are shown in Table 2. Walls of AAE2 hyphae grown on CM had distinct layering 
of moderately electrondense material, compared to walls of AAE1 hyphae grown on CM, or 
walls of AAE2 hyphae grown on 1 M sucrose or 10 µg/mL Calcofluor (Fig. 6 and Table 2). The 
AAE2 walls appeared to be similar to wildtype when grown on CM containing 1 M sucrose or 
10 µg/mL Calcofluor. 
 
4. Discussion 
 
The A. nidulans genome has a single sequence, AN3112.4, with high homology to UDP-
galactopyranose mutase identified in other systems, which we call ugmA. Replacing the ugmA 
coding sequence with AfpyrG showed that A. nidulans ugmA is not essential. The ugmA∆ strains 
grew on medium lacking pyrimidines, and could complete their asexual life cycle, producing 
viable conidia. However, ugmA∆ strains had compact colonial growth, reduced conidiation, and 
aberrant hyphal morphology and wall structure. UGM is not essential in the protozoan L. major, 
but its deletion led to attenuated virulence (Kleczka et al., 2007). Studies on prokaryotic UGM 
showed it was essential for growth and viability in bacteria (Pan et al., 2001). Similarly, A. 
fumigatus glfA is not essential, but contributes to pathogenicity when tested in 
immunosuppressed mice (Schmalhorst et al., 2008).  
Galf has been found in A. nidulans cell walls (Bennett et al., 1984), consistent with 
results of Wallis et al. (2001) who used monoclonal antibody EBA2 to immunolocalize Galf to 
conidia and conidiophores in A. niger. For strain AAE1, we had strong EBA2 localization to 
conidia and to a lesser extent to hyphae and phialides. Even with high-sensitivity confocal 
imaging settings, we had no immunofluorescent signal for AAE2 conidiophores and metulae, 
although perhaps this could be due to masking from outer wall layers. In contrast to AAE1, none 
of the AAE2 cell types bound EBA2, suggesting that they were indeed depleted for Galf. Thus, 
the presence of Galf in hyphal and conidial walls of A. nidulans appears to be due to the action of 
ugmA.  
Damveld et al. (2008) screened for cell wall mutants in A. niger, using a constitutively 
activated stress response pathway to seek genes involved in cell wall integrity. They identified 
mutants in a UGM homologue, A. niger ugmA, and showed by sequence comparison that A. 
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niger and A. nidulans ugmA were closely related. Like A. niger, A. nidulans ugmA is predicted to 
have five introns (Damveld et al., 2008). Related A. niger sequences designated ugmB were 
present in at least two other Aspergillus spp, but not in A. nidulans. The A. niger ugmB sequence 
was full length, but ugmB∆ in a wildtype or in a ugmA∆ background did not generate an 
additional phenotype (Damveld et al., 2008). Unlike ugmA, ugmB function is unknown. 
Aspergillus niger ugmA∆ strains showed increased sensitivity to Calcofluor compared to 
a wildtype strain (Damveld et al., 2008), consistent with results from Kim et al. (2008). 
Unexpectedly, the A. nidulans AAE2 hyphal phenotype was partially remediated on medium 
containing 10 µg/mL (but not 30 µg/mL) Calcofluor; this phenotype was reminiscent of growth 
on 1 M sucrose. This result is consistent with our TEM results showing that AAE2 cell wall 
thickness on CM containing 10 µg/mL Calcofluor was about a third as thick as on CM alone. 
Aspergillus nidulans mutants that are hypersensitive to growth on Calcofluor have been 
described previously (Hill et al., 2006), as has remediation on high osmolarity medium, but to 
our knowledge Calcofluor remediation has not. Damveld et al. (2008) assessed colony growth of 
A. niger ugmA mutants on medium containing 10 µg/mL Calcofluor, but did not examine them 
microscopically. Calcofluor treatment has been shown to increase chitin production in 
Saccharomyces (García-Rodriguez et al., 2000) but apparently that chitin is weaker, so the 
mechanism by which remediation occurs is unclear.  
The ugmA deletion had a dramatic effect on A. nidulans hyphal walls imaged with TEM, 
and wall thicknesses measured with TEM were consistent with relative Calcofluor staining. 
Damveld et al (2008, and references therein) suggest that wall stress may induce compensatory 
synthesis of chitin and α -glucan. A comparable effect could account for the increased wall 
thickness in our AAE2 hyphal walls and changes in Calcofluor binding. Following partial 
remediation by growing AAE2 on 1 M sucrose or 10 µg/mL Calcofluor, hyphal wall cross-
sections imaged by TEM resembled those of AAE1. Thus, at least some of the defects induced 
by deletion of A. nidulans ugmA can be remediated by treatments likely to have substantially 
different targets.  
In contrast to our TEM results showing that AAE1 walls were significantly thinner than 
those of AAE2, Schmalhorst et al. (2008) found using freeze fracture SEM that wildtype A. 
fumigatus hyphal walls were substantially thicker than those of a ∆glfA strain. The A. fumigatus 
hyphae may have been older than ours (which were 16 h), since they lacked substantial 
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cytoplasm. In addition, TEM and SEM preparation techniques differ substantially. If the ∆glfA 
wall were as diffuse as that of AAE2 hyphae, it could have collapsed during drying. Given that 
walls of the wildtype A. fumigatus (Schmalhorst et al., 2008) and A. nidulans (this study) strains 
had substantially different thickness, even though they have similar overall composition (Guest 
and Momany, 2000), it will be important in the future to compare similar aged cells with both 
techniques. 
In sum, we have shown that A. nidulans ugmA is important for wildtype growth, but is 
not essential for survival. The ugmA∆ phenotype is consistent with defects related in cell wall 
deposition and maturation. We are continuing to explore the biochemistry and ultrastructure of 
A. nidulans ugmA∆ strains. 
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Tables 
Table 1. Biological materials used in this study 
Aspergillus nidulans 
A1149 a     pyrG89; pyroA4; nkuA::argB 
AAE1 b    pyrG89:N. crassa pyr4+; pyroA4; nkuA::argB 
AAE2 (ugmAΔ) b   AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AAE3(ugmAΔ:AfglfA) b AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB; AfglfA 
AOZ1 b    swoA1; wA3, GFP-tubA 
 
Plasmids 
ARp1 c    AMA1, Neurospora crassa pyr4+, ampR 
pAO81 a     S-TAG, A. fumigatus pyrG, kanR 
pET22 d    A. fumigatus glfA, ampR 
 
Primers 5’ → 3’ b 
P1    GACTCTTGAGATTTGCTTGGGTCTC 
P2    CCTGGAGCATTCCTTGTCTG 
P3    AATTGCGACTTGGACGACATAGAAGAGAGCGAAGCTGCAG 
P4    GAGTATGCGGCAAGTCATGAAATAAAACTCTTCTGCGTGG 
P5    CTGTTTGGCCGCCTAATAGC 
P6    GTGTTTACCAAGAATATGTTCATCGA 
P8    CACATCCGACTGCACTTCC 
P21    ATGCTTAGTCTAGCTCGCAAGAC 
P23    CTGCGCCTTATTCTTAGCAAA 
AfpyrGF   ATGTCGTCCAAGTCGCAATT 
AfpyrGR   TCATGACTTGCCGCATACTC 
AfugmAF   CCCTCCAGCTCCGTCGAC 
AfugmAR   CTGGGCCTTGCTCTTGGC  
nkuAF   CCCCGTCCGTCTGCAG 
nkuAR   AACTTCGTCTCAAGTAACTCCTCCAC 
 
a  www.fgsc.net 
b  This study 
c  Shi et al., 2004 
d Bakker et al., 2005 
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Table 2. Morphometric comparison a of near-isogenic wildtype morphology (AAE1) and 
UDP-galactopyranose mutase deletion (ugmA∆) strains bc 
A. Growth on CM   AAE1   ugmA∆1  ugmA∆2  ugmA∆3 
Hyphal width (µm)   2.7±0.4 d  3.6±0.6 e  3.3±0.6 f  3.6±0.7 e 
Basal cell length (µm)  26.9±1.2 d  14.9±0.7 e  19.5±0.9 f  15.3±0.6 e 
Total colony length (µm)  252±25.7 d  317±27.3 d  378±79.5 d  348±25.0 d 
Total tips per colony   2.4±0.2 e  7.6±0.5 d  8.3±1.4 d  8.2±0.4 d 
Hyphal growth index 
(µm hypha/tip)     105      42        46         42 
Wall thickness (nm)   54.0±2.4 d   204±10.5 f      n/a       n/a 
 
B. Growth on amended CM CM + 1 M sucrose   CM+10 µg/mL calcofluor 
AAE1  AAE2   AAE1  AAE2 
Hyphal width (µm)   2.4±0.1 d   3.1±0.1 f 2.6±0.0 d  3.1±0.0 f  
Basal cell length (µm)  26.1±1.4 d  15.3±0.7 e  20.8±1.1 f  21.8±1.5 f 
Total colony length (µm)  206±13.6 e  140±10.4 f   209±31.6 e  244±20.9 d  
Total tips per colony   2.8±0.2 d  4.1±0.2 e  2.7±0.2 d  7.2±0.5 f 
Hyphal growth index 
(µm hypha/tip)       73       32      77      34 
Wall thickness (nm)      n/a   66.0±3.5 de    n/a   77.8±3.8 e 
 
a Measurements are expressed as mean ± standard error, for 50 hyphae (width and basal cell 
length), 30 colonies (total colony length and total tips per colony), and 10 transmission 
electron micrograph near-median sections. n/a, not assessed. 
b Strains were grown for 14 h at 28 ºC on dialysis tubing overlying agar-solidified medium. 
See Materials and Methods for details. AAE2 is ugmA∆1. 
c For each measurement type, values followed by different letters (d-f) are significantly different 
(P<0.05; ANOVA). Summary statistics: hyphal width (P = 0.0001; F = 54.314), basal cell 
length (P = 0.0001; F = 38.772); total colony length (P = 0.082; F = 2.299); tips per colony (P 
= 0.0001; F = 27.115). 
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Figures 
 
 
Fig. 1. Interconversion of UDP-galactopyranose (UDP-Galp) and UDP-galactofuranose 
(UDP-Galf) by UDP galactopyranose mutase. The equilibrium of this reaction is heavily in 
favour of UDP-Galp. 
Amira El-Ganiny PhD thesis May 2011 
70 
 
 
 
Fig. 2. Strategy for and results of deleting Aspergillus nidulans UDP-galactopyranose 
mutase (ugmA) to create ugmA∆ strains. (A–F) Deletion strategy. The 5’ and 3’ regions 
(5’UTR and 3’UTR, respectively) flanking AN3112 were amplified using P1 + P3 and P4 + P6, 
respectively, from strain A1149 (nkuA∆, pyrG89) genomic DNA template. Primer sequences are 
in Table 1. P3 and P4 are bridging primers between the flanking regions and the selectable 
marker. (B) The selectable marker, A. fumigatus pyrG, was amplified from plasmid AO81 with 
pyrGF and pyrGR. (C) Fusion PCR (semi-nested, with P2 + P5) using mixed template (5’UTR, 
AfpyrG, 3’UTR), with complementary ends generated the bridging primers P3 and P4, created 
(D) the linear AN3112 knockout construct with AN3112 flanking regions. (E) A1149 protoplasts 
were transformed with the knockout construct. Homologous recombination between the flanking 
regions replaced AN3112 with AfpyrG, creating ugmA∆. The flanking regions were not altered 
by the homologous recombination, so primer sites remain intact. (F) Predicted ugmA∆ genomic 
DNA. (G–I) PCR comparisons of genomic template from A1149 and ugmA∆ strains. (G) Using 
primers P1 + P6, to amplify ugmA plus flanking regions. (H) Using primers P1 + P8, to 
demonstrate that AfpyrG had integrated at the ugmA locus. (I) Using primers P21 + P23, to 
demonstrate the presence of ugmA in A1149, and its absence from the ugmA∆ strains.	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Fig. 3. Conidiation in Aspergillus nidulans wildtype AAE1 (A, C, E, and G), and 
UDP-galactopyranose mutase deletion strain AAE2 (B, D, F, and H), 3 d after inoculation. 
(A and B) Colony morphology of AAE1 and AAE2 strains. The centres of AAE1 colonies (A) 
have green conidia, whereas AAE2 colonies (B) have only faint pigmentation due to sparse 
conidiation. AAE1 colonies are surrounded by a fringe of hyphae extending into the medium 
(arrows in A) whereas these are lacking in AAE2 colonies. (C and D) A stereomicroscope 
images of the centres of colonies in A and B. Bars in C and D = 100 lm. As seen from above, an 
AAE1 colony (C) has closely packed conidial heads, whereas an AAE2 colony (D) has relatively 
few, widely separated, conidial heads that produced mature green conidia (e.g., arrows). (E–H) 
Scanning electron micrographs of AAE1 (E and G) and AAE2 colonies (F and H). Bars in E–H = 
10 µ m. AAE1 colonies (E and G) produce conidiophores (arrowheads) with conidial heads 
bearing long chains of spores, whereas AAE2 colonies had sterile aerial hyphae with sparse 
conidiation (arrows in F). (H) An AAE2 colony showing chains of spores (arrow) on one 
conidial head, whereas others have abnormal or arrested development. 
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Fig. 4. Walls of Aspergillus nidulans AAE2 (ugmA∆) and AAE1 (wildtype) strains following 
(A) Calcofluor staining at 16 h, or (B–F) Galf immunolocalization at 36 h. Bars = 10 µm. (A) 
Germlings were stained with the same solution of Hoechst 33258 for nuclei and Calcofluor for 
cell walls, and visualized with confocal microscopy. The AAE2 hyphal walls are thick, and stain 
unevenly: double-headed arrows indicate hyphal walls with considerable variability in staining 
intensity despite being nearmedian optical sections. Some AAE2 hyphal tips stained intensely 
(large arrows) while other did not, even though both types were a similar optical section. 
Wildtype morphology AAE1 hyphal walls (A, inset) stained lightly compared to septa and spore 
(s) walls. Unlike the wildtype strain, hyphal wall staining in the AAE2 strain often obscured 
visualization of nuclei (small arrows). (B–G) Paired immunofluorescence and transmitted images 
of Galf localization using the EBA2 monoclonal antibody (see Section 2). (B) In the AAE1 
strain, Galf was present in hyphal walls (arrows), in spores, and to a slight extent in phialides. No 
localization was detected on the conidiophore or metula walls. (C) Galf in hyphal walls of 
AAE1. The AAE2 conidiophores (D and E), spores (F), and hyphae (G) did not stain under the 
same preparation and imaging conditions as used for (B) and (C). 
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Fig. 5. Colony growth (A–E) and hyphal morphology for AAE1 (F–J) and ugmA∆ strains 
(K–O) after 2 d. Map to the inoculation pattern is at the bottom left. Strains were grown on 
complete medium, CM (A, F, and K); on CM + 1 M sucrose (B, G, and L); on CM + 10 µg/mL 
Calcofluor (C, H, and M); on CM + 30 µg/mL Calcofluor (D, I, and N); on CM + 1 M sucrose + 
30 µg/mL Calcofluor (E, J, and O). 
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Fig. 6. Transmission electron micrographs of Aspergillus nidulans ugmA∆ strain AAE2 (A–
D) and wildtype strain AAE1 (E–F) growing on complete medium (CM); AAE2 hyphae 
growing on CM containing 1 molar sucrose (G–H) or CM containing 10 µg/mL Calcofluor (I–J). 
Bars in A, E, G, I = 1 µm. Images in B–C, F, H, J are transverse sections that correspond to the 
boxed regions in A, E, G, I, respectively, and have been contrast-adjusted and magnified to 
highlight wall structure. Image D is a transverse section of another AAE2 hypha growing on CM 
for which a full cross section was not available. Arrows indicate the outer edge of the two 
prominent wall layers for AAE2 hyphae growing on CM (A–D), and the outer wall of hyphae in 
other samples (F, H, J). N, nucleus; M, mitochondrion. 
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Supplemental materials 
Supplemental Figure A:  Rescue of the ugmAΔ phenotype by complementation with AfglfA  
a)  AAE2 (ugmAΔ) colonies transformed with AfglfA protein 
expression plasmid pET22b. AfglfA from pET22b has been shown 
to mediate Galf-Galp conversion (Bakker et al. 2005 Biol Chem. 
386, 657-662). After 4 d growth at 37 ºC, a single putative 
ugmAΔ:AfglfA colony with wildtype green conidia (black arrow) 
amongst many ugmAΔ colonies. 
b) PCR of pET22b and of genomic DNA template extracted from 
the putative ugmAΔ:AfglfA colony shown in (a) using primers 
AfglfAF [CCCTCCAGCTCCGTCGAC] and  
AfglfAR [CTGGGCCTTGCTCTTGGC]. We believe that 
pET22b has integrated into the genome, since in six independent 
experiments we have been unable to rescue pET22b by 
transforming genomic DNA extracted from this strain into E. coli 
and selecting for ampicillin resistance. Differences in template 
concentration are consistent with the weak amplification of AfglfA from genomic DNA. 
 c)  Hyphae (left) and a typical young conidiophore (right) of the ugmAΔ:AfglfA strain, which 
were stained with Calcofluor for septa and Hoechst 33258 for nuclei, and imaged with 
confocal epifluorescence microscopy. Nuclear morphology and spacing in the hyphae (left) is 
consistent with wildtype strains. Note synchronous development of metulae (m) and phialides 
(ph). Bars = 10 µm. 
 
 
 
 
d)Morphometry of the ugmAΔ:AfglfA strain hyphae. Width: 3.0 ± 0.1 µm (n=50); basal cell 
length: 39.9 ± 2.9 µm (n=30). Compare with ugmAΔ strains (Table 2). 
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Supplemental Figure B: Following mating, ugmA segregates independently of nkuA and 
swoA. 
AAE2 (ugmΔ::AfpyrG; nkuAΔ::argB; pyroA1 and AOZ1 (swoA1ts; wA3; argB2; GFP-tubA) 
were mated as described in Kaminskyj (2001). AOZ1 was created by mating swoA1 strain AXL4 
(a gift of Michelle Momany: Shaw and Momany 2002 Fung. Genet. Biol. 37: 263-270) and 
LO1022 (a gift of Liz and Berl Oakley: Horio and Oakley 2005 Molec. Biol. Cell 16: 918-926). 
Cleistothecia from the AAE2::AOZ1 cross containing viable spores were isolated only following 
extended incubation, ~3 months.  
a) Independent inheritance of ugmAΔ and swoA1. Typical results are shown for single 
ascospore progeny from an AAE2::AOZ1 cross. 
Parental swoA1 and ugmAΔ strains and their progeny 
were grown on fully supplemented medium at 37 ºC. 
Both ugmAΔ and swoA1 have diminished sporulation at 
37 ºC, but can be distinguished by their colony 
morphologies. Wildtype vs diminished sporulation was 
seen in 43:97 progeny, which is consistent with 
independent segregation of ugmAΔ and swoA1, and 
severely defective growth of [ugmAΔ ,swoA1] double 
mutants (e. g., arrowheads). For all single ascospore colonies showing wildtype sporulation, 
green : white = 22 : 21. Together, these data are consistent with independent inheritance of 
ugmAΔ and swoA1.  
b) Independent inheritance of ugmA and nkuA in progeny from AAE2::AOZ1. Genomic 
DNA was extracted from six randomly-selected progeny with the ugmAΔ colony phenotype, and 
tested for the presence of nkuA+ using PCR and primers nkuAF [CCCCGTCCGTCTGCAG], and 
nkuAR [AACTTCGTCTCAAGTAACTCCTCCAC], which are expected to amplify a 1981 bp 
fragment. Segregation of nkuAΔ and nkuA+ 
(lanes ABC and DEF, respectively), 
independent of ugmA. The positive control 
template was A. nidulans A28 genomic DNA 
(lane G).  
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Chapter 3 
Characterization of Aspergillus nidulans UDP-glucose -4-epimerase, UgeA 
This chapter studies the biological roles of UgeA, the upstream enzyme of Galf 
biosynthesis pathway, UgeA catalyze the reaction that create the substrate of UgmA. This 
manuscript has been published as “Aspergillus nidulans UDP-glucose-4-epimerase UgeA has 
multiple roles in wall architecture, hyphal morphogenesis, and asexual development” In Fungal 
Genetics and Biology 47: 629-635. El-Ganiny, Sheoran, Sanders, and Kaminskyj, 2010. 
The objectives of the research in this chapter were 
1) To identify putative UDP-glucose/galactose 4-epimerase in A. nidulans. 
2) To determine if UgeA is essential for viability of A. nidulans.  
3) To investigate the effects of ugeA deletion and [ugeA, ugmA] double deletion on colony 
growth, hyphal morphogenesis and cell wall ultrastructure. 
4) To determine the subcellular localization of A. nidulans UgeA and UgmA 
In this chapter, I have done the following part of the research: identification of A. 
nidulans UgeA, construction and validation of ugeAΔ and [ugeAΔ, ugmAΔ] strains, 
characterization of generated strains using fluorescence microscopy, SEM and TEM, comparing 
growth of wild type, ugeAΔ, ugmAΔ and [ugeAΔ, ugmAΔ] strains on glucose and galactose 
containing media, localization of UgeA and UgmA by C-terminus tagging with GFP and finally 
cloning of UgeA into expression vector. Inder Sheoran who was working in Dr. Sanders lab 
expressed UgeA in E. coli, purified the enzyme with affinity chromatography and tested its 
enzymatic activity in vitro.  I wrote the first draft of the paper (excluding the in vitro enzymatic 
activity of UgeA). My supervisor Dr. Kaminskyj edited this draft, did the statistical analysis and 
the final processing of figures prior accepting it for publication. 
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Abstract 
 
Aspergillus nidulans UDP-glucose-4-epimerase UgeA interconverts UDP-glucose and 
UDP-galactose and participates in galactose metabolism. The sugar moiety of UDP-galactose is 
predominantly found as galactopyranose (Galp, the six-membered ring form), which is the 
substrate for UDP-galactopyranose mutase (encoded by ugmA) to generate UDP-galactofuranose 
(Galf, the five-membered ring form) that is found in fungal walls. In A. fumigatus, Galf residues 
appear to be important for virulence. The ugeAΔ strain is viable, and has defects including wide, 
slow growing, highly branched hyphae and reduced conidiation that resemble the ugmAΔ strain. 
As for the ugmAΔ strain, ugeAΔ colonies had substantially reduced sporulation but normal spore 
viability. Conidia of the ugeAΔ strain could not form colonies on galactose as a sole carbon 
source, however they produced short, multinucleate germlings suggesting they ceased to grow 
from starvation rather than galactose toxicity. UgeA purified from an expression plasmid had a 
relative molecular weight of 40.6 kDa, and showed in vitro UDP-glucose-4-epimerase activity. 
Transmission electron microscope cross-sections of ugeAΔ hyphae had wild type appearance and 
distribution of organelles. The ugeAΔ walls were twice the thickness of wild type hyphae, but 
half the thickness of ugmAΔ walls. The outer wall appearance was similar for the ugeAΔ and 
ugmAΔ strains, and both strains showed increased substrate adhesion. Localization of UgeA-GFP 
and UgmA-GFP was cytoplasmic, and was similar on glucose and galactose. Neither gene 
product had a longitudinal polarized distribution and both were excluded from some organelles. 
The roles of UgeA in A. nidulans growth and morphogenesis are consistent with the importance 
of Galf, and are related but not identical to the roles of UgmA. 
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1. Introduction 
 
Fungi and protozoa are morphologically simple eukaryotes that are becoming 
increasingly important human pathogens. In 1939, Aspergillus fumigatus infections were 
considered to be ‘so rare as to be of little practical importance’ (reviewed in Latgé and Steinbach 
2009), whereas now A. fumigatus is considered to be a predominant opportunistic and also a 
primary human fungal pathogen (Fedorova et al. 2008).  Diseases caused by fungi and protozoa 
are often therapeutically intractable due to their underlying metabolic similarities with animal 
systems, and systemic fungal infections have high mortality even with aggressive treatment. 
There are relatively few antifungal drugs, most targeting ergosterol and its biosynthetic pathway 
(amphotericin B, azoles, allylamines) or more recently against fungal cell walls (echinocandins), 
but many of these are losing effectiveness due emerging fungal resistance (Cowen 2008). 
About 20 % of fungal genome function relates to cell wall formation and maintenance 
(Lesage and Bussey 2006). The fungal cell wall comprises about 20 % of its biomass, and 
mediates interactions between the fungal organism and its environment, which is the host in the 
case of pathogenic species (Klis et al. 2007). Wall function is generally resilient to deletion of 
individual genes (de Groot et al. 2009) and to chemical stressors that trigger compensatory cell 
wall stress response pathways (Damveld et al. 2008). Fungal walls are remodeled during growth 
in culture (Momany et al. 2004) and in response to their environment (Gastebois et al. 2009, 
Hurtado-Guerrero et al. 2009). As with other human fungal pathogens, A. fumigatus forms 
biofilms in host tissue (Seidler et al. 2008, Loussert et al. 2009) that are more drug resistant than 
planktonic cultures (Seidler et al. 2008). Since fungal extracellular carbohydrates are not found 
in animal systems (Beverly et al. 2005), they and their biosynthetic pathways are drug 
development targets (Pederson and Turco 2003). 
Galf (the five-membered ring form of galactose) residues are found in the walls and 
extracellular carbohydrate sheaths of bacteria, protists, fungi, and plants, but not in animals 
(Beverly et al. 2005). The chemistry of Galf-containing polysaccharides is reviewed in Richards 
and Lowary (2009). As summarized in Fig. 1, UDP-Galf is formed from UDP-galactopyranose 
(UDP-Galp, the six-membered ring form) by UDP-galactopyranose mutase (UGM) (Beverly et 
al. 2005) prior to incorporation in the extracellular carbohydrate-containing compounds. Galf is 
essential in prokaryotes (Nassau et al. 1996, Sanders et al. 2001, Beverly et al. 2005) and some 
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protozoans (Roper et al. 2005, MacRae et al. 2006) but generally not so in fungi. Nevertheless, 
Galf is important for wild type fungal growth, cell morphogenesis, wall architecture, and 
conidiation (Wallis et al. 2001, Damveld et al. 2008, El-Ganiny et al. 2008, Lamarre et al. 2009). 
Furthermore, Galf is important for pathogenesis in fungi (Bar-Peled et al. 2004, Perfect 2005, 
Moyrand et al. 2007, Schmalhorst et al. 2008, Lamarre et al. 2009), and in protozoan parasites 
(Spath et al. 2000, Roper et al. 2005, MacRae et al. 2006). 
The wall carbohydrate composition and architecture of A. fumigatus is the focus of 
intensive study, and was recently reviewed (Rementeria et al. 2005, Gastebois et al. 2009, Latgé 
and Steinbach 2009). Aspergillus nidulans and A. fumigatus cell walls have similar but not 
identical carbohydrate composition (Guest and Momany 2000). Although Galf is not essential in 
Aspergillus (Damveld et al. 2008, El-Ganiny et al. 2008, Schmalhorst et al. 2008), it clearly has 
important roles in wild type growth and pathogenesis, and is a potential drug target for 
combination therapy. For example, deletion of A. nidulans ugmA (UDP-galactopyranose 
mutase), which is required for Galf synthesis and so for wild type wall formation, causes 
compact colonial growth, abnormal hyphal wall structure and reduced conidiation (El-Ganiny et 
al. 2008).  
In species ranging from Escherichia coli to human, UDP-glucose-4-epimerase (UGE, 
also called UDP-galactose-4-epimerase) catalyzes the inter-conversion of UDP-glucose and 
UDP-galactose (Fig. 1) (Allard et al. 2001, Holden et al. 2003). In various systems UGE is 
encoded by genes named UGE, GalE, GAL10. In Saccharomyces cerevisiae, galactose 
metabolism (Leloir pathway) enzymes are encoded by GAL1 (galactokinase), GAL7 (galactose-
1-phosphate uridylyltransferase), and GAL10 (combined mutarotase and UDP-glucose/galactose-
4-epimerase) (Douglas and Hawthorne 1964). The ScGAL10 epimerase function is essential for 
survival in the presence of traces of galactose, even if an alternate carbon source such as glycerol 
is available (Ross et al. 2004). 
Some eukaryotes depend on UGE function for growth. Trypanosoma cruzi UGE 
(encoded by TcGALE) is the only source of galactose for its surface galactomannan synthesis, 
since its sole hexose transporter is unable to transport galactose (MacRae et al. 2006). TcGALE 
appears to be essential for T. cruzi survival in culture (MacRae et al. 2006). Aspergillus nidulans 
has 17 putative hexose transporters that are not yet fully characterized (Wei et al. 2004) and 
complex primary carbon metabolism (Flipphi et al. 2009). Nevertheless, deleting UDP-
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galactopyranose mutase resulted in impaired cell growth, wild type morphogenesis, and 
sporulation (El-Ganiny et al. 2008). Thus A. nidulans galactose metabolism pathway appears to 
be a chink in its metabolic armour 
Aspergillus nidulans ugeA (AN4727) encodes a UDP-glucose-4-epimerase. We present 
preliminary characterization of A. nidulans ugeA through analysis of the ugeAΔ deletion strain. 
Strains with single and double deletions of ugeA and ugmA produced phenotypically similar 
colonies. As expected, the ugeA∆ strain could not produce colonies on galactose as a sole carbon 
source, consistent with in vitro epimerase function of expressed UgeA.  
 
2. Materials and methods 
 
2.1 Strains and culture condition 
Strains and plasmids are listed in Table 1, and primers in Supplemental Table A. 
Aspergillus nidulans strains were grown as described in El-Ganiny et al. (2008). DNA 
manipulations and transformations followed procedures in Osmani et al. (2006) and Szewczyk et 
al. (2007).  
 
2.2 Strain construction 
Strain construction followed procedures described in El-Ganiny et al. (2008) based on 
Osmani et al. (2006) and Szewczyk et al. (2007). AN4727 (ugeA) was deleted from A. nidulans 
nkuAΔ strain A1147 using AfpyrG as a selectable marker (amplified from pAO18) to generate 
AAE4, and also from strain A1149 using the same marker to generate AAE5. Deletion of 
AN3112 (ugmA) from AAE5 used AfpyroA as a selectable marker (amplified from pTN1) to 
generate the [ugeAΔ, ugmAΔ] double deletion strain, AAE8. GFP-tagging constructs were 
amplified from pFNO3. Deletions and tagging were confirmed by PCR or gDNA template as 
shown in Supplemental Fig. A. 
For long-term protoplast storage (Ken Bruno, personal communication), freshly made 
protoplasts were resuspended in STC buffer (1 M sorbitol, 50 mM Tris pH8, 50 mM CaCl2) and 
adjusted to a concentration of at least 1.2 x 107/mL. The protoplast-STC suspension was mixed 
with a solution of 40 % (w/v) PEG4000, at 1:4 (v/v) PEG:protoplast-STC. DMSO was added to a 
final concentration of 7 %. Aliquots of 200-300 µL protoplast-STC-DMSO suspension were 
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frozen to -80 °C. For transformation, the protoplast suspension was thawed on wet ice, mixed 
with DNA, and incubated for 20 min on wet ice. This was mixed with 1 mL of 40 % (w/v) 
PEG4000, incubated at room temperature for 20 min, then spread on selective medium containing 
1 M sucrose. 
 
2.3 Microscopy, cell morphometry, and sporulation 
Cell morphometry was characterized by fluorescence microscopy as described in El-
Ganiny et al. (2008). Briefly, spores were germinated on dialysis tubing overlying CM agar or on 
coverslips, grown for 16 h, fixed in formalin, stained with Hoechst 33258, and examined using 
confocal laser fluorescence microscopy (CLSM) using a Zeiss META 510. Spore production and 
viability were determined as described previously (El-Ganiny et al. 2008). Hyphal widths and 
basal cell lengths were measured for 50 cells per strain. UgeA and UgmA were localized in 
growing hyphae of C-terminal GFP-tagged strains (Table 1).  
SEM and TEM procedures were described previously (El-Ganiny et al. 2008). Hyphal 
wall thickness was measured on cross-sections of ten hyphae per strain where the cell membrane 
lipid bilayer was clearly resolved. 
 
2.4 cDNA, recombinant UgeA production and activity 
RNA was extracted using a Qiagen RNeasy kit, following manufacturer’s instructions. 
Genomic DNA contamination was cleaned with DNaseI (Fermentas). cDNA was generated 
using an oligo-dt primer and RevertAid TM M-MulVRT (Fermentas) following manufacturer’s 
instructions, and ligated into pCR4-TOPO. Constructs were confirmed by DNA sequencing at 
Plant Biotechnology Institute (PBI), NRC Saskatoon. The ugeA cDNA was subcloned into the 
pEHISTEV vector (Liu and Naismith, 2009) after PCR amplification with ugeAF and ugeAR 
primers that contained Nco1 and BamH1 restriction sites, and Nco1 and BamH1 digestion. The 
resultant plasmid was confirmed by DNA sequencing, then pHISTEV-UgeA was transfected into 
BL21-gold (DE3) (Novagen) expression cells. These were grown in LB-media with kanamycin 
at 37 ºC to OD 0.5, transferred to 15 ºC, then induced with 0.2 mM IPTG to express the 
recombinant protein. The His6-UgeA was purified from cell lysate of induced cultures using 
Ni2+-NTA affinity chromatography. Epimerase activity of the purified protein was assayed 
spectrophotometerically as described in Rosti et al. (2007) as conversion of UDP-galactose to 
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UDP-glucose, and confirmed with HPLC (Waters) using CarboPac PA1 (Dionex Inc). 
UDP-galactose and UDP-glucose and standards had retention times of 30.5 and 33.3 minutes 
respectively, when eluted with 0.2 M ammonium acetate buffer (pH 7.85).   
 
3. Results 
 
3.1 Aspergillus nidulans UDP-glucose/galactose-4-epimerase ugeA  
The A. nidulans predicted amino acid sequence at the Broad Institute website was 
Aspergillus nidulans ANID4727.1 has 51 % homology to GalE, and was named UgeA. Amino 
acid identity with characterized fungal UGEs is shown in Table 2. UgeA is predicted to be 372 
amino acids long, with a molecular weight of 40.6 kDa. The ugeA coding sequence was 
predicted to have four exons and three introns. This was confirmed by isolating and sequencing 
ugeA cDNA. The ugeA deletion strain was constructed and shown to be viable (Fig. 2A), but its 
hyphae was morphologically different from wild type (Fig. 2B) .The [ugeAΔ, ugmAΔ] double 
deletion strain was also viable (Fig. 2C). Confirmation of the ugeAΔ deletions used PCR of 
gDNA from these strains as described previously (El-Ganiny et al. 2008) and shown in 
Supplemental data Fig. A.   
 
3.2 Characterization of the Aspergillus nidulans ugeA∆ and [ugeA∆, ugmA∆] strains 
Strains were grown for 16 h at 28 °C, then fixed, stained with Hoechst 33258 to visualize 
nuclei (and lightly contrast cell walls), and examined with CLSM (Fig. 2). The ugeAΔ and 
[ugeAΔ, ugmAΔ] hyphae resembled those of the ugmAΔ strain (El-Ganiny et al. 2008): wide and 
highly branched, with short basal cells and abundant nuclei (Table 3). 
The ugeAΔ and [ugeAΔ, ugmAΔ] strains were streaked for single colonies, and grown for 
3 d at 28 °C until they produced pigmented conidia. Isolated colonies were assessed for 
conidium production as described in El-Ganiny et al. (2008). The ugeAΔ and [ugeAΔ, ugmAΔ] 
strains had substantially reduced sporulation (Table 3), comparable to the ugmAΔ strain. Spore 
viability was not affected by deleting either or both of ugeA and ugmA.  
Scanning electron microscopy (SEM) of 3 d-old ugeAΔ colonies showed abundant aerial 
mycelium but few conidiophores (Suppl. data Fig. Ba arrows and box). The ugeAΔ strain 
conidiophores were morphologically aberrant (Suppl. data Fig. Bb). Conidium production by the 
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ugeAΔ strain was scant, consistent with conidiation rates shown in Table 3. 
Transmission electron micrographs of cross-sectioned hyphae from 2 d-old colonies of 
wild type, ugeAΔ and ugmAΔ strains are shown in Supp. data Fig. Ca. The ugeA∆ hyphal walls 
were mostly electron-transparent and about twice as thick as wild type walls (Suppl. data Fig. 
Cb, Table 3). The ugmA∆ walls did not have a discrete electron-transparent inner layer (Suppl. 
data Fig. Cc). UgeA and UgmA appear to have different functions in hyphal wall formation. 
 
3.3 Localization of UgeA and UgmA using GFP tagging.  
Strains with UgeA-GFP and UgmA-GFP under the control of their wild type promoter 
were examined with confocal fluorescence microscopy. UgeA-GFP and UgmA-GFP strains were 
morphologically wild type. Both the UgeA-GFP and UgmA-GFP fluorescence patterns were 
cytoplasmic, and both lacked a pronounced longitudinal gradient of abundance (Fig. 3). 
Subcellular localization of UgeA-GFP and UgmA-GFP was similar when the strains were grown 
on glucose and galactose (UgeA-GFP Fig. 3b, cf Fig. 3A, B; UgmA-GFP Fig. 3c1, cf Fig. 3C). 
In addition, a UgmA-RFP strain that had the ugmAΔ morphology presumably due to impaired 
UgmA function also had a non-polarized cytoplasmic distribution (Fig. 3c2). 
 
3.4 Growth of ugeAΔ and ugmAΔ strains on glucose and galactose as sole carbon sources 
Wild type, ugeAΔ, and ugmAΔ, and double-deletion strains were grown on minimal 
medium containing 1 % glucose or 1 % galactose as sole carbon sources. All strains grew on 
glucose (Fig. 4A), and all grew faster at 37 °C (not shown). Wild type hyphal and colony 
morphology was not substantially reduced by growth on galactose, although colony growth was 
sparser and sporulation was somewhat delayed. The ugmAΔ hyphal morphogenesis defect was 
partly remediated on 1 % galactose. The ugeAΔ spores produced germ tubes that contained at 
least four nuclei (not shown) but they were unable to form colonies. The [ugeAΔ, ugmAΔ] spores 
produced cylindrical and sparsely branched germ tubes that did not form colonies (Fig. 4A). 
Hyphal morphogenesis defects can frequently be remediated by growth on high 
osmolarity medium, which we also had shown for 10 µg/mL Calcofluor. Wild type, ugeAΔ, and 
ugmAΔ, and double-deletion strains were grown on minimal medium containing 1 % glucose 
amended with 1 M sucrose, or with 10 µg/mL or 30 µg/mL Calcofluor. Colonies and hyphae 
grown on these media are shown in Supplemental Fig. D and E, respectively. The 1 M sucrose 
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partly remediated the hyphal morphology but not the colony growth phenotypes of the single and 
double deletion strains. Growth and hyphal phenotypes of the single and double deletions strains 
were partly remediated on 10 µg/mL Calcofluor, but not on 30 µg/mL Calcofluor.   
In wild type A. nidulans, Galf localizes to conidial and hyphal walls (El-Ganiny et al. 
2008). As with the ugmAΔ strain described in El-Ganiny et al. (2008), we were unable to 
immunolocalize Galf in ugeAΔ strain hyphae or spores (not shown). This is consistent with the 
demonstrated function of UgeA, shown below (Fig. 4B-D). 
 
3.5 In vitro enzymatic activity of UgeA 
UgeA was expressed with an N-terminal His6 tag, and purified using Ni2+-NTA affinity 
chromatography. SDS-PAGE electrophoresis on a 10 % polyacrylamide gel showed that purified 
UgeA had an approximate molecular weight of 40.6 kDa (not shown) consistent with the 
expected translation product. UgeA was able to convert UDP-galactose to UDP-glucose in vitro¸ 
and vice versa, as tested with coupled reactions. Enzyme activity was linearly related to the 
amount of UgeA in the reaction mix (not shown). Using either UDP-galactose (Fig. 4B) or 
UDP-glucose (Fig. 4C) as substrates for UgeA resulted in two peaks in a 75:25 mixture of 
UDP-glucose:UDP-galactose (Fig. 4D). The data in Fig. 4D show the HPLC result with 
UDP-galactose as substrate. Similar results are seen with UDP-glucose as substrate (not shown). 
  
4. Discussion 
 
4.1 Aspergillus nidulans ugeA encodes a UDP-glucose-4-epimerase.  
The A nidulans UgeA sequence was identified by its homology to human GalE (Daude et 
al. 1995). Galactose metabolism is mediated by enzymes in the Leloir pathway (Holden et al. 
2003). These include galactose mutarotase (also called galactose-1-epimerase), galactokinase, 
galactose-1-phosphate uridylyltransferase, and UDP-glucose-4-epimerase. In fungi like 
Saccharomyces cerevisiae and Candida albicans, the UDP-glucose-4-epimerase and mutarotase 
functions are both encoded by GAL10, which has two domains (Ross et al. 2004, Singh et al. 
2007). Other eukaryotes including fungi like Aspergillus have separate mutarotase- and 
epimerase-coding genes. Aspergillus nidulans UgeA was predicted to be a 
UDP-glucose-4-epimerase by sequence comparison. The A. nidulans ugeA sequence has similar 
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exon organization to that of the predicted A. fumigatus sequence afu5g10780, with which it 
shares 93 % sequence identity. The phenotype of the ugeAΔ strain is closely related to that of the 
ugmAΔ strain (El-Ganiny et al. 2008), suggesting that UgeA is the source of the UDP-Galp that 
ultimately generates wall Galf residues needed for wild type A. nidulans growth and 
development. 
Hydropathy analysis of C. neoformans UGE1 and UGE2 (Moyrand et al. 2008) suggested 
these proteins each have a single membrane-spanning domain near their N-terminal. 
CnUGE1-RFP and CnUGE2-GFP distribution were associated with the cell membrane at 37 ºC, 
but only CnUGE2-GFP was cell membrane-associated at 25 ºC (Moyrand et al. 2008). 
Hydropathy analysis of A. nidulans UgeA shows that it lacks a predicted membrane-spanning 
domain. The cellular distribution of UgeA-GFP was cytoplasmic, like that of UgmA-GFP, and 
consistent with our expectation of their metabolic function. The lack of a longitudinal abundance 
gradient for UgeA-GFP and UgmA-GFP is consistent with the length of hypha required to 
support growth of the tip, and with relatively long-distance intracellular transport of 
wall-building components. 
The UgeA-GFP and UgmA-GFP distributions were similar when wild type morphology 
tagged strains were grown on glucose and galactose. Also, a UgmA-RFP strain that appeared to 
have impaired UgmA function since grew with the ugmAΔ hyphal phenotype had a 
non-polarized cytoplasmic distribution, and was excluded from nuclei. Thus, localization of 
these gene products did not appear to be affected by nutrition or hyphal morphogenesis. 
 
4.2 Galactose à  glucose conversion in Aspergillus nidulans uses UgeA.  
Wild type A. nidulans strains can grow on galactose as a sole carbon source. Aspergillus 
nidulans has 17 putative hexose transporters (Wei et al. 2004) and a primary carbon metabolism 
that permits nutritional flexibility (Flipphia et al. 2009). However, the ugeAΔ strain did not form 
colonies when grown on galactose. Galactose was toxic to an S. cerevisiae GAL10Δ (epimerase-
mutarotase) strain (Mehta et al. 1999). Although A. nidulans ugeAΔ spores were unable to form 
colonies when grown on galactose, they produced multinucleate germlings so they were 
probably exhausting their endogenous reserves, rather than succumbing to toxicity. A. nidulans 
appears to lack the ability to import nutritionally significant amounts of galactose from its 
surroundings, so UgeA is likely the source for glucose to support metabolism during growth on 
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galactose. Consistent with these results, we have shown that expressed UgeA interconverts UDP-
galactose and UDP-glucose in vitro, with an equilibrium in favour of UDP-glucose.  
 
4.3 The phenotype of ugeAΔ and [ugeAΔ, ugmAΔ] strains.  
The ugeAΔ strain cell morphometry, hyphal branching pattern, and sporulation resembled 
that of ugmAΔ strains described previously (El-Ganiny et al. 2008). The colony growth and 
hyphal morphogenesis defects of the single and double deletion strains were partially remediated 
by high osmolarity and by low levels of Calcofluor, consistent with results shown previously for 
the ugmAΔ strain (El-Ganiny et al. 2008). Cytoplasmic UDP-Galp is needed to produce 
UDP-Galf for the A. nidulans hyphal wall. In solution, Galp and Galf are naturally in equilibrium 
(95:5) so growing the ugmAΔ strain on galactose would have provided low-abundance Galf, 
which could account for the partial remediation.  
The organelle appearance and distribution in TEM cross-sections of ugeAΔ and ugmAΔ 
hyphae resembled wild type strains. The ugeAΔ hyphal walls were more than twice as thick as 
wild type strains, consistent with hyphal morphogenesis and wall defects in another A. nidulans 
mutant (Kaminskyj and Boire 2004). Compared to ugeAΔ strain, the ugmAΔ hyphae had a 
relatively poorly consolidated and more electron dense inner wall layer. Both deletion strains had 
a loose fibrillar outer wall layer, suggesting that A. nidulans Galf is required for normal wall 
surface construction. Differences in the wall architecture of ugeAΔ and ugmAΔ strains, despite 
related functions of UgeA and UgmA, and similar colony phenotypes for the ugeAΔ and ugmAΔ 
strains, is consistent with the complexity of fungal cell wall formation. Lamarre et al. (2009) 
showed that some of the Galf in the outer layer of the A. fumigatus wall is in the 
galactomannanan, and that AfUGM1Δ strains have exposed mannose on their cell wall surface 
that contributes to a morphologically altered and more adhesive wall surface. Consistent with 
this, A. nidulans ugmAΔ and ugeAΔ hyphae adhered more firmly to glass coverslips than do 
wild type strains. The electron dense material on the surface of ugeAΔ walls seen with TEM may 
be material that adhered during liquid shake culture. Taken together, Galf residues appear to have 
roles in multiple aspects of A. nidulans hyphal wall structure and function, consistent with a 
large body of work on A. fumigatus (reviewed in Latgé 2009). 
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4.4 The Galf synthesis pathway is expected to be therapeutically useful target.   
We have shown that galactose metabolism mediated by UgeA and UgmA, which is 
required for deposition of Galf residues in the wall, is not essential in A. nidulans. However, 
deleting ugmA or ugeA seriously perturbs cell growth and sporulation, reducing fitness of these 
strains. With the exception of polyenes that effectively target ergosterol in fungal cell 
membranes but have substantial human toxicity, antifungal drugs that target single aspects of 
fungal metabolism have proven repeatedly to lack durability (Cowen 2008). Inhibitors that target 
Galf synthesis are expected to be therapeutically useful in combination with established 
antifungals.  
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Tables 
Table 1: Strains and plasmids used in this study 
Aspergillus nidulans   
A1147 a pyrG89; argB2; pabaB22; nkuA::argB; riboB2  
A1149 a pyrG89; pyroA4; nkuA::argB  
AAE1 b pyrG89::Ncpyr4+ ; pyroA4; nkuA::argB  
AAE2 (ugmAΔ) b AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB  
AAE4 (ugeAΔ) c AN4727::AfpyrG; pyrG89; argB2; pabaB22; nkuA::argB; riboB2 
AAE5 (ugeAΔ) c AN4727::AfpyrG; pyroA4, nkuA::argB; 
AAE6 (ugmA-GFP) c AN3112-GA5-GFP + Af pyrG; pyrG89; pyroA4; nkuA::argB  
AAE7 (ugeA-GFP) c AN4727-GA5-GFP + Af pyrG; pyrG89; pyroA4; nkuA::argB  
AAE8 (ugeAΔ, ugmAΔ) c AN4727::AfpyrG; AN3112::AfpyroA;  pyrG89; pyroA4; nkuA::argB  
Escherichia coli d BL21-gold (DE3)  
Plasmids 
pAO18 a S-TAG, AfpyrG, KanR  
pCR4-TOPOe KanR, ampR 
pFNO3 a GA5-GFP + Af pyrG, KanR  
pTN1 a AfpyroA, AmpR  
pHISTEV f modified pET30a, KanR 
 
a  Fungal Genetics Stock Center www.fgsc.net 
b  El-Ganiny et al. (2008) 
c  This study 
d Novagen 
e Invitrogen 
f Liu and Naismith (2009) 
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Table 2: Percent amino acid sequence identity of Aspergillus nidulans UgeA with selected 
fungal UDP-glucose-4-epimerases, and with the human and A. fumigatus sequences used in 
ugeA identification. 
 
Organism  Gene name UGEAp amino acid identity   
Aspergillus fumigatus  afu5g10780  93  
Candida albicans  Gal10  57 
Cryptococcus neoformans  UGE1   47   
C. neoformans UGE2  45   
Homo sapiens  GalE  51  
Kluyveromyces lactis  Gal10  55  
Pichia stipitis  GALK  61  
Saccharomyces cerevisiae  GAL10   57  
Schizosaccharomyces pombe  uge1  58  
S. pombe gal10  58  
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Table 3: Cell characteristics of ugeAΔ, ugmAΔ, and [ugeAΔ, ugmAΔ] and related strains a 
 
 Hyphal width  Basal cell Nuclei/ Wall thickness Conidia  
 (µm) length (µm) basal cell  (nm)  / colony % 
wildtype b 2.4 ± 0.0 e 26 ± 1 e 4.2 ± 1.1 e   54 ±  2 e   100  
ugeAΔ c 3.6 ± 0.1 f 14 ± 1 f 3.2 ± 1.2 f 123 ±  4 f       4  
ugmAΔ d 3.1 ± 0.1 f 15 ± 1 f 3.6 ± 1.0 f 204 ± 10 g        2  
ugeAΔ, ugmAΔ c 3.2 ± 0.4 f 16 ± 5 f 3.5 ± 1.1 f     -- h            1 
 
a  In any one column, values followed by different letters (e-g) are significantly different 
(ANOVA, P < 0.05) 
b  AAE1 is near isogenic wild type to the transformant parent strain (El-Ganiny et al, 2008). 
c  This study 
d AAE1 and ugmAΔ morphometry was originally presented in (El-Ganiny et al. 2008) 
h  Not quantified 
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Figures 
 
 
Fig. 1.  UDP-galactofuranose synthesis in Aspergillus nidulans.  
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Fig. 2. Phenotype of (A) ugeAΔ, (B) wild type and (C) [ugeAΔ, ugmAΔ] germlings grown on 
1 % glucose and stained with Hoechst 33258. Arrowhead in B indicates the end of the hyphal tip. 
Bar in B = 10 µm for all parts.   
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Fig. 3. UgeA (A, B) and UgmA (C) localization patterns on glucose and galactose. 
UgeA-GFP and UgmA-GFP were localized by confocal fluorescence microscopy in wild type 
phenotype hyphae. Both proteins were cytoplasmic, lacked pronounced longitudinal polarization, 
and had comparable localization patterns when grown on glucose (A–C) or galactose (insets b 
and c1). Areas of lower fluorescence intensity are indicated by small and large arrowheads and 
arrows. In contrast to the UgmAGFP strain, which had wild type hyphae, a UgmA-RFP strain 
had ugmAD phenotype hyphae (inset c2), suggesting that UgmA function had been 
compromised, however this did not noticeably affect protein distribution. Bar in C = 5 lm, for all 
parts. 
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Fig. 4. Aspergillus nidulans UgeA converts UDP-galactose → UDP-glucose. (A) Growth of A. 
nidulans wild type, ugmAΔ, ugeAΔ, and double-deletion strains on minimal medium containing 
1% glucose or 1% galactose, and micrographs of these strains grown on 1% galactose. Bar = 100 
µm for all micrographs. When germinated on galactose, the wild type hyphal morphology was 
unaffected although colony growth and sporulation was sparse; the ugmAΔ hyphal phenotype 
was partly remediated; the ugeAΔ strain produced wild type germlings but failed to form 
colonies; the [ugmAΔ, ugeAΔ] strain produced short wild type germlings (arrowheads). (B–D) 
UgeA converts UDP-galactose to UDP-glucose in vitro. B) UDP-galactose standard (peak 1, at 
30.5 min). C) UDP-glucose standard (peak 2, at 33.3 min). (D) A 10 min incubation of UDP-
galactose with UgeA gives an mixture of UDP-galactose:UDP-glucose = 25:75. Comparable 
results (not shown) are seen when incubating UDP-glucose with UgmA for 10 min. 
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Supplementary materials 
Supplementary table A: Primers used in this study 
Primer name sequence 5’ à  3’                                                                    use                                 
P1 AfpyrGF ATGTCGTCCAAGTCGCAATT ugeA deletion 
P2 AfpyrGR         TCATGACTTGCCGCATACTC                             ugeA deletion 
P8 MidpyrGR CACATCCGACTGCACTTCC                                                               Confirmatory PCR 
P9 AFpyroAF          ATGGCTTCCAACGGTACCA                                                               ugmA deletion 
P10 AFpyroAR        TTACCATCCTCTCTTGGCCA                                                             ugmA deletion  
P16 MidpyroAR       TCAACAACATCTCCGGTACC                                                          Confirmatory PCR 
P21 ugmAF ATGCTTAGTCTAGCTCGCAAGAC UgmA-GFP 
P23 ugmAR GCCTGCACCAGCTCCCTGCGCCTTATTCTTAGCAAA UgmA-GFP 
P24 DugmAF AGTATGCGGCAAGTCATGAAATAAAACTCTTCTGCGTGGATG UgmA-GFP 
P26 DugmAR GTGTTTACCAAGAATATGTTCATCGA UgmA-GFP 
P22 TugmAFuF ATATCCTACAAGGCAGGATGACC UgmA-GFP 
P25 TugmAFuR TGATCGTCCATCCCATACTTG UgmA-GFP 
P27 5GA-GFPF       GGAGCTGGTGCAGGC                                                          UgmA-GFP & UgeA-GFP  
P28 5GA-GFPR TCATGACTTGCCGCATACT                                                  UmgA-GFP & UgeA-GFP 
P41 upugeAF           CTCCTATGGTATGTCTCTTCCAACTT                                                 ugeA deletion                     
P43 upugeAR          AATTGCGACTTGGACGACATGGTGAATGTGAATTGAATGCAG      ugeA deletion 
P44 dugeAF            GAGTATGCGGCAAGTCATGAATGGAAATCTTGAATGGATT   ugeA deletion & tagging 
P46 DugeAR AACTCGACTTTTCGCAGCTC                                                          ugeA deletion & tagging 
P42 FugeAdF         TCCTAACTTTTGTTACTTTAGGCCC                                                ugeA deletion 
P45 FugeAdR         GGGTACAAAACCGCTACGC                                                             ugeA deletion                                             
P47 ugeAF ATGCCTTCTGGATCTGTCCT UgeA-GFP 
P95 TugeAFusF CAACACCAATAATTATTGACCCTTC UgeA-GFP 
P96 TugeAFusR ACCGCTACGCACTCAAGC UgeA-GFP 
P104 ugeAR GCCTGCACCAGCTCCTTTCTTGAGCTGTTCCAGC UgeA-GFP 
ugeAF (NcoI) CGCATGCCATGGGAATGCCTTCTGGATCTGTCCTTG ugeA cloning 
ugeAR (BamH1) GCGCGCGGATCCTTATTTCTTGAGCTGTTCCAGC ugeA cloning 
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 Supplementary Fig. A: Confirmation PCRs. The ugeAΔ strain was confirmed using wild type 
A1149 gDNA and ugeAΔ gDNA templates. These were amplified with P41 and P8 (ugeA 
upstream and midpyrG selectable marker), P41 and P46 (ugeA upstream and ugeA downstream), 
P47 and P48 (which amplify ugeA). The UgeA-GFP strain was confirmed using wild type A1149 
gDNA and UgeA-GFP gDNA templates, amplified with P41 and P8 (ugeA upstream and 
midpyrG selectable marker). The UgmA-GFP strain was confirmed using wild type A1149 
gDNA and UgmA-GFP gDNA templates, amplified with P21 and P8 (ugmA upstream and 
midpyrG selectable marker). 
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Supplementary Fig. B. Scanning electron micrographs of a 3 d old colony (a) and 
conidiophore (b) of a ugeAΔ strain. Bar in A = 10 µm. 
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Supplementary Fig. C. Transmission electron micrographs of hyphal cross-sections of 
wild type (a), ugeAΔ (b), and ugmAΔ (c) strains. Boxed area in A is shown at higher 
magnification in C. Bar in A = 10 µm. 
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Supplementary Fig. D. Growth of Aspergillus nidulans strains on a variety of media. 
Wild type, ugmAΔ, ugeAΔ and double-deletion strains were grown on glucose supplemented 
with 1 M sucrose, 10 µg/mL Calcofluor, 30 µg/mL Calcofluor. 
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Supplementary Fig. E. Hyphal phenotype for the colonies shown in Supplementary Fig. D. 
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Chapter 4 
Characterization of Aspergillus nidulans UDP-galactofuranose transporter, 
UgtA 
This chapter study UgtA, the downstream enzyme to UgmA in the Galf biosynthesis 
pathway. The function of UgtA is to transport UDP-Galf units from cytoplasm to membrane 
bound organelles for further processing. This chapter has been submitted to Fungal Genetics and 
Biology Journal as “Roles of the Aspergillus nidulans UDP-galactofuranose transporter, UgtA in 
wild type hyphal morphogenesis, conidiation, cell wall architecture and drug sensitivity”. Afroz, 
El-Ganiny, Sanders, and Kaminskyj (accepted, 2011). 
 The objectives for the research in this chapter were 
1) To find if the A. nidulans genome contains a potential UDP-galactofuranose transporter. 
2) To determine if UgtA is essential for viability of A. nidulans. 
3) To examine if A. fumigatus glfB and A. nidulans ugtA are functionally homologous. 
4) To find if UgtA is also Golgi-localized, as A. fumigatus GlfB. 
5) To characterize ugtA deletion on A. nidulans regarding morphogenesis and sporulation. 
6) To determine ugtA deletion sensitivity towards wall targeting agents. 
My roles in this paper: I identified the UgtA coding sequence in A. nidulans (AN3113), 
and did the hydropathy analysis of UgtA sequence. I trained and provided daily supervision and 
guidance to a newly arrived MSc candidate, Sharmin Afroz. I taught Sharmin how to grow and 
manipulate A. nidulans strains, how to design primers and access information from databases. I 
also taught her different technique like gDNA extraction, RNA extraction, cDNA synthesis, 
cloning, fusion PCR, protoplasting, transformation and antifungal susceptibility testing. Sharmin 
was involved in deletion of ugtA and characterization of the ugtAΔ strain, tagging of UgtA, 
complementation of ugtAΔ defects and the preliminary antifungal sensitivity testing. I did the 
statistical analysis of the data and wrote the first draft of the manuscript with input from Ms 
Afroz, we are listed as co-first authors on this manuscript. This manuscript was edited by Dr. 
Kaminskyj prior to submission and acceptance. 
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Abstract:  
 
Galactofuranose (Galf) is the 5-member-ring form of galactose found in the walls of 
fungi including Aspergillus, but not in mammals. UDP-galactofuranose mutase (UgmA, 
ANID_3112.1) generates UDP-Galf from UDP-galactopyranose (UDP-Galp, 6-member ring 
form). UgmA-GFP is cytoplasmic, so the UDP-Galf residues it produces must be transported into 
an endomembrane compartment prior to incorporation into cell wall components. The adjacent 
gene, ANID_3113.1 (which we call UgtA) was identified as being likely to encode the 
A. nidulans UDP-Galf transporter, based on its high amino acid sequence identity with its 
recently described orthologue in A. fumigatus, GlfB. The ugtA deletion (ugtAΔ) strain had a 
phenotype similar to that of ugmAΔ: compact colonies, wide, highly branched hyphae, and 
reduced sporulation. The ugtAΔ hyphal walls were more than three-fold thicker than wild type 
strains, accumulated exogenous material during submerged culture, and did not bind the EBA2 
antibody. However, unlike the ugmAΔ strain, ugtAΔ metulae often produced triplets of phialides, 
rather than pairs, and ugtAΔ spore germination was substantially reduced. AfglfB restored 
wild type growth in the ugtAΔ strain, showing that these genes have homologous function. 
AfGlfB had been shown using density-gradient centrifugation to be associated with Golgi-
derived membranes. Subcellular localization of UgtA-GFP under the control of its constitutive 
promoter showed a tip-high gradient of punctate GFP fluorescence in fungal hyphae, consistent 
with localization in fungal Golgi. Notably, the ugtAΔ strain was significantly more sensitive to 
Caspofungin, Calcofluor White, and Congo Red, all of which interfere with cell walls, 
suggesting that drugs targeting UgtA function could be useful in combination antifungal therapy.  
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1. Introduction 
 
Cell walls support and protect fungal organisms, and are their interface with the 
environment. Aspergillus nidulans hyphal walls are about 20 % of cell dry weight (de Groot et 
al., 2009). A similar proportion of the fungal genome appears to relate to cell wall formation and 
maintenance (Harris, 2009). Aspergillus hyphal wall carbohydrates include chitin, glucans, and 
mannans (Leitao, 2003; Bowman and Free, 2006; Latgé, 2009). Some wall carbohydrates such as 
galactomannan contain a five-membered ring form of galactose called galactofuranose (Galf) 
(Bernard and Latgé, 2001; Peltier et al., 2008). Galf residues are reported to be about 5 % of the 
A. fumigatus wall (reviewed in Lamarre et al., 2009). Wild type A. fumigatus hyphal wall 
surfaces appear to have Galf residues that mask a mannose-containing layer whose exposure 
contributes to enhanced substrate adhesion (Lamarre et al., 2009). Atomic force microscopy of 
wild type and Galf biosynthesis enzyme deletion strains shows that Galf is important for wall 
surface structure, strength, and adhesion (Paul et al., 2011). In addition, Galf has been implicated 
in A. fumigatus pathogenicity (Latgé, 2009) although the mechanism is not yet understood. 
 Cell surface glycans and glycoconjugates are important for function of organisms 
including fungi. In addition, approximately 80 % of secreted proteins are covalently linked to a 
sugar prior to secretion (Caffaro and Hirschberg, 2006). Glycosylation requires a sugar donor 
that typically is a nucleoside diphosphate sugar (NDP-sugar) or nucleoside monophosphate sugar 
(Bakker et al., 2005; Handford et al., 2006). Many nucleotide sugars are synthesized in the 
cytosol, and then translocated to the lumen of Golgi or ER (Hirschberg, 1998) by nucleotide-
sugar transporters (NSTs). NSTs translocate cytosolic nucleotide-sugars to the endomembrane 
system using luminal UMP as an antiporter substrate, so that the entrance of NDP-sugar is 
coupled to the exit of NMP (Reyes and Orellana, 2008, Sesma et al., 2009). Within the 
endomembrane compartment, nucleotide sugars serve as sugar donors for glycosyltransferase 
reactions, reviewed in Klutts et al. (2006).  
Biosynthesis of glycoconjugates and polysaccharides takes place in the endomembrane 
system (Reyes and Orellana, 2008, Reyes et al., 2010). NSTs are integral proteins typically with 
six to ten transmembrane domains that frequently are located at the Golgi apparatus (Handford et 
al., 2006). NSTs are structurally conserved and can readily be identified from genome databases; 
however, their substrate specificity cannot be predicted from the sequence (Berninsone and 
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Hirschberg, 2000). Many NSTs have been shown to transport more than one type of substrate 
(Handford et al., 2006).  
UDP-Galf is a nucleotide diphosphate sugar that is synthesized in the cytosol  (El-Ganiny 
et al., 2010), so it must be translocated into a membrane-bound organelle prior to incorporation 
into glycoconjugates. The UDP-Galf transporter identified in A. fumigatus was shown to localize 
to Golgi equivalents using both density-gradient centrifugation and immunolocalization (Engel et 
al., 2009).  
We have characterized the A. nidulans UDP-galactofuranose transporter UgtA, whose 
deletion phenotype generally resembles that of the UgmA (El-Ganiny et al., 2008) and UgeA 
(El-Ganiny et al., 2010) deletion strains, although there were differences related to sporulation 
and germination. AfglfB restored wild type growth in the ugtAΔ strain, showing that these genes 
have homologous function. UgtA-GFP had a tip-high punctate distribution in hyphae, consistent 
with localization in fungal Golgi. Notably, the ugtAΔ strain was significantly more sensitive to 
caspofungin, suggesting that drugs that could be developed to target the Galf biosynthesis 
pathway have potential for combination therapy. 
 
2. Materials and Methods 
 
2.1 Strains and culture conditions 
Strains, plasmids and primers are listed in Supplemental Table A. Aspergillus nidulans 
strains were grown as described in (El-Ganiny et al., 2008) on complete medium (CM) as 
described in (Kaminskyj, 2001). Some experiments used CM containing 1 % galactose (CM-Gal) 
rather than glucose. Protoplasting followed procedures in Osmani et al. (2006). Long-term 
storage of transformation-competent protoplasts is described in El-Ganiny et al. (2010).  
 
2.2 Strain construction and validation 
Construction of the ugtA deletion (ugtA∆) strain ASA1 used the method described in 
El-Ganiny et al. (2010) based on Osmani et al. (2006) and Szewczyk et al. (2007). 
ANID_03113.1 was deleted from the wild type A. nidulans strain A1149 using AfpyrG as a 
selectable marker (amplified from pAO18). Confirmation was done by isolating gDNA from 
Amira El-Ganiny PhD thesis May 2011 
115 
 
putative knockout strains and using it as template for PCR with combinations of primers shown 
in Suppl. Table A and Suppl. Figure A. 
The ugtA cDNA was prepared as described in El-Ganiny et al. (2010), and cloned into 
pCR4-TOPO. The positions and lengths of intron sequences predicted by the Broad website were 
confirmed by sequencing this cDNA at the Plant Biotechnology Institute (PBI), NRC, Saskatoon.  
An A. nidulans strain that was C-terminal tagged UgtA (UgtA-GFP) under the control of 
its endogenous promoter, was generated as described in El-Ganiny et al. (2010) using a tagging 
construct (5GA-GFP-AfpyrG) amplified from plasmid pFNO3. Confirmation of GFP-tagged 
strains containing these constructs is shown in Suppl. Figure D.  
A plasmid containing the AfglfB coding sequence (a generous gift of Francoise Routier) was 
transformed into ugtA∆ protoplasts to create a strain containing ugtA:AfglfB to test for functional 
homology between these genes. Transformation was confirmed by PCR using ugtA∆:AfglfB 
gDNA template and primers SA72 and SA73 (Suppl. Table A and suppl. Figure E). 
 
2.3 Microscopy, cell morphometry and sporulation, UgtA localization: 
Strain morphometry followed procedures described in El-Ganiny et al. (2008). Freshly 
harvested spores were grown on coverslips for 16 h at 28 ºC in CM liquid, fixed in buffered 
3.7 % formaldehyde, stained with 0.4 µg/mL Hoechst 33258 (for nuclei) and 0.2 µg/mL 
Calcofluor (for cell walls). Samples were imaged by confocal microscopy using a Zeiss 
META510 with 63 x N.A. 1.2 multi-immersion objective, or structured illumination microscopy 
using a Zeiss Apotome with a 60x N.A. 1.4 oil-immersion objective. For Hoechst 33258- and 
Calcofluor-stained samples, excitation used a 405 nm diode laser or 365 nm light emitting diode, 
and filters as described in El-Ganiny et al. (2008). Cell measurements used analysis software 
bundled with these systems. Some sporulating ugtA∆ cultures were imaged after Hoechst 33258 
staining to examine nuclei in conidiophores. For morphometric analysis, hyphal width at septa 
and basal cell length (distance between adjacent septa) were measured for 50 cells per strain, and 
nuclei were counted in these cells. 
 To assess relative spore production, individual isolated wild type and ugtA∆ colonies 
grown 4 d at 37 °C were harvested to count their conidia. To assess spore viability, we counted 
the number of colonies that formed when equal numbers of freshly harvested spores (three 
replicate plates with about 200 spores per plate) were germinated at 28 °C for 24 h.  
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Scanning electron microscopy examined sporulating colonies that had grown for 4 d at 
37 ºC (El-Ganiny et al. 2008). These were fixed by immersion in 1 % glutaraldehyde, dehydrated 
in acetone, frozen to -80 ºC, critical point dried (Polaron E3000, Series II), and sputter coated 
with gold (Edwards model S150B). Samples were imaged with a JEOL 840A scanning electron 
microscope. 
Transmission electron microscopy examined hyphae that had grown overnight either 
submerged in liquid growth medium, or supported on dialysis tubing overlying agar, samples 
were prepared as described in (Kaminskyj, 2000). Cells were fixed for 1 h in 1 % glutaraldehyde 
in 50 mM phosphate buffer, pH 7, post-fixed for 1 h in 1 % osmium tetroxide in the same buffer, 
and dehydrated in a graded ethanol series. After transfer to 100 % anhydrous acetone, samples 
were embedded in Epon 812, which was polymerized at 60 ºC for 2 d. Silver sections (~ 75 nm 
thick) were collected on formvar-coated slot grids, stained with uranyl acetate and lead citrate, 
and imaged with a Philips CM10 operating at 60 kV. Films were digitized at 1200 dpi.  
The UgtA product was C-terminal tagged with GFP, under control of its endogenous 
promoter, as described in El-Ganiny et al. (2010). Confirmation of this tagging construct is 
shown in Suppl Fig. D. GFP excitation used confocal fluorescence microscopy and an argon 
laser as described in El-Ganiny et al. (2010). 
 
2.4. Antifungal susceptibility testing 
Drug sensitivity of the wild type and ugtA∆ strains was compared using disc diffusion 
(Kontoyiannis et al, 2003; Rodriguez-Tudela et al, 2008). Briefly, 1 x 107 freshly-harvested 
spores were inoculated on plates containing 20 mL of RPMI agar (Rodriguez-Tudela et al, 2008). 
Sterile 6 mm-round filter paper discs were placed on the agar surface. Then, 10 µL of the 
following solutions were added to disc surfaces: Caspofungin (20 mg/mL, in water), Congo Red 
(10 mg/mL, in water), and Calcofluor White (10 mg/mL, in 25mM KOH) (Hill et al, 2006). The 
plates were incubated at 28 ºC for 24 h and 48 h. Four replicate plates were prepared for each 
strain, and examined at 24 h and 48 h. The radius of the zone of growth inhibition (no fungal 
growth) in mm was calculated as [Average inhibition diameter – 6 mm]/2.   
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3. Results 
 
3.1 UgtA identification, deletion, and complementation 
UDP-galactopyranose mutase (UgmA; ANID_3112) converts UDP-galactopyranose 
(UDP-Galp) into UDP-Galf (El-Ganiny et al., 2008), a process that occurs in the cytoplasm 
(El-Ganiny et al., 2010). Before Galf can be incorporated into cell wall components, it must be 
transported into an endomembrane compartment, where it is expected to be a substrate for a 
glycosyltransferase (Berninsone and Hirschberg, 2000). Aspergillus fumigatus AFUA_3G12700 
was recently characterized as a UDP-galactofuranose transporter by Engel et al. (2009) and 
named GlfB. BLAST comparison with the A. nidulans genome database showed that 
ANID_03113.1 had 88 % amino acid sequence identity with GlfB. We named the putative 
A. nidulans UDP-Galf transporter UgtA.  
ANID_3113.1 was deleted by replacing it with AfpyrG in strain A1149 (El-Ganiny et al., 
2008; and Suppl Fig. A). Conidia from primary transformant colonies germinated and grew on 
selective medium, suggesting that UgtA is dispensable for viability. As shown in Suppl Fig. A, 
genomic DNA from ugtAΔ strains but not the wild type morphology parent strain A1149 
contained AfpyrG. In contrast, the parental but not the deletion strains contained the ugtA coding 
sequence. Thus, UgtA is not essential for spore germination and growth. 
A plasmid containing the AfglfB sequence was transformed into ugtA∆ protoplasts, 
creating a ugtA∆:AfglfB strain, to test whether these sequences were functionally homologous. 
AfglfB fully complemented ugtA∆ defects and restored the wild type hyphal morphology and 
sporulation phenotypes (Fig. 1; Table 1). 
The ugtA genomic sequence ANID_3113.3 is on chromosome 3. UgtA is predicted to be 
400 amino acids (Suppl. Figure B). Hydropathy analysis using TMHMM2.0 suggests that it has 
11 membrane-spanning regions (Suppl. Figure B). UgtA is predicted to be 1446 nucleotide bases 
and to have five exons, which we confirmed by isolating and sequencing the ugtA cDNA. The 
ugtA predicted gDNA and cDNA sequence shown in Suppl. Figure C agreed with those shown 
on the Broad A. nidulans genome database. 
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3.2 Roles of UgtA in Aspergillus nidulans morphogenesis and sporulation 
Fig. 1 shows colony and hyphal phenotypes of wild type, ugtAΔ, and ugmAΔ, and 
ugtA∆:AfglfB strains grown on CM and CM-Gal. The ugtAΔ strain had a compact colonial 
morphology unlike wild type, but similar to the ugmAΔ strain (El-Ganiny et al., 2008).  
Sporulation was delayed and/or reduced in ugtAΔ colonies compared to wild type. The 
wild type and ugtA∆:AfglfB colonies had begun to produce pigmented conidia by 2 d (Fig. 1A, 
H) and were sporulating abundantly by 3 d. In contrast at 3 d, the ugtAΔ and ugmAΔ colonies 
had barely begun to sporulate, so that the center of the colony was only faintly pigmented (Fig. 
1B, C). Sporulation of ugtA∆ colonies was improved by growth on CM-Gal (Fig. 1F) compared 
to CM (Fig. 1B), although colony growth was not remediated. The morphology of hyphae at the 
margins of the colonies in Fig. 1 A-H is shown in Fig. 1 A’-H’. The wild type and ugtA∆:AfglfB 
hyphae were slender and relatively unbranced, whereas the ugtAΔ strain hyphae resembled those 
of the ugmAΔ strain. 
Fig. 2 shows typical cellular morphologies of the wild type, ugtA∆, and ugtA∆:AfglfB 
strains grown in liquid CM for 16 h at 28 °C. In this figure, the wild type and ugtA∆:AfglfB cells 
were stained with Calcofluor and Hoechst 33258, but the ugtA∆ cells were stained only with 
Hoechst 33258. This stain accumulates non-specifically in cell walls (Kaminskyj and Hamer, 
1998), suggesting that the ugtA∆ hyphal walls were considerably thicker than those of wild type 
strains. Staining ugtA∆ hyphae with Calcofluor and Hoechst 33258 together masked nucleus 
visibility due to intense wall staining (data not shown), consistent with their hyphal walls being 
thicker than wild type. A morphometric comparison of wild type, ugtA∆ and ugtA∆:AfglfB 
hyphae is shown in Table 1.  
The ugtAΔ strain was grown on dialysis tubing lying on agar medium for 4 d at 37 °C to 
examine conidiophore morphology using scanning electron microscopy (SEM) (Fig. 3A). The 
ugtAΔ conidiophore structures were smaller than wild type strains. In addition, whereas 
wild type A. nidulans metulae each produce two phialides (Mims et al., 1988), some ugtAΔ 
metulae produced three phialides (arrows in Fig. 3B, C). Each of these phialides was able to 
produce conidia (Fig. 3 B, C). Notably, unlike ugmAΔ (El-Ganiny et al., 2008) germination of 
the ugtAΔ conidia was only half that of wild type strains (Table 1). 
Hyphal wall thickness and surface adhesion characteristics of wild type and ugtAΔ hyphae 
were examined using transmission electron microscopy (TEM) (Fig. 4). We used cross-sections 
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of near-apical regions of actively growing hyphae that contained organelle-rich cytoplasm. The 
organelle appearance and distribution were qualitatively similar between the wild type and 
ugtAΔ hyphae. Two growth conditions were compared: 16 h old cultures grown in liquid CM, 
and similar age cultures grown on dialysis tubing overlying solid CM. In both cases, the ugtAΔ 
near-apical hyphal walls were at least three-fold thicker than wild type strains (Table 1; Fig. 4). 
Also unlike wild type (Fig. 4B), ugtAΔ hyphae grown in liquid CM were thickly coated with 
material (Fig. 4D) that we attribute to exogenous components from growth in the culture medium 
adhering to the hyphal wall surfaces. Similar accumulations of material on ugtAΔ hyphae grown 
in liquid culture are seen in Fig. 2. 
 
3.3 Localization of Aspergillus nidulans UgtA 
Aspergillus nidulans UgtA was C-terminal tagged with GFP under the control of the 
endogenous ugtA promoter. The UgtA-GFP strain had wild type hyphae and colony morphology 
and sporulated abundantly, suggesting that the construct is fully functional. The UgtA-GFP 
localization pattern was punctate, and more abundant at hyphal tips (Fig. 5A) than basal regions 
(Fig. 5B), both consistent with Golgi distribution. These were motile, and moved in both 
directions. In conidiophores, UgtA-GFP also had a punctate distribution and was prominent in 
phialides and young conidia (data not shown). 
 
3.4. Testing sensitivity to antifungal drugs 
 We used the radius of zone of inhibition as an end point to show the sensitivity of our 
strains towards the used wall targeting agents. Growth inhibition is defined as the clear zone 
where hyphae are unable to grow (see arrows in Fig. 6), rather than the surrounding region where 
growth is sparse. At 48 h (the standard time for drug sensitivity tests of this type), ugtA∆ strain 
was more sensitive than wild type strain to Caspofungin (Fig. 6). 
 
4. Discussion 
4.1 Aspergillus nidulans contains a putative galactofuranose nucleotide sugar transporter 
that is predicted to be a transmembrane protein. 
NSTs are proteins that translocate sugars from their site of synthesis in the cytosol 
(Berninsone and Hirschberg, 2000) into the lumen of Golgi or ER (Kuhn and White, 1976;  
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Hirschberg, 1998; Eckhardt et al., 1999). BLAST comparison of A. nidulans predicted protein 
sequences with the recently characterized A. fumigatus UDP-galactofuranose transporter, GlfB 
(Engel et al., 2009) showed that the A. nidulans genome database had a single sequence 
(ANID_03113.1) with high homology, which we call UgtA. UgtA is immediately downstream of 
UgmA (ANID_3112.1), which encodes UDP-galactopyranose mutase (El-Ganiny et al., 2008) 
that makes the UgtA possible candidate. ugmA is on the (–) strand while ugtA is on the 
(+) strand, so each gene has its own promoter. The A. fumigatus genes encoding 
UDP-galactofuranose mutase (GlfA) and the UDP-galactofuranose transporter (GlfB) are 
adjacent in their genome (Engel et al., 2009). Similarly, galactose metabolism genes are 
clustered in other fungi (Moyrand et al., 2008). 
Comparison of UgtA and related sequences showed that their identity is highest at the 
putative active site (Engel et al., 2009). Two lysine residues, positions 59 and 294 in A. 
fumigatus GalfB are predicted to be involved in substrate binding (Engel et al., 2009). The 
position of these residues is highlighted in Supplemental Fig. B. Neither is in a transmembrane 
domain, consistent with their expected function, K59 is luminal and K294 is cytoplasmic. 
Nucleotide sugar transporters analyzed to date typically have 6–10 transmembrane 
domains (Handford et al., 2006). UgtA is predicted to have 11 transmembrane domains. 
Confirmation will require the UgtA crystal structure, which will be a challenging task. Currently, 
we are exploring interactions between UgmA and cytoplasmic loops of UgtA.  
For production of Galf-containing cell wall components (Latge, 2009), additional 
processing steps in one or more compartments of the endomembrane system involving 
glycosylation enzymes called galactofuranosyl transferases conjugate Galf subunits to each other 
and to other cell wall components. Two galactofuranosyl transferases have been identified in the 
genome of Mycobacterium (Belanova et al., 2008; Szczepina et al., 2010), one in Leishmania 
(Gaur et al., 2009, Novozhilova and Bovin, 2010), but none in fungi (Deshpande et al., 2008). 
 
4.2 Roles of Aspergillus nidulans UgtA in morphogenesis and development 
Aspergillus nidulans UgtA is not essential for survival in vitro, however UgtA has 
important roles in wild type hyphal growth and sporulation. These results are consistent with our 
previous studies on UgmA (El-Ganiny et al., 2008) and UgeA (El-Ganiny et al., 2010), which 
catalyze reactions immediately upstream of UgtA. Notably, deletion of any of these three genes 
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caused substantially similar hyphal growth abnormalities. Thus, it appears that preventing Galf 
biosynthesis or downstream stages in its incorporation into the A. nidulans cell wall is equally 
devastating to fungal vigour.  
Nucleotide sugars are substrates for glycosylation reactions in the Golgi equivalent or 
endoplasmic reticulum. Inactivation of related transporters in mammals, yeast and protozoa has 
been shown to cause problems in morphology or/and virulence (Hirschberg, 1998, Arakawa et 
al., 2006)). Cryptococcus neoformans and A. nidulans both have two GDP-mannose transporters, 
called Gmt1/Gmt2 and GmtA/GmtB, respectively. Deletion of C. neoformans Gmt1 caused 
capsule integrity defects (Cottrell et al., 2007). Mutation of GmtA in A. nidulans caused hyphal 
morphology defects and hypersensitivity to Calcofluor (Jackson-Hayes et al. 2008, Liu et al., 
2010). An A. fumigatus Galf deficient strain glfA∆, was found to be less virulent in animal model 
(Schmalhorst et al., 2008). 
Lamarre et al. (2009) showed that the A. fumigatus ugm1∆ strain (called glfA in 
Schmalhorst et al., 2008) had increased the adhesion to surfaces including glass and latex, and 
other hyphae (Lamarre, 2009). Hyphal wall surface adhesion can be quantified using atomic 
force microscopy and spectroscopy: both ugeA∆ and ugmA∆ strains had increased adhesion to 
silicon nitride compared to wild type (Paul et al., 2011). In our current study, ASA1 grown in 
liquid CM became covered with extraneous material, also suggesting it had increased 
adhesiveness compared to wild type. Taken together, surface Galf residues on Aspergillus 
hyphae appear to moderate hyphal adhesion, perhaps by masking a mannose-containing layer. 
 
4.3 Subcellular localization of UgtA is consistent with its predicted protein function 
The UgtA-GFP Golgi localization pattern shown in this study is consistent with density 
gradient centrifugation and immunofluorscence results for A. fumigatus GlfB (Engel et al., 
2009). Golgi distribution in A. nidulans has previously been shown to be punctate, and more 
abundant near hyphal tips (Breakspear et al., 2007; Hubbard and Kaminskyj, 2008) Similarly, the 
GDP-mannose transporter (GMT) in Saccharomyces cerevisiae (Dean et al., 1997), Candida 
albicans (Nishikawa et al., 2002), and A. nidulans (Jackson-Hayes et al., 2008) localize to Golgi. 
In contrast, the UDP-glucose/galactose transporter in Arabidopsis thaliana (AtUTr1, AtUTr3) 
was found to localize the endoplasmic reticulum, perhaps due to its additional role in mediating 
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the unfolded protein response (Reyes et al., 2006; Rollwitz er al., 2006). We are actively 
studying interactions between UgtA and UgmA. 
 
4.4 AfGlfB can restore the function of  A. nidulans UgtA 
After transforming the AfglfB containing plasmid into the ugtA∆ strain, the ugtA∆:AfglfB 
colony has wild type morphology where the size of the colony and sporulatrion was similar to 
AAE1 strain. Morphometric analysis also showed that the hyphae of the ugtA∆:AfglfB strain 
restore the wild type characters of AAE1 strain. This indicates that AfGlfB complemented the 
defects in the ugtA∆ as it performs the same function.  
 
4.5. ugtA∆ is more sensitive to antifungal cell wall targeting agents than wild type strain. 
       The disc diffusion assay of Caspofungin, CR and CFW represents different sensitivity 
index. In the case of ugtA∆ strain more attenuation of growth was observed than wild type strain 
AAE1 after both 24 hrs and 48 hrs. As a cell wall defective strain, ugtA∆ was anticipated to be 
most sensitive to these antifungal agents. This anticipated result consistent with our experiment 
result. 
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Table 1. Hyphal morphometry, conidium production, germination, and wall thickness for 
wild type (AAE1), ugtAΔ  (ASA1), and ugtAΔ:AfglfB (ASA3) strains. 
 
  Wild type ugtAΔ        ugtAΔ:AfglfB   
Hyphal width (µm ± SE) a 2.2 ± 0.1c 3.5 ± 0.1 d 2.0 ± 0.0 c 
Basal cell length (µm ± SE) a 24 ± 1 c 16 ± 1 d 22 ± 0.5 c 
Nuclei per basal cell a (± SE) 4.3 ± 0.4 c 3.7 ± 1.0 d 3.6 ± 0.1 d 
Spore production/colony (millions) 107 c 1.33 d n/a 
Germination efficiency 96 % 55 % n/a 
Wall thickness (nm ± SE) b 53 ± 0.1 c 183 ± 1 d n/a 
 
a For hyphal morphometry, values presentd are average of 50 measurment ̸ strain  (mean ± SE), 
from two independent expermints. For each measurement, values followed by different 
letters (c-d) are significantly different. Statistical analyasis was done using Graphpad Prism 
(ANOVA, P ≤ 0.05) 
b Wall thickness of 10 different hyphal sections per strain (typically three measurement sites), 
measured where the cell membrane was crisply focused.  
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Figure 1: Effect of ugtA deletion on colony morphology (A-H) and on hyphal morphology 
at the edges of those colonies (A’-H’). Wild type (A, E, A’, E’); ugtA∆ (B, F, B’, F’), ugmA∆ 
(C, G, C’, G’), and ugtA∆:AfglfB (D, H, D’, H’) grown on complete medium containing 1 % 
glucose (A-D, A’-D’) or 1 % galactose (E-H, E’-H’). Bar in A’ represents 100 µm, for images 
A’-H’.  
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Figure 2: Hyphae of wild type (A), ugtA∆ (B), and ugtA∆:AfglfB (C) strains grown in liquid 
medium and stained with Hoechst 33258. Pictures shown as merged confocal fluorescence and 
transmitted images. Arrows in (B) indicate detritus that has accumulated from the medium 
during culturing. Bar in (A) represents 10 µm, for A, B and C.  
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Figure 3. Aspergillus nidulans ugtAΔ metulae occasionally bear phialide triplets. 
(A-C) Scanning electron microscopy of a four days-old ugtAΔ colony showing variable 
conidiophore maturation. Bar in C = 10 µm, for A-C. A) Conidiophore vesicles of ugtAΔ are 
typically smaller than those of wild type strains, so ugtAΔ has fewer metulae per conidiophore, 
and the conidial chains are splayed, not tightly packed. The conidiophore in the center of (A) is 
shown at higher magnification in (B). B, C) Some ugtAΔ metulae (m) bear phialide triplets. A 
chain of spores is produced by each phialide (e. g. black arrows in B, C).   
(D-F) Confocal images of an ugtAΔ conidiophore stained with Hoechst 33258. Bar in F = 10 µm, 
for D-F. D) fluorescence, E) merged, F) transmitted. D) The metula on the right has produced 
three phialides, each of which has a single nucleus (1-3). F) Each of the phialides in D is 
sporulating (F), but only the spore on phialide 1 contains a nucleus. 
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Figure 4. Transmission electron micrographs of cross-sections of wild type and ASA1 
hyphae. A) Wild type grown on dialysis tubing, B) wild type grown in liquid medium, C) ugtAΔ 
grown on dialysis tubing, D) ugtAΔ grown in liquid medium.  
The hypha in A was sectioned at an angle to the hyphal axis, so it is oval in profile. Wall 
thickness measurements were made where the cell membrane was crisply in focus (see 
Methods). Arrows indicate the outer surface of the ugtAΔ cell walls in C and D. Unlike the 
wildtype strain AAE1 (B), considerable material adhered to the ASA1 (ugtAΔ) hyphal surface 
during growth in liquid medium (D). Bar in A = 100 nm, for A-D.  
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Figure 5. Localization of UgtA-GFP in (a) tip and (b) basal hyphal regions. Showing 
punctate patterns more abundant at the hypha tip, these are consistent with fungal Golgi 
equivalents. These images are merge of fluorescent and transmitted light. Septa, arrows in b. Bar 
in a = 5 µm, for a and b.  
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Figure 6. Sensitivity of wild type (A) and ugtA∆ (B) to antifungal agents. CR, Congo Red; 
CFW, Calcofluor White; Casp, Caspofungin. End point is zone of inhibition radius (zone with no 
visible growth, indicated by arrow). 
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Supplemental Table A. Strains, plasmids and primers used in this study 
Strains 
A1149a pyrG89; pyroA4; nkuA:: argB 
AAE1b pyrG89:: Ncpyr4+; pyroA4; nkuA::argB 
AAE2 (ugmAΔ)b AN3112::AfpyrG; pyrG89; pyroA4; nkuA :: argB 
ASA1 (ugtAΔ)c AN3113::AfpyrG; pyrG89; pyroA4; nkuA :: argB 
ASA2 (UgtA-GFP)c  AN3113-GA5-GFP-AfpyrG; pyrG89; pyroA4; nkuA:: argB 
ASA3 (ugtAΔ:AfglfB)c AN3113::AfpyrG: AfglfB; pyrG89; pyroA4; nkuA::argB 
Plasmids 
pAO18 a S-TAG, AfpyrG, KanR 
pFNO3 a GA5-GFP+ AfpyrG, KanR 
pCR4-TOPO d KanR, ampR  
pAfglfB e pYEScupFLAGK ampR 
Primers (5’ à  3’)  
ugtA Deletion: 
SA1, up ugtA Fc     AAATAATATCTGCTTCGACCCACA   
SA2, up ugtA pyrG, Rc     AATTGCGACTTGGACGACATTTTGAGAGCGCGAGCTTG 
SA3, dn ugtA pyrG, Fc  GAGTATGCGGCAAGTCATGAATCAACCTTCGTGAGCAGTTTT 
SA4, dn ugtA Rc    TGCGCGACACTCCAAAT 
SA5, Fus ugtA Fc    ATAGTGACAATAATTTTCTCCAGAGAA 
SA6, Fus ugtA Rc    TATGCAGTTCTGCACTCCTATTC 
Confirmatory PCR: 
Ame8, MidpyrG, Rb    CACATCCGACTGCACTTCC 
SA1, up ugtA Fc    AAATAATATCTGCTTCGACCCACA 
SA4, dn ugtA Rc    TGCGCGACACTCCAAAT 
SA7, ugtA amplif Fc    ATGAGCAGCTCCGAAGAGAA 
SA8, ugtA amplif Rc     CTCCAGCGCCTGCACCAGCTCCAGCATTGCAGTACTGGCA 
SA72 AfglfB F c                     ATGAGTAACGAAGGAGAAAAAGCC 
SA73 AfglfB R c                    TTACGCATTCCCAGCAG T T 
ugtA-GFP Tagging: 
Ame 27 tag cassette F b      GGAGCTGGTGCAGGC 
Ame 28 tag cassette R b     TCATGACTTGCCGCATACT 
SA43, ugtA amplif Fc      TTGATCTGCGGTAACGTTACAT 
SA36, ugtA amplif Rc      GGCCTGCACCAGCTCCAGCATTGCCAGTACTGGCA  
SA37, dn ugtA pyrG, Fc GAGTATGCGGCAAGTCATGAATCAACCTTCGTGAGCAGTTTT 
SA4,   dn ugtA R c     AGTATGCGGCAAGTCATGAATCAACCTTCGTGAGCAGTTTT 
SA44, ugtA-GFP fus Fc       AATGCTCAAGGTACGGACG 
SA12, ugtA-GFP fus Rc    TGCAGTTCTGCACTCCTATTC 
ugtA cDNA cloning: 
SA30 ugtA cloning Fc      ATGAGCAGCTCCGAAGAGAA 
SA31 ugtA cloning Rc      TTAAGCATTGCCAGTACTGGC 
a Fungal Genetics Stock Center, www.fgsc.net 
b El-Ganiny et al. (2008) 
c This study 
d Invitrogen 
e Engel et al. (2009) 
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Supplemental Figure A. Strategy (A-E) and confirmation PCR (F, G) for Aspergillus 
nidulans ugtA deletion. The deletion strategy has previously been described in El-Ganiny et 
al. (2008). In addition to growth of conidium-derived colonies on selective media, 
confirmation of A3113.1 (ugtA) deletion used genomic DNA templates isolated from the 
transformation parent strain A1149 and 8 putative ugtA deletion strains (ugtAΔ). Primer 
binding sites are shown in A and B. 
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a.  
 
b.  
Cytoplasmic Transmembrane Lumenal 
MSSSEEKVRTSGEVSRPEPTLPTVNPAVDKPEPPKPTFHPAVYVTSWIAL  50 
SSSVILFNKHILDYAQFRFPIILTTWHLAFATFMTQVLARTTTLLDGRKT  100 
VKMTGRVYLRAIVPIGLFFSLSLICGNVTYLYLSVAFIQMLKATTPVAVL  150 
LATWGMGMAPVNLKVLTNVSVIVFGVIIASFGEIKFVFIGFLFQIAGIIF  200 
EATRLVMVQRLLSSAEYKMDPLVSLYYFAPVCAVMNGVTALFLEVPTLTM  250 
DHIYNVGVWTLLANAMVAFMLNVSVVFLIGKTSSLVMTLCGVLKDILLVV  300 
ASMVIWNTPVTALQFFGYSIALIGLVYYKLGGDKIKEYTSQANRAWAEYG  350 
ATHPAQRRFVIIGAALLSFFLLVGSMAPSYAPDSVANVKGMLGGASTGNA  400 
 
Supplemental Figure B: Aspergillus nidulans UgtA in silico analysis.  
a. Predicted hydropathy (TMHMM2.0).  
b. UgtA amino acid sequence, colour-coded to correspond with the hydropathy analysis. 
Lumenal amino acids are anticipated to be within the Golgi equivalent. The highlighted 
lysine residues are predicted by Engel et al. (2009) to be important for A. fumigatus UgtA 
function. 
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1  ATGAGCAGCTCCGAAGAGAAAGTAAGAACCTCCGGCGAGGTCTCTCGCCCGGAACCTACT 
61  CTGCCTACCGTCAACCCTGCCGTCGACAAGCCAGAACCCCCGAAGCCGACCTTCCACCCT 
121  GCCGTCTATGTTACgtgagtcgaccccgatcctatgcaattcaagacgattgtactaaac 
181  ccgcgatgatttcagTTCCTGGATTGCCCTGAGTTCAAGTGTTATCCTGTTCAACAAGCA 
241  CATCCTTGACTATGCTCAGTTCCgtgagtccactttgctccgcaagctgcaggctgtcaa 
301  ttgaagcgaacgaggctgacttcgattcggttcagGATTCCCTATCATCCTTACAACATG 
361  GCATCTGGCGTTCGCGACTTTCATGACGCAGGTTCTCGCTCGCACTACAACCCTCCTTGA 
421  CGGCCGCAAGACCGTCAAGATGACTGGTCGTGTCTACCTCCGCGCCATTGTCCCTATCGG 
481  TCTCTTCTTCAGTCTGAGTTTGATCTGCGGTAACGTTACATACCTGTACCTAAGTGTTGC 
541  ATTTATCCAAATGCTCAAGgtacggacggacctctgtttgggattcgatgtggcataaac 
601  taataaccgctatttagGCCACCACTCCTGTTGCTGTTCTGCTTGCCACTTGGGGTATGG 
661  GCATGGCACCCGTCAACCTCAAGGTTCTTACAAACGTCAGCGTCATTGTCTTCGGTGTCA 
721  TCATCGCCTCTTTCGGTGAGATCAAGTTTGTCTTCATCGGTTTCCTCTTCCAGATTGCCG 
781  GTATCATCTTCGAGGCCACCCGATTGGTCATGGTGCAGCGCCTGCTCAGCTCCGCGGAGT 
841  ACAAGATGGACCCTCTTGTCTCCCTTTACTATTTCGCTCCGGTCTGCGCTGTCATGAACG 
901  GTGTCACTGCTCTGTTCCTTGAGGTTCCTACCCTGACTATGGACCACATCTACAACGTCG 
961  GCGTCTGGACTCTCCTGGCCAACGCCATGGTCGCCTTCATGCTGAACGTCTCCGTTGTCT 
1021 TCCTGgtaggtaatctccattttgagtactctactgttgcctaacagtcaattatagATC 
1081  GGAAAGACTTCTTCTTTGGTCATGACCCTTTGCGGTGTCCTTAAGGATATCCTTCTTGTT 
1141 GTCGCCTCCATGGTCATCTGGAACACTCCTGTCACCGCCCTCCAGTTCTTCGGTTACTCG 
1201 ATTGCCCTCATTGGTCTCGTCTACTACAAGCTCGGTGGCGACAAGATCAAGGAATACACC 
1261 AGCCAGGCTAACCGTGCCTGGGCTGAATACGGTGCCACTCACCCCGCTCAGCGCCGCTTT 
1321 GTGATCATTGGTGCTGCTCTCCTTAGCTTCTTCTTGCTCGTTGGCTCCATGGCACCCAGC 
1381 TACGCTCCCGATTCCGTTGCCAACGTCAAGGGCATGCTTGGCGGTGCCAGTACTGGCAAT 
1421 GCTTAA 
 
Supplemental Figure C: EXON-intron structure of ugtA. The cDNA sequence (UPPER case) 
was amplified from strain A1149; introns from the gDNA (lower case) sequence are from the 
Broad Institute, strain A4, which confirmed by sequencing at PBI, Saskatoon. 
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Supplemental Figure D: Confirmation of ugtA-gfp tagging. Using SA7 (ugtA F) and SA4 
(down ugtA R) primers 
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Supplemental Figure E: PCR confirming complementation of ugtA∆ with AfglfB. Using 
SA72 (AfglfB F) and SA73 (AfglfB R) primers.  
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Chapter 5 
The importance of galactofuranose in Aspergillus nidulans hyphal wall surface 
characters 
This chapter studied the effect of deletion of one or more of the Galf biosynthesis genes 
on the cell wall surface characters in A. nidulans. This chapter was accepted for publication in 
Eukaryotic Cell 10(5), 646-653 as “Quantifying the importance of galactofuranose in Aspergillus 
nidulans hyphal wall surface organization by atomic force microscopy”. Paul, El-Ganiny, 
Abbas, Kaminskyj and Dahms, 2011. 
 The objectives of the research in this chapter were 
1) To determine the cell wall architecture of A. nidulans strains deleted for one or two of the 
Galf biosynthesis genes  
2) To investigate the effect of Galf biosynthesis gene deletion strains on the organization and 
maturation of cell wall subunits, and their adhesion to hydrophilic surfaces. 
3) To study the cell wall viscoelasticity and adhesion of Galf biosynthesis gene deletion 
strain. 
This work was based on some of the galactofuranose deletion strains that I generated 
during my PhD thesis project. I did all of the cell biological characterization of these strains, 
including confocal microscopy, and transmission electron microscopy. I also did the tagging and 
overexpression for UgeB. I was the direct supervisor of Mariam Abbas, who was a visiting 
summer student from Dahms lab in 2008. During that time I taught her how to grow and 
manipulate Aspergillus strains. Biplab Paul is an MSc student in the lab of Tanya Dahms, 
Mariam and Biplab did the AFM studies at the University of Regina, assisted by T Dahms for the 
statistical analysis. We supplied their lab with the strains, consumables and expertise for them to 
culture these for atomic force microscopy. I wrote the part of the manuscript which is related to 
the work I have done. Editing of the final manuscript was done by Dr. Kaminskyj and Dr. 
Dahms. 
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Abstract  
 
The fungal wall mediates cell-environment interactions. Galactofuranose (Galf), the five-
member ring form of galactose, has a relatively low abundance in Aspergillus walls yet is 
important for fungal growth and fitness. A. nidulans strains deleted for Galf biosynthesis 
enzymes UgeA (UDP-glucose-4-epimerase) and UgmA (UDP-galactopyranose mutase) lacked 
immunolocalizable Galf, had growth and sporulation defects, and had abnormal wall 
architecture. We used atomic force microscopy and force spectroscopy to image and quantify 
cell wall viscoelasticity and surface adhesion of ugeA∆ and ugmA∆ strains. We compared them 
with a wild type (AAE1) and the ugeB deletion strain, which has wild type growth and 
sporulation. Our results suggest that UgeA and UgmA are important for cell wall surface subunit 
organization and wall viscoelasticity. The ugeA∆ and ugmA∆ strains had significantly larger 
surface subunits and lower cell wall viscoelastic moduli than those of AAE1 or ugeBΔ hyphae. 
Double deletion strains, [ugeA∆, ugeBΔ] and [ugeA∆, ugmA∆], had more disorganized surface 
subunits than single deletion strains, and changes in wall surface structure correlated with 
changes in its viscoelastic modulus for both fixed and living hyphae. Wild type walls had the 
largest viscoelastic modulus, while those of the double deletion strains had the least. The ugmA∆ 
and particularly the [ugeA∆, ugmA∆] strains were more adhesive to hydrophilic surfaces than 
wild type, consistent with changes in wall viscoelasticity and surface organization. We propose 
that Galf is necessary for full maturation of A. nidulans walls during hyphal extension. 
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1. Introduction 
 
The fungal wall supports and shields the hyphal cytoplasm, and mediates interactions 
between the cell and its environment. Fungal walls are typically about 30 % of cell dry weight 
(7, 10), and a similar portion of the fungal genome is thought to contribute to cell wall 
biosynthesis and/or maintenance (11, 17). Fungal walls are composed of a variety of 
carbohydrate polymers (7, 11, 15), however, deleting many wall biosynthesis genes appears to be 
compensated by genetic redundancy and/or by induction of the cell wall integrity pathway (6, 7, 
23). 
The Aspergillus wall is reinforced by chitin fibrils, and has a matrix containing alpha- 
and beta-glucans, other sugars including galactomannans, and proteins. Galactofuranose (Galf) is 
the five-member ring form of galactose that is found in the cell walls of Aspergillus (6, 7, 23), 
other fungi (reviewed in (15)), and certain other microbes (3).  Deletion of UDP-galactopyranose 
mutase in several Aspergillus species has shown that Galf, despite its relatively low abundance, 
is important for wild type fungal growth, cell morphogenesis, hyphal adhesion, wall architecture, 
and spore development (6, 8, 9, 14, 16, 25) and may mediate pathogenesis (1, 21-23).  
The A. nidulans gene products UgeA (UDP-glucose-4-epimerase) (8), and UgmA (UDP-
galactopyranose mutase) (9) catalyze sequential steps in Galf biosynthesis (Figure 1). The ugeAΔ 
and ugmAΔ deletion strains have similarly compact colonies, aberrant hyphal growth and 
reduced sporulation. The hyphal walls of these strains differ from wild type and with each other 
as visualized using transmission electron microscopy (TEM) (8).  
  Atomic force microscopy (AFM) imaging uses a fine-tipped probe mounted on a flexible 
cantilever to raster scan the surface of an object generating a topographic map. An 
approach-retract cycle of the AFM probe, called force spectroscopy (FS), can be used to 
calculate the viscoelastic modulus of the whole organism or its cell surface, and surface 
adhesion. Previously we used AFM to show that A. nidulans cell walls of growing hyphal tips 
differ from those of mature regions (18), and to document changes associated with spore 
swelling, germination and the non-polarized hyphal growth of temperature sensitive mutants 
(19). Here, we compare the hyphal walls of wild type and a suite of Galf biosynthesis pathway 
deletion strains using TEM, AFM and FS to gain a better understanding of the role played by 
Galf in Aspergillus nidulans cell wall organization. 
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2. Materials and Methods  
 
2.1 Strains and culture conditions 
Aspergillus nidulans Escherichia coli strains were grown as described in (8, 9). Deletion 
strain construction followed procedures described in (8, 9) using nkuAΔ strains, plasmids and 
primers listed in supplemental Table SA. AN2951 (ugeB) was deleted from A1149 using 
AfpyroA as selectable marker (amplified from pTN1) to generate AAE9. Thereafter, ugeA was 
deleted from AAE9 using AfpyrG as selectable marker (amplified from pAO18) to create the 
[ugeAΔ, ugeBΔ] double deletion strain AAE10. Construction of AAE8 [ugeAΔ, ugmAΔ] was 
described in (8). All Aspergillus nidulans strains were cultured in either liquid or solid complete 
medium (CM), as described in (13). 
One litre of CM contains 10 g D-glucose, 2 g peptone, 1 g yeast extract, 1 g casamino 
acids, 50 mL 20 x nitrate salts (formulation follows), 1 mL trace elements (formulation follows), 
and 1 mL of vitamin solution (formulation follows). The pH of the CM was adjusted to 6.5 with 
KOH solution. When required, CM was solidified with 18 g/L Bacto agar. One litre of the 20 x 
nitrate salts solution contains: 120 g NaNO3, 10.4 g KCl, 10.4 g MgSO4⋅7H2O, 30.4 g KH2PO4. 
One hundred millilitres of trace element solution contains: 2.2 g ZnSO4⋅7H2O, 1.1 g H3BO3, 0.5 
g MnCl2·4 H2O, 0.5 g FeSO4·7 H2O, 0.17 g CoCl2·6 H2O, 0.16 g CuSO4·5 H2O, 0.15 g 
Na2MoO4·2 H2O, 5 g Na4EDTA. The pH of the trace elements solution was adjusted to pH 6.5 
with KOH. One hundred millilitres of vitamin solution contains: 100 mg each of biotin, 
pyridoxin, thiamine, riboflavin, p-aminobenzoic acid, nicotinic acid, and 2 drops of chloroform 
added as preservative. The vitamin solution was stored in a dark bottle, since riboflavin is light 
sensitive. The 20 x nitrate salts, trace elements, and vitamin solutions were autoclaved for 20 min 
at 121 °C, cooled to room temperature, then stored at 4 °C. For growth of A. nidulans 
auxotrophic strains (see Table SA), CM was supplemented with the appropriate nutrient as 
described in (13). 
 
2.2. Confocal fluorescence and transmission electron microscopy (TEM)  
Samples were prepared for light microscopy as described in (9). Briefly, freshly 
harvested spores were grown on coverslips for 16 h at 28 ºC in complete medium (CM) liquid, 
fixed and stained with Hoechst 33258 (for nuclei) Calcofluor (for cell walls), then imaged by 
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confocal microscopy. Hyphal width and basal cell length were measured at septal positions in 
mature regions (~ 40µm from the tip) for 50 cells per strain using LSM examiner. 
For TEM, wild type and gene deletion strains were grown on dialysis tubing laid over 
complete medium agar for 1 d at 28 °C, then fixed, embedded, and sectioned for as described 
previously (9). Hyphal wall thickness was measured on TEM cross-sections of ten hyphae per 
strain, typically three measurements per hypha, at places where the cell membrane was crisply 
focussed.  
 
2.3. Atomic force microscopy (AFM) 
Samples for imaging fixed hyphae were prepared for AFM as previously described (18, 
19). Briefly, conidia were germinated in liquid growth medium between two glass coverslips for 
16 h. The top coverslip was carefully removed, and the hyphae were fixed with 3.7 % 
formaldehyde in 50 mM phosphate buffer, pH7.0, containing 0.2 % Triton X-100, followed by 
rinsing with distilled water and air drying. For live cell AFM imaging, hyphae were grown on 
dialysis tubing (Spectrapor, 12-14 kDa) overlaying agar medium. After 16 h growth, the dialysis 
tubing was transferred to a glass coverslip. Sterile Whatman #4 filter paper placed beneath the 
dialysis tubing was used to deliver liquid growth medium by capillary action, ~ 20 µL at a time.  
An ExplorerTM AF microscope (Veeco http://www.veeco.com/) with a dry scanner 
(Veeco, model 5460-00) was used for contact mode imaging and force spectroscopy (FS), as 
previously described (18, 19). Hyphae were visualized by CCD camera (200 ×) and imaged first 
at low resolution (200 × 200 lines per scan). All topographic and lateral force data were collected 
from high-resolution images (500 × 500 lines per scan) of fixed and live (scan rate = 1 and 2 Hz, 
respectively) cells using Si3N4 probe tips (Veeco model #1520-00, k = 0.05 nN/nm, nominal 
resonance n = 17 kHz). Images represent typical results. AFM tip size and shape was calibrated 
using gold spheres according to (27).  
 
2.4. Force spectroscopy (FS) 
Cantilever spring constants, kc, were determined prior to each force measurement using 
resonance frequencies according to (5). Tip-sample interaction was tracked by cantilever 
deflection as a function of Z piezo elongation during probe approach and retraction. For soft 
materials, meaningful FS comparisons often depend on the velocity of the surface approach (4). 
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In this case, the approach velocity did not significantly affect the hyphal spring constant (data not 
shown), but this parameter was kept constant (100 nm/s) to facilitate comparison of viscoelastic 
moduli between samples. Repeated measurements of individual sites on mature walls gave 
consistent values, and images obtained before and after FS were unchanged (data not shown), 
indicating that the walls were not damaged during data collection. Values were averaged from 
force curves collected in triplicate at ten separate points on the surface of mature hyphal walls (≥ 
40 µm from the tip) for five hyphae per sample and typically three different samples.  
Force approach curves measure the unit force (nN) required to indent a surface at a given 
distance (nm), so the slope corresponding to the b-c segment of the approach cycle (refer to 
Figure 5A) was used to examine the relative cell wall elasticity. FS data were plotted as 
deflection (nA) versus distance (nm), converted to force (nN) versus distance (nm) curves using 
the piezo sensor response, and the slope of the line b-c (m) in nN/m used to determine the spring 
constant kw of the cell wall according to: 
 
kw = mskc/mh-ms          (1) 
 
where ms is the sample slope and mh is the slope for a hard surface (mica). The value of kw was 
used for the subsequent determination of Young’s modulus according to the equation (28): 
 
E ~ 0.80 kw/h (R/h)1.5         (2) 
 
where E is the cell wall viscoelastic (Young’s) modulus, R is the hyphal radius measured by 
either Confocal or AFM, and h is the thickness of the cell wall measured by TEM. Surface 
adhesion values were measured from the last segment of the retraction cycle (Figure 5A, 
segment e–f). If there is a chemical attraction between the sample and the Si3N4 AFM probe, 
which is hydrophilic, segment e–f will be a measure of its intensity in nN.  
 
2.4. Data Processing and Analysis 
AFM images were processed using horizontal levelling, with the maximal height adjusted 
for optimum contrast (SPMLab version 6.0 software, Veeco). Hyphal widths at mature regions 
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(~ 40 µm from the tip) and surface feature dimensions from topography and lateral force images 
were measured at the FWHM of the peak height. AFM data are presented as mean ± standard 
deviation or as ranges of values. TEM and confocal data are presented as mean ± standard error 
of the mean. Differences in the mean subunit sizes of wild type and deletion strain hyphae were 
tested by a one-way ANOVA (InStat 3, GraphPad Prism). Standard errors propagated through 
equations 1 and 2 were calculated for viscoelastic moduli, and a Student’s t-test (two-tailed) was 
used to assess significant difference between values (InStat3, GraphPad Prism).   
 
3. Results  
 
Building on our previous experience using AFM to study A. nidulans hyphae (18, 19) we 
compared a suite of A. nidulans strains deleted for Galf biosynthesis enzymes UgeA and UgmA, 
the near-isogenic wild type strain AAE1, a strain deleted for an epimerase (UgeB) that did not 
affect hyphal morphogenesis, and double deletion strains [ugeAΔ, ugeBΔ] and [ugeAΔ, ugmAΔ]. 
Double mutants were used to further explore the function of individual gene products. Even 
enzymes that mediate a known biochemical function may have collateral defects in a deletion 
strain based on protein-protein interactions, for example if the protein is part of a scaffold for a 
multi-enzyme.  
 
3.1. Characterization of Aspergillus nidulans ugeB  
Aspergillus nidulans ANID2951.4 (which we named UgeB) shares 38 % amino acid 
sequence identity with UgeA (8), and had been annotated as a UDP-glucose/galactose-4-
epimerase (www.broadinstitute.org/annotation/genome/aspergillus_group/). The ugeB genomic 
sequence has a single exon that encodes a 428 amino acid peptide. The ugeB cDNA could not be 
amplified (three attempts), unlike ugmA (7) and ugeA (8). We deleted ugeB (Figure SA) as 
described in (9), and confirmed the deletion using PCR (Table SA, Figure SA). A [ugeAΔ, 
ugeBΔ] strain was generated and confirmed (Figure SB) as described in (8). The ugmAΔ strain 
was described in (9) and the ugeAΔ and [ugeAΔ, ugmAΔ] strains were described in (8). UgeB 
was expressed in vitro using the genomic sequence, which does not contain introns, purified, and 
shown to convert UDP-galactose into a product that is not UDP-glucose, following the procedure 
shown in (8, and data not shown). This unknown product awaits conclusive identification.   
Amira El-Ganiny PhD thesis May 2011 
149 
 
The ugeB sequence was put under the control of the AlcA promoter and also tagged with 
red fluorescent protein (El-Ganiny and Kaminskyj, in preparation), then over-expressed by 
culturing on CM containing 100 mM threonine (CMT). Under these conditions, pAlcA-ugeB-rfp 
was expressed, albeit weakly, in conidia and to a lesser extent in mature hyphae (Figure SC), but 
was not detectable in hyphal tips (data not shown). 
 
3.2. Morphology of Aspergillus nidulans strains deleted for Galf biosynthesis genes 
Confocal microscopy images showing the hyphal morphology of the suite of Galf 
biosynthesis deletion strains examined in this study (AAE1, ugeAΔ, ugeBΔ, [ugeAΔ, ugeBΔ], 
ugmAΔ, [ugeAΔ, ugmAΔ]) are shown in Figure 2. Strain morphometry is described in Table 1. 
Unlike the previously described ugeAΔ and ugmAΔ deletion strains, which had wide and highly 
branched hyphae and reduced sporulation (8, 9), the ugeBΔ strain had wild type morphology 
hyphae and growth rate, and abundant sporulation (Table 1; Figure 2; data not shown). The 
[ugeAΔ, ugeBΔ] strain was viable when grown on media containing glucose as carbon source, 
but it did not form colonies on media containing galactose as the sole carbon source (due to 
ugeAΔ), and its hyphae were wide and branched like those of ugeAΔ (Table 1; Figure 2).  
Transmission electron micrographs of hyphal cross-sections showed that the walls of 
ugeA∆ and ugmA∆ strains were two-fold and four-fold thicker, respectively, than those of AAE1 
(Table 1, Figure 3) (8, 9). Given the general correlation between hyphal morphology and wall 
thickness (e.g. 8, 9, 11, 12, 20, 24), we expected that the hyphal wall thickness of ugeBΔ might 
be similar to AAE1. Instead, the ugeBΔ strain hyphal walls were almost two-fold thicker than 
AAE1 (Table 1, Figure 3). Also unexpectedly, the [ugeAΔ, ugeBΔ] strain hyphal walls were 
about twice as thick as either single deletion strain, even thicker than those of the [ugeAΔ, 
ugmAΔ] strain (Table 1, Figure 3).  
TEM images of the ugeAΔ (Supplementary Figure Cb in 8) and ugeBΔ (data not shown) 
strains grown in liquid shake culture accumulated debris, not observed for the same strains 
grown on dialysis tubing (Figure 3) or for the [ugeAΔ, ugeBΔ] strain (data not shown). 
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3.3. Atomic force microscopy imaging of wild type and Galf gene biosynthesis deletion 
strains 
We used AFM imaging to acquire high-spatial resolution information about the hyphal 
wall surfaces of two wild type and four Galf biosynthesis gene deletion strains. AFM imaging 
provides quantitative depth resolution, thus facilitating surface subunit measurements (18, 19). 
Our previous work demonstrated that for the wild type strain, A28, the walls of hyphal tips and 
tips of lateral branches had matured by 3 µm behind the apex, at which point their surfaces 
resembled unbranched regions 20 µm and 40 µm behind the tip (18). To ensure that wall 
surfaces were mature for all strains, we chose analysis sites that were at least 40 µm behind the 
hyphal tips, expecting that wall maturation might be slower in the Galf biosynthesis gene 
deletion strains. AFM data can be collected from living or fixed cells (e.g. (18)). We present 
images of fixed hyphae for comparing wall surfaces amongst the suite of Galf biosynthesis gene 
deletion strains, since hyphal wall subunit size and distribution were similar to living cells but 
were more clearly defined (18).  
Contact mode AFM imaging simultaneously collects topography and lateral force 
information. The latter represents a convolution of topography and tip-sample interactions for 
rough samples, thus producing relief images with more clearly defined edge features (18). High 
resolution images of fixed wild type (AAE1) and Galf biosynthesis gene deletion strain hyphae 
(Figure 4) show distinct differences in their surface subunit size (Table 1) and packing. AAE1 
hyphae had small rounded subunits with a consistent size and even packing. In contrast, both the 
ugeAΔ and ugmAΔ strain hyphae had substantially larger and more variable-sized hyphal wall 
surface subunits than AAE1, and also had more disorganized subunit packing. The hyphal wall 
of the ugeBΔ strain most closely resembled that of AAE1, but with slightly elongated subunits. 
The [ugeAΔ, ugeBΔ] hyphal surface was notable in that its surface appeared fibrillar in the 
topographic images, hence maximum subunit sizes were not measured. Thus, both UgeA and 
UgeB appear to be important for wild type hyphal wall surface formation. The [ugeAΔ, ugmAΔ] 
strain hyphal wall surface subunits were similar in size to ugmAΔ. Taken together, each member 
of the suite of Galf deletion strains produced a distinctive wall phenotype.  
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3.4. Cell wall viscoelasticity and adhesion of wild type and Galf biosynthesis gene 
deletion strains 
Viscoelasticity is the property describing materials such as hyphal walls, which exhibit 
both viscous (fluid-like) and elastic mechanical properties. Cell wall spring constants measured 
by FS (Figure 5A, segment b-c) were used to calculate their viscoelastic modulus for both fixed 
and live hyphae of AAE1 and the suite of Galf gene deletion strains (Table 1). Cell wall 
viscoelastic moduli for the single deletion strains, UgeAΔ and UgeBΔ, were significantly lower 
than that of AAE1 (Table 1). Viscoelastic moduli of ugmAΔ and the double deletion strains 
[ugeAΔ, ugeBΔ] and [ugeAΔ, ugmAΔ] were at least an order of magnitude smaller than AAE1 
(Table 1). 
Notably, viscoelastic moduli of fixed hyphal walls were typically three-fold higher than 
that of live ones (Table 1). Hyphal wall viscoelasticity for the suite of Galf deletion strains 
exhibited the same trend for fixed and live hyphae.  
The Si3N4 AFM probes used in this study have hydrophilic surfaces. We used the e-f 
segment of the FS curve (Figure 5A) to quantify adhesion between A. nidulans wall surfaces and 
the AFM tip during the retraction phase. AAE1 wall surface adhesion to Si3N4 is shown in 
(Table 1). The ugmAΔ and [ugeAΔ, ugmAΔ] hyphae had significantly (p < 0.05) stronger 
adhesion to the hydrophilic tip than wild type hyphae. 
 
4. Discussion  
Our most notable finding is that perturbing A. nidulans cell wall maturation by deleting 
genes in the Galf biosynthesis pathway, has profound effects on wall surface subunit size and 
packing that are directly associated with cell wall viscoelasticity. This is despite the fact that 
none of these genes is essential for growth in culture. Previously, we used AFM and FS to show 
for the first time that growing hyphal tips of a wild type A. nidulans strain, A28 (18), had wall 
surface characteristics that were consistent with long-accepted models of wall deposition and 
maturation (2, 26) that had yet to be quantitatively tested. 
El-Ganiny et al. (8, 9) had shown using molecular biology, fluorescence microscopy and 
TEM that the ugeAΔ and ugmAΔ deletion strain hyphal morphogenetic defects appeared to be 
correlated with a lack of immunolocalizable wall Galf and to aberrant hyphal wall architecture. 
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Now, we have used high spatial resolution AFM imaging and FS to directly quantify wall defects 
in this suite of Galf biosynthesis gene deletion strains and to compare them to wild type strains. 
 
4.1. Galf is required for wild type Aspergillus nidulans hyphal wall formation 
This AFM study is the first to make quantitative measurements of cell wall surface 
subunit features, wall viscoelasticity and adhesive properties of A. nidulans strains that had been 
deleted for enzymes having roles in Galf biosynthesis. Strong but circumstantial data in 
El-Ganiny et al (9) showed that A. nidulans strains lacking UgmA had defective hyphal 
morphogenesis, colony growth, and spore development deficits that correlated with lack of 
immunodetectable wall Galf. Using TEM cross sections, El-Ganiny et al (9) showed that hyphal 
walls of the ugmAΔ strain were more than four times the thickness of AAE1 and had poorly 
consolidated surfaces suggesting that Galf may play a role in wall organization.  
Previously, we showed using AFM imaging that growing tips of wild type A. nidulans 
had ellipsoidal surface subunits that were larger and more variable in size than the round 
subunits found 3 µm or further back (Fig 3. in 18). Consistent with the decrease in subunit size 
and improved organization as a function of maturation, we showed an increase in surface 
hydrophobicity (Fig. 6D in 18) attributed to decreased exposure of sugar hydroxyl groups. 
El-Ganiny’s study (9) suggested that the ugmAΔ strain walls were weaker than wild type since 
this phenotype was partially remediated by growth on 1 M sucrose.  
Our present study shows that both ugeAΔ and ugmAΔ strains had substantially larger 
surface subunits than AAE1. In contrast, the ugeBΔ strains, which had wild type colony 
phenotype and growth rate, had subunit sizes very similar to AAE1. Thus, it appears that 
A. nidulans surface subunit size is inversely correlated with cell wall maturation in A28 (18) and 
a suite of deletion mutants in the Galf biosynthetic pathway. Our data also show that wall surface 
organization correlates with wall viscoelastic moduli, and that these data are mirrored by the 
thickness and surface layer characteristics visualized in hyphal cross sections using TEM.  
Viscoelastic moduli of fixed and living cell walls had a strong positive correlation, 
demonstrating the value of comparing fixed strains, thus reducing data collection time. The 
viscoelastic moduli of fixed hyphal walls were consistently larger, revealing the relationship 
between chemical cross-linking of the cell wall and its viscoelasticity. The data offer insight into 
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the enzymatic cross-linking of hyphal wall components as an integral step in wall maturation, 
where cross-linking likely contributes to wall integrity by increasing viscoelasticity.  
The A4 (28), A28 (18) and AAE1 (current work) are morphological wild type strains. 
The cell wall viscoelastic modulus of the fixed AEE1 strain was lower than that determined for 
fixed, rehydrated A4 by Zhao and coworkers (28). Although both studies used the same method 
to determine cantilever spring constants (5), it is only an estimate and can account for the 
difference in viscoelastic moduli. The viscoelastic modulus of live AEE1 cell walls (Table 1) 
was lower than that reported previously for A28 (115 ± 31 MPa; 18). However, since the latter 
study compared viscoelastic moduli in different regions along single hyphae, cantilevers were 
not calibrated. 
We used Zhao’s model (18), which assumes the indentation of a contiguous layer (cell 
wall) surrounding a large cylinder (hyphae; Figure 5B), to calculate cell wall viscoelastic moduli. 
A plot of the dimensionless unit Eh/kw versus (R/h)1.5 (data not shown) suggests this model fits 
AEE1, ugeAΔ and ugeBΔ strains, better than it does the poorly ordered walls of the ugmAΔ, 
[ugeAΔ ugeBΔ] and [ugeAΔ ugmAΔ] strains. Differences can at least in part be attributed to the 
composition and organization of cell wall components (Figure 5B), whereas viscoelastic moduli 
for ugmAΔ, [ugeAΔ ugeBΔ] and [ugeAΔ ugmAΔ] strains suggests the AFM tip may penetrate the 
loosely packed cell wall surface. The Si3N4 AFM tips used in this study have tips that are about 5 
nm wide (18). The subunits of the ugmAΔ and [ugeAΔ ugmAΔ] strains are 20-fold larger (Table 
1), so the AFM tip could possibly pierce an individual subunit. The surface of the [ugeAΔ 
ugeBΔ] strain has a fibrillar appearance (Figure 5C), so its interaction with the AFM tip could be 
unlike the other deletion strains we studied. 
 
4.2. Galf appears to mediate Aspergillus nidulans hyphal wall surface and hyphal 
adhesion 
Lamarre et al (14) suggested that hyphal wall Galf plays a role in A. fumigatus hyphal 
wall surface properties, which they showed qualitatively by the accumulation of material on 
Afugm1Δ hyphal walls using SEM, and by hyphal adhesion to substrates including glass and 
plastic coverslips, latex beads and epithelial respiratory cells.  
We quantified the adhesion between the hydrophilic Si3N4 AFM tip and walls of living 
AAE1, ugmAΔ and [ugeAΔ, ugmAΔ] hyphae. The increasing hyphal wall surface disorder in 
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ugmAΔ and [ugeAΔ, ugmAΔ] strains correlates with effects on hyphal wall viscoelasticity and 
adhesion. The loose packing of hyphal walls surfaces observed by AFM imaging of Galf mutants 
would expose polar groups normally masked during wall maturation, increasing hydrophilic 
character of the wall surface and resulting in greater adhesion. Consistent with Lamarre et al (14) 
the ugmAΔ and [ugeAΔ, ugmAΔ] strains tended to adhere to microscope coverslips compared to 
AAE1 and ugeBΔ (data not shown). Adhesion values between the Si3N4 tip and ugmAΔ and 
[ugeAΔ, ugmAΔ] walls were comparable to those previously reported for A28 hyphae at growing 
tips, where the wall is newly deposited and not yet mature (~ 9 nN, (18)). Thus, surface subunit 
size, wall viscoelasticity, and wall adhesion to hydrophilic surfaces show consistent trends for 
wild type and Galf gene deletion strains. 
Schmalhorst et al. (23) provided data to suggest that the A. fumigatus glfAΔ (homologous 
to A. nidulans ugmA (9)) strain had attenuated virulence in a murine model for systemic 
aspergillosis. However, scanning electron microscopy of cross-fractured glfAΔ hyphal walls 
were half the thickness of wild type A. fumigatus walls, the opposite trend to our study that 
deserves further attention. 
By combining gene deletion characterizations with TEM, AFM, and FS, we have shown 
that Galf is important for Aspergillus hyphal wall maturation. However, despite the strong 
correlation between our results and those of Lamarre et al (14) we are not yet able to determine 
the likely location(s) of Galf-containing molecules in Aspergillus walls. Indeed, Latgé’s 2010 
model (16) discusses these molecules without indicating many details relating to their 
deployment in the three-dimensional wall architecture.  
We have shown that perturbing wildtype Galf cell wall deposition has substantial effects 
on the surface ultrastructure and viscoelasticity of the Apergillus nidulans cell wall. Galf appears 
to have crucial and multiple roles in Aspergillus hyphal cell wall maturation and integrity. 
Studies addressing potential roles of mannose in A. nidulans wall structure and adhesive 
properties, and potential roles of Galf in pathogenicity are underway. 
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Table 1. Morphological characteristics, maximum dimension of surface subunits, and cell wall      
viscoelastic moduli of wild type and Galf biosynthesis enzyme gene deletion strains.  
Strain Hyphal 
widtha  
 
(µm) ± SE 
Wall 
thicknessb  
 
(nm) ± SE  
Subunit 
maximum 
dimension  
(nm) ± SD 
Viscoelastic 
moduli of 
fixed hyphal 
wall  
(MPa)c ± SD 
Viscoelastic 
moduli of live 
hyphal wall  
(MPa)c ± SD 
Adhesion  
(nN) ± SDd 
Wild type 
(AAE1) 
 
2.4 ± 0.0 54 ± 2 35 ± 5 211 ± 15 82.3 ± 12.9 5.7 ± 1.6 
ugeAΔ 
 
3.6 ± 0.1 104 ± 10 63 ± 10 99 ± 48 24.6 ± 13.7 ND 
ugeBΔ 
 
2.5 ± 0.0 95 ± 11 39 ± 8 74 ± 22 22.5 ± 8.6 ND 
ugeAΔ, 
ugeBΔ 
 
3.5 ± 0.1 217 ± 62 NDd 38 ± 21 9.8 ± 5.1 ND 
ugmAΔ 
 
3.1 ± 0.1 204 ± 10 108 ± 35 14± 2 3.1 ± 0.4 8.1 ± 0.3 
ugeAΔ, 
ugmAΔ 
3.2 ± 0.4 162 ± 8 97 ± 23 0.05 ± 0.02 0.03 ± 0.01 17.3 ± 3.9 
a There was no significant difference in hyphal width for fixed or live hyphae measured either by 
confocal microscopy or AFM 
b Measured from TEM hyphal cross-sections. See Materials and Methods section.  
c SD was calculated from errors propagated through equations 1 and 2. See Materials and 
Methods section. 
d Not determined. See Results section. 
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Figure 1: Biosynthesis of Galf from UDP-Glucose. UDP-glucose is converted to UDP-
galactopyranose by UDP-glucose 4-epimerase (UgeA). In the reaction shown, 
UDP-galactopyranose is converted to the final product UDP-galactofuranose by 
UDP-galactopyranose mutase (UgmA). These two enzymes are localized in the cytoplasm, and 
then UDP-galactofuranose is transported to the fungal Golgi equivalent, which is the site of 
incorporation into other cell wall components. 
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Figure 2. Appearance of the wild type and Galf-biosynthesis deletion strain hyphae use in 
this study. Strains were grown for 16 h, then fixed and stained with Hoechst 33258 to visualize 
nuclei. Images are combined fluorescence and transmitted light. Bar = 5 µm (for all images).  
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Figure 3. Transmission electron micrographs of hyphal wall cross-sections of AAE1 and 
Galf-biosynthesis deletion strains used in this study. Bar = 100 nm (in A, wild type image, for 
all parts). Impressions regarding the relative hyphal diameter as assessed by curvature may be 
misleading, because some hyphal cross sections were not perpendicular to the hyphal axis. 
Images have been contrast adjusted to highlight wall structure; the cytoplasm is dark because 
wall carbohydrates stain poorly for TEM. Arrows indicate the outer boundaries of cell wall 
thickness measurements. 
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Figure 4: Atomic force microscopy images of wild type and Galf-biosynthesis deletion 
strains used in this study. Grey scale for lateral force images is ~ 2 nA and for topography 
images ranges from 50-70 nm. Bar in A = 200 nm, and is valid for all images.  
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Figure 5: A) Representative force curve shows tip approach (a-c) with jump into contact (b)  
and tip retraction (c-g). The slope of b-c was used to calculate sample viscoelastic modulus and 
segment f-e represents tip-sample adhesion. Schematic representation of the AFM tip (black) 
interacting with the hyphal surface (grey) of B) AEE1, ugeAΔ, ugeBΔ, in which the entire cell 
wall is deformed by tip indentation, compared to that of C) ugmAΔ, [ugeAΔ,ugeBΔ] and 
[ugeAΔ,ugmAΔ] in which the tip likely deforms the loosely packed, larger individual subunits or 
penetrates the space between.  
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Supplemental materials: 
Supplemental Table SA: Strains, plasmids and primers used in this study  
Strains and plasmids  
A1149 (wild type)a                      pyrG89; pyroA4; nkuA::argB  
AAE1 (wild type)b                      pyrG89::Ncpyr4+; pyroA4; nkuA::argB 
AAE2 (ugmAΔ) b                 AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AAE5 (ugeAΔ) c                  AN4727::AfpyrG; pyrG89; pyroA4, nkuA::argB 
AAE8 (ugeAΔ, ugmAΔ)c         AN4727::AfpyrG; AN3112::AfpyroA; pyrG89; pyroA4; nkuA::argB 
AAE9 (ugeBΔ) d                   AN2951::AfpyroA, pyrG89; pyroA4; nkuA::argB 
AAE10 (ugeAΔ, ugeBΔ) d    AN4727::AfpyrG; AN2951::AfpyroA; pyrG89; pyroA4, nkuA::argB 
pAO18 a                                      S-TAG, AfpyrG, KanR 
pTN1 a                                        AfpyroA, AmpR 
Primers  5’ à 3’ 
ugeB deletion 
Ame 9 PyroA F ATGGCTTCCAACGGTACCA 
Ame 10    PyroA R           TTACCATCCTCTCTTGGCCA 
Ame 71 upugeB F GAGCAGGGTACACATAGAGAGGG 
Ame 72 upugeB R TGGTACCGTTGGAAGCCATTGTTGATGGCACTTCAAACAAG 
Ame 75 down ugeB F TGGCCAAGAGAGGATGGTAATGCTGTTAAAAACTGAGCCCG 
Ame 76 down ugeB R GTCCACATTAAAGCTTCTGAGTCCA 
Ame 80 ugeBd fus F TAGTTGAATGACAGAGATCGGTCC 
Ame 81 ugeBd fus R CTCTACCAGCACTGCATCTGAA 
Confirmation PCR 
Ame 8 Mid pyrG F CACATCCGACTGCACTTCC 
Ame 16 Mid pyroA R TCAACAACATCTCCGGTACC 
Ame 41 up ugeA F CTCCTATGGTATGTCTCTTCCAACTT 
 
a    Fungal Genetics Stock Center www.fgsc.net.  
b    El-Ganiny et al. (2008). 
c    El-Ganiny et al. (2010). 
d    This study.  
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Supplemental Figure SA. Confirmatory PCR for ugeB∆ strain  
A) Cartoons of wild type (A1149) and ugeB∆ (AAE9) genomic DNA, and primer binding sites.  
Expected amplicon sizes for combinations of genomic DNA template and primer pairs.  
B) Agarose gels showing the expected amplicon sizes for these template-primer combinations.  
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Supplemental Figure SB. Confirmatory PCR for [ugeA∆, ugeB∆] strain 
A) Cartoons of wild type and [ugeA∆, ugeB∆] (AAE10) genomic DNA at the ugeA and ugeB 
loci, and primer binding sites. For each locus, PCR with wild type template and primers 
specific for the selectable marker (p8, p16) is not expected to amplify a product. 
B) Agarose gels showing the expected amplicon sizes for these template-primer combinations. 
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Supplemental Figure SC. Localization of Aspergillus nidulans ugeB, Gene expression is 
under the control of alcA(p), which is strongly induced by growth on CM containing 100 mM 
threonine (CMT). The pAlcA-ugeB-rfp fluorescence was imaged using confocal microscopy (a 
and b are transmitted and fluorescence images respectively). Bar = 10 µm. 
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Chapter 6 
Exploring the Goldilocks effect: effects of changing the level of expression of 
Aspergillus nidulans UDP-galactopyranose mutase 
 
 In the previous chapters we used gene deletion strategy to study the biological function of 
Galf biosynthesis enzymes. In this chapter we are using promoter exchange strategy to 
investigate the effect of changing the level of expression of Galf biosynthesis enzymes on drug 
sensitivity and morphogenesis of Aspergillus nidulans. This chapter will be submitted for 
publication as “Exploring the Goldilocks effect: level of expression of Galf biosynthesis enzymes 
affects antifungal drug sensitivity as well as hyphal and colony morphogenesis in Aspergillus 
nidulans”. El-Ganiny, Sanders and Kaminskyj, in preparation 
 The objectives of the research in this chapter are 
1) To study the effects of ugmA repression and overexpression on colony and hyphal 
morphogenesis of A. nidulans (Goldilocks effect) 
2) To assess the sensitivity of alcA(p)-ugmA strains and ugmAΔ towards commercially 
available antifungal drugs. 
 In this chapter I did all the experimental design, the practical work and data analysis. I 
wrote the first draft of the paper (current version) which will be edited by my supervisor Dr. 
Kaminskyj after submission according to the reviewer comments. 
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Abstract 
 
The fungal cell wall is essential for the fungus and absent from humans. Galactofuranose 
(Galf) is about 5 % of the Aspergillus fumigatus cell wall carbohydrate, where it decorates 
certain carbohydrates and lipids. In systemic aspergillosis, Galf has been shown to be a virulence 
determinant. Previously, we characterized genes in the A. nidulans Galf biosynthesis pathway, 
and showed that AfglfA and AfglfB were functionally homologous to their A. nidulans 
counterparts ugmA and ugtA respectively. Gene deletions of those and another member of this 
pathway; ugeA caused substantially reduced growth and sporulation. As part of our ongoing 
program to assess members of the Galf biosynthesis pathway as targets for antifungal drug 
development, we generated conditional A. nidulans strains using the alcohol dehydrogenase 
promoter alcA(p), qRT-PCR was used to select the suitable media for induction and repression of 
ugmA. We characterized our alcA(p)-ugmA strain under overexpression and repression 
conditions using fluorescence microscopy and SEM. As expected, repression of ugmA 
phenocopied the knockout strains. Although ugmA overexpression colonies had wild type 
morphology and sporulation, the hyphae of alcA(p)-ugmA strain hyphae was wide and highly 
branched. These results showed that decreasing or increasing ugmA expression perturbed several 
aspects of A. nidulans growth and that balanced expression of ugmA is required to have a wild 
type phenotype, which we called the Goldilocks effect. We examined the sensitivity of the 
alcA(p)-ugmA strain under repression and overexpression conditions towards four commercially 
available antifungals in different drug classes: polyenes, azoles, allylamines and echinocandins. 
Our data showed that overexpression of ugmA caused slight decrease in sensitivity to terbinafine 
(allylamine), whereas its repression increased the sensitivity to caspofungin (echinocandin), and 
amphotericin B (polyene), but not the other drug classes. Drugs that target Galf–biosynthesis 
(once developed) could be useful in combination with some other antifungals to improve 
antifungal therapy. 
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1. Introduction 
 
Human invasive fungal infections are increasing dramatically due to many reasons 
including: the improved medical technology leading to increase in the number of 
immunosuppressed patients and the overuse of antibacterial antibiotics. Aspergillus species are 
second only to Candida species as a cause of systemic fungal infections (Erjavec et al., 2009). 
Systemic fungal infections are a significant cause of morbidity and mortality despite 
treatment (Lass-Florl, 2009). Treatment of these infections is challenging because fungi are 
eukaryotes and hence they share many biochemical pathways with mammals. Echinocandins are 
the only antifungal drugs that inhibit an aspect of fungal wall synthesis, β-1,3-glucan synthesis 
(Espinel-Ingroff, 2009). There is a pressing need to develop additional antifungals (Mircus et al., 
2009) particularly against different aspects of fungal physiology. We are exploring new targets in 
the fungal cell wall. 
The cell wall is essential for fungal growth. It protects the cell from external damage and 
stress, and mediates the interaction between the fungus and its environment. If the cell wall is 
removed or weakened, the fungal cell cannot survive in natural environments (Aimanianda and 
Latgé, 2010). About 90% of the fungal cell wall is composed of polysaccharides that are not 
found in human hosts (Latge, 2007). Galactofuranose (Galf) is the five-membered ring form of 
galactose that is found in the cell wall of many microorganisms including fungi but not in 
mammals. Galf residues form the side chains of many glycoconjugates including galactomannan; 
an indicator of invasive aspergillosis.  Galf is essential for the virulence of protozoa and fungi 
including Aspergillus fumigatus (Schmalhorst et al., 2008). Because Galf is both a cell wall 
component and plays a role in virulence, Galf metabolism is thought to be a promising target for 
drug development (Pedersen and Turco, 2003). New antifungal strategies are focusing on 
reducing virulence of the pathogen and minimizing its harm to the host rather than killing the 
pathogen (Gauwerky et al., 2009). 
UDP-galactopyranose mutase (UGM) is a key enzyme in Galf biosynthesis. UGM 
catalyzes the synthesis of UDP-galactofuranose (UDP-Galf) from UDP-galactopyranose 
(UDP-Galp). UGM is encoded by a single gene in both Aspergillus nidulans and A. fumigatus 
(ugmA/glfA) (El-Ganiny et al., 2008; Schmalhorst et al 2008). Although gene deletion studies 
showed that UGM was not essential for survival in vitro, loss of UGM was shown to result in 
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loss of virulence of A. fumigatus (Schmalhorst et al., 2008). El-Ganiny et al. (2008) also showed 
that  A. fumigatus and A. nidulans UGM genes were functionally homologous. 
A complementary approach to study gene function is the use of conditional gene 
expression strains, where the endogenous promoter is replaced by regulatable promoter to 
control gene expression (Ichinomiya et al., 2002). In A. nidulans the alcohol dehydrogenase 
promoter alcA(p) has been used to study the function of many genes. Generally, alcA(p) is 
induced by alcohols, including threonine, and repressed by glucose (Romero et al., 2003; Tribus 
et al., 2010). 
We generated a conditional alcA(p)-ugmA strain, and used it to study the effect of 
induction or repression of ugmA on morphogenesis of A. nidulans, and its sensitivity to 
antifungal drugs. Threonine was used for induction of ugmA and glucose was used for its 
repression. Expression levels were confirmed using qRT-PCR. The colony and hyphal 
characteristics of the alcA(p)-ugmA strain were studied using confocal microscopy and SEM. 
Our results showed that the colony characters and sporulation resemble the wild type under 
induction conditions and phenocopies the deletion mutants when ugmA is repressed. 
Unexpectedly the hyphae of AlcAp-ugmA strain were wide, highly branched with frequent septa 
under repression and induction conditions which is similar to ugmA∆ phenotype indicating that 
increasing ugmA concentration is not totally benign. Under gene repression conditions, the 
alcA(p)-ugmA strain was more sensitive to the wall targeting agent caspofungin and the cell 
membrane targeting agent amphotericin B. Our results suggest that Galf biosynthesis is worth 
further exploration for antifungal chemotherapy, either alone or in combination with other 
antifungals. 
 
2. Materials and methods 
2.1. Strains, plasmids and culture conditions 
 Strains, primers and plasmids are listed in Table 1. Aspergillus nidulans strains were 
grown on complete media (CM) with required nutritional supplements as described previously 
(Kaminskyj, 2001). CM was modified as follows to manipulate alcA(p)-ugmA expression: 
Maximum repression used CM containing 3% glucose (CM3G). Induction of alcA(p)-ugmA used 
CM lacking glucose but containing 100 mM threonine (CMT).  CM with 100 mM threonine and 
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0.1% fructose (CMFT) was used to give intermediate or near wild type expression of ugmA in 
the alcA(p)-ugmA strain.  
 
2.2. Strain construction and confirmation 
 Protoplasting and transformation followed procedures in Osmani et al. (2006) and 
Szewczyk et al. (2007). Long-term storage of competent protoplasts is described in (El-Ganiny et 
al., 2010). The promoter exchange construct consists of alcA promoter plus AfpyrG as selectable 
marker which amplified from plasmid palcA(p). This construct was inserted between the 
upstream of ugmA and the ugmA coding sequence using fusion PCR. The construct was 
transformed into A1149 protoplasts, so that AfpyrG would be under the control of ugmA(p) 
whereas ugmA would be under the control of alcA(p). Genomic DNA (gDNA) was isolated from 
putative strains and wild type and used as template for confirmatory PCR (CPCR).  
Supplemental figure 1 showed the results of CPCR using two different combinations of primers. 
 
2.3.  qRT-PCR 
 Wild type (AAE1) and alcA(p)-ugmA (AAE12) spores were inoculated on CMT, CMFT 
and CM3G media, and incubated at 28°C with shaking for 16 hr. The mycelia were collected by 
centrifugation, flash frozen in liquid nitrogen then lyophilized. Total RNA was extracted from 
lyophilized mycelia using an RNeasy plant Kit (Qiagen) following manufacturer instructions. 
RNA concentration was measured using a Nanodrop, and then diluted to 400-500 ng/µL. gDNA 
elimination and reverse transcription were done using a QuaniTect reverse transcription kit 
(Qiagen) following the manufacturer’s instructions (Cuero et al., 2003).  
Quantitative real time PCR (qRT-PCR) was performed in 96-well optical plates. Each run 
was assayed in triplicate, using total volume of 20 µL reactions containing cDNA at appropriate 
dilution and using SYBR green fluorescein (Qiagen), with no template control (NTC) for each 
gene. Actin was used as a reference gene (Bohle et al., 2007). Primers actF and actR (Table 1) 
were designed using Invitrogen OligoPerfect™ Designer tool. These primers were used to 
amplify regions containing one intron in the gene, producing a ~200 bp band from cDNA and a 
~400 bp band from gDNA (to detect gDNA contamination). The primers ugmF and ugmR 
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(Table 1) were designed to amplify a 100 bp band. qRT-PCR amplification was done in IQ 
Cycler (Biorad) using the following PCR conditions: 95°C/15 min for one cycle, 95°C/15 s, 
55°C/40 s and 72°C/30 s for 40 cycles and final extension cycle of 72°C/2 min. Melting curve 
analysis was done using the following cycle: 15 s at 65°C with increase 0.5°C each cycle till 
95°C. The relative expression of ugmA were normalized to actin and calculated according to the 
ΔΔCt method (Livak and Schmittgen, 2001). Two independent biological replicates were 
performed for each strain/culture condition. 
 
2.4. Colony growth and sporulation 
 The colony characters were examined as described in El-Ganiny et al. (2008). Briefly, 
wild type and alcA(p)-ugmA strains were streaked on CMT, CMFT and CM3G media and 
incubated for 3 d at 28°C to give isolated colonies (Figure 2). Diameter of these colonies were 
measured (10 colony/strain). The number of spores /colony were counted by selecting individual 
colonies that had grown in isolation from single spore, and dispensing spores of each colony in 
microfuge tube containing 1 mL  water. A hemocytometer was used to count the number of 
spore / colony. Four colonies were assessed for each strain and medium combination; two 
samples were counted for each colony. 
  
2.5. Microscopy: confocal and SEM  
 Samples prepared for confocal fluorescence microscopy as described in El-Ganiny et al. 
(2008). Freshly harvested spores were grown on coverslips at 28 ºC for 16 h in CM media with 
carbon sources as described above. Hyphae were fixed and stained with Hoechst 33258 (for 
nuclei) and Calcofluor (for cell walls). Samples were imaged using a Zeiss META510. LSM 
image browser software was used for the morphometeric analysis. Hyphal width (at septa) and 
basal cell length (distance between adjacent septa) were measured for 50 cells per strain, from 
two independent samples. 
 Scanning electron microscopy (SEM) was used to examine sporulating colonies 
following El-Ganiny et al. (2008). Wild type and alcA(p)-ugmA strains were grown on dialysis 
tubing laid on CM with defined carbon sources for 3 d at 28ºC. Colonies were fixed by 
immersion in 2 % glutaraldehyde, dehydrated in acetone, critical point dried (Polaron E3000, 
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Series II), and gold sputter coated (Edwards model S150B). Samples were imaged with a JEOL 
840A scanning electron microscope. 
 
2.6. Antifungal susceptibility testing 
Antifungal agents and analytical grade solvents were obtained from the following 
manufacturers: amphotericin B, terbinafine, itraconazole, dimethyl sulphoxide (DMSO) (Sigma 
Chemicals, USA), ethanol (VWR) and caspofungin (Merck & Co., Inc. USA). These four 
antifungal drugs represent different antifungal drug classes. Stock solutions were prepared as 
follows: amphotericin B (20 mg/mL in DMSO), itraconazole (1.6 mg/mL in DMSO), terbinafine 
(1.6 mg/mL in 50% ethanol) and caspofungin (20mg/mL in sterile water). These stock solutions 
were aliquoted and stored at -80 ºC. 
Wild type (AAE1) and alcA(p)-ugmA (AAE12) strains were grown under repression 
(CM3G) and induction (CMT) conditions; wild type and ugmAΔ (AAE2) strains were grown on 
CM. Spores collected from 4 day old plates, because ugmAΔ and alcA(p)-ugmA strains were 
delayed for sporulation.  Spore suspensions were filtered through VWR 413 grade papers to 
move any hyphae or conidiophores, then counted by hemocytometer and adjusted to the same 
concentration. 
Antifungal susceptibility testing was done by employing a disc diffusion method similar 
to that described in Kontoyiannis et al. (2003). Briefly, 1 x 107 spores were inoculated in 20 mL 
media (CMT or CM3G) and poured in Petri plates (9 cm diameter). After the medium had 
hardened, sterile ¼  inch (6mm) paper discs were placed on the agar surface. Antifungal drug 
stock solutions (described above) were micropipetted onto individual disks: 10 µL of terbinafine 
and itraconazole, or 20 µL of amphotericin B and caspofungin. The plates were incubated at 
28 ºC and assessed after 48 h. The radius of the zone of inhibition in millimeters was quantified 
as: [diameter with no visible growth – disk diameter] / 2. Four biological replicates were 
assessed for each strain and medium combination, two measurements were taken for each disk 
on each plate, at orthogonal orientations. Solvent controls (DMSO and 50% ethanol) showed no 
zone of inhibition.   
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2.7. Data processing and analysis 
 Confocal images were processed using LSM examiner software, other images were 
processed using Adobe Photoshop 7.1. software. Statistical analysis used Graphpad prism 5 for 
analysis of variance.  
 
3. Results 
 
The alcohol dehydrogenase I promoter, alcA(p) has been used successfully to control the 
expression of many genes in Aspergillus (Romero et al., 2003; Tribus et al., 2010). Previously 
we deleted A. nidulans ugmA to explore its biological roles in morphogensis, conidiation, and 
wall ultrastructure of Aspergillus nidulans (El-Ganiny et al., 2008). In this study we explored the 
role of UgmA overexpression and repression on hyphal and colony morphogensis and on 
sensitivity to antifungals using a single strain (alcAp-ugmA) in which we can conditionally 
repress or overexpress ugmA. As Galf is an important component of the cell wall, and its lack 
produces a distinctive colony phenotype and weaker cell walls (El-Ganiny et al., 2008; Paul et 
al., 2011) we expected that controlling ugmA expression would have a profound effect on colony 
and hyphal morphology. We further hypothesized that overexpression or repression ugmA would 
affect strain sensitivity to antifungal drugs especially the wall targeting agents. 
 
3.1. Construction and validation of alcAp-ugmA strain 
  Fusion PCR was used to generate a construct that replaced the ugmA endogenous 
promoter with the conditional promoter alcA(p). AfpyrG was used as a selectable marker 
(Szewczyk et al., 2007). To confirm that the construct integrated at the ugmA locus, confirmatory 
PCR using two sets of primers was performed. Primers Ame1 (upstream F) and Ame23 (ugmA 
R) amplified 2.9 Kb band from wildtype and 5.2 Kb band from alcA(p)-ugmA strains. The 
primers Ame1 and Ame134 (midpromoter R) produced a 2.8 Kb band with alcAp-ugmA strains 
and no band with wild type gDNA as expected (Suppl. Figure A).  
After promoter replacement, the alcA(p)-ugmA strain was grown on CM media with 
different carbon sources to select the most suitable media for overexpression and maximum 
repression of ugmA. Wild type and alcA(p)-ugmA were streaked on CM media containing 
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threonine, ethanol, fructose-threonine, glycerol or glucose as sole carbon sources, and on a 
mixture of carbon sources: YEPD (1% yeast extract, 2% peptone, 2% glucose/dextrose, 2% agar) 
medium (Zarrin et al., 2005). qRT-PCR was used to assess the ability of CMT, CMFT and 
CM3G media to induce or repress ugmA  (Table 2 and Figure 1). We found that threonine 
containing medium (CMT) give the best induction of ugmA, showing more than 5 times increase 
in ugmA expression compared to wild type strain grown under the same conditions (Figure 1a), 
In comparison, fructose-threonine medium (CMFT) resulted in a slight decrease in ugmA 
expression (about 50% decrease than wild type), Medium with 3% glucose (CM3G) showed 
maximum repression of ugmA; about 100 times decrease in its expression (Figure 1b).  
 
3.2. Repression of ugmA leads to compact colonial growth and reduced sporulation 
 In previous studies, glucose and threonine containing media have been used to repress or 
overexpress alcA(p)-regulated genes, respectively (Tribus et al., 2010). In this study, growing the 
alcA(p)-ugmA strain on CM3G (repression) media resulted in a decrease in colony size and in 
sporulation. On CM3G, the colony size of alcA(p)-ugmA strain was about 20% that of the wild 
type strain, and alcA(p)-ugmA sporulation was less than 2% that of wild type (Table 2 and Figure 
2). SEM images showed that reduction in sporulation was due to both the decrease in the number 
of conidiophores and the aborted formation of some conidiophores (Figure 3). Thus, repression 
of alcA(p)-ugmA produced a colony phenotype that was general comparable to that of the 
ugmAΔ strain. 
We have shown previously that deletion of ugmA had a greater effect on sporulation than its 
repression did in this study (El-Ganiny et al., 2008). To test whether this was related to growth 
on CMT or CM3G, wild type and alcA(p)-ugmA strains were grown on YEPD medium, which 
has been used by others to modulate expression of alcA(p)-regulated strains (Zarrin et al., 2005).  
Unexpectedly, although, the alcA(p)-ugmA strain colony and sporulation phenotype were 
substantially more similar to ugmA deletion, however on YEPD the sporulation of wild type 
strain was also greatly reduced (Suppl Figure B). We found that CMFT medium caused only a 
slight decrease in ugmA expression, and moderate effect on colony size and sporulation was 
noticed. Colony size of alcA(p)-ugmA was 2/3 that of wild type, whereas sporulation of alcA(p)-
ugmA was about 40% of wild type grown on same media. Increasing expression of ugmA by 
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growing on CMT has minor effect on colony size which decreased by 25% and sporulation 
which has about 30% reduction compared to wild type (Table 2). 
 
3.3. Both overexpression and repression of ugmA affect hyphal morphology  
 Previous work in our group showed that deletion of genes in Galf biosynthesis pathway 
affect hyphal morphogenesis producing wide, uneven hyphae with increased branching and 
formation  of septa (El-Ganiny et al., 2008; El-Ganiny et al., 2010; Paul et al., 2011; Afroz et al., 
accepted). In this study we expected that ugmA repression would produce hyphae that look 
similar to the ugmA deletion, whereas ugmA overexpression would give wild type hyphae, 
consistent with wild type colony and sporulation. However hyphal examination using confocal 
microscopy showed that both maximum repression and overexpression of ugmA had comparable 
effects on hyphal morphometry, causing increased hyphal width (23% and 20% increase 
respectively) and decreased basal cell length (43% and 50% decrease respectively) in 
comparison to wild type strain grown under the same conditions. The alcA(p)-ugmA strain grown 
on CMFT had wild type hyphal width, but had 46% decrease in basal cell length compared with 
wild type grown on same media (Table 2, Figure 4). 
  
3.4.  Repression of ugmA increases sensitivity to caspofungin and amphotericin B  
 Sensitivity of wild type (AAE1), ugmA∆ (AAE2) and alcA(p)-ugmA (AAE12) strains to 
antifungal drugs from four different target classes was tested using disc diffusion method. Our 
results showed that there was a small difference in sensitivity of alcA(p)-ugmA and wild type 
strain under overexpression condition (CMT), whereas under repression conditions alcA(p)-
ugmA was notably more sensitive to both caspofungin and amphotericin B. For each drug, there 
was a more than 100% increase in the radius of inhibition zone (Table 3, Figure 5). Other 
antifungal agents including 5-fluorocytosine (5-FC) and nikkomycin Z (NKZ) were assayed for 
their antifungal activity towards wild type and Galf-defective strains.  However, they did not 
inhibit the growth of wild type or Galf-defective strains (data not shown). Nikkomycin Z caused 
slightly higher swelling of the geminated spores of the Galf-defective strain (ugmA∆) in 
comparison to wild type strain when examined microscopically (Suppl. Figure C).  
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4. Discussion 
 
 The number of immunocompromised patients with invasive fungal infections has been 
increased dramatically. Treatment of systemic fungal infections is problematic due to the limited 
treatment options (Lass-Florl, 2009). Four classes of antifungal drugs (polyenes, azoles, 
allylamines and morpholines) target cell membrane ergosterol and ergosterol biosynthesis. 
Echinocandins are the only antifungal drugs that target fungal cell wall synthesis by inhibiting 
β-1,3-glucan synthase. Echinocandins are less toxic to humans but they still have narrow 
spectrum and emerging cases of resistance. This puts a pressure on the scientific community to 
find novel antifungal drug targets. Virulence factors of fungi could be new potential drug targets, 
as new approaches attempt to hinder ability of fungi to cause any harm to the host rather than 
killing the fungus (Gauwerky et al., 2009). 
 Galf is a monosaccharide in the fungal cell wall that forms the side chains of many 
glycoconjugates (Latge, 2009). Galactofuranosyl residues are found to be immunodominant that 
indicates infections with Aspergillus (Bennett et al., 1985; Shibata et al., 2009), and a virulence 
determinant in Aspergillus fumigatus (Schmalhorst et al., 2008). Several studies have 
documented the importance of ugmA (one of the enzymes involved in Galf biosynthesis) in 
fungal growth and morphogensis, and showed that deletion of ugmA is correlated with depletion 
of Galf residues from Aspergillus cell walls (Damveld et al., 2008; El-Ganiny et al., 2008; 
Schmalhorst et al., 2008; Lamarre, 2009).  
Previous studies have used the promoter exchange strategy to explore the role and 
essentiality of many genes (e.g. Hu et al., 2007; Monteiro and De Lucas, 2010). This study is the 
first study to explore the roles of Galf biosynthesis enzymes on growth, morphogenesis and drug 
sensitivity of Aspergillus nidulans strains using alcA regulated strains. Here we are presenting 
detailed information on UgmA-regulatable strains. Comparable results were found for UgeA and 
UgtA which function immediately upstream and downstream of UgmA (data not shown). 
 
4.1. ugmA repression affects drug sensitivity, colony and hyphal morphogensis 
Our results showed that repression of ugmA increased the strain sensitivity to some 
antifungal drugs including caspofungin and amphotericin B. repression of ugmA also caused 
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compact colonial growth, reduced sporulation, increased hyphal width, branching and septum 
formation . Similarly, repression of genes that play a role in cell wall formation affected growth 
and morphogensis in other Aspergillus species.  For example repression of a chitin synthase, 
chsB showed the importance of class IV chitin synthase on hyphal growth and conidiation of A. 
nidulans: as an alcAp-chsB strain showed slow growth and produced highly branched hyphae 
under repressing conditions (Ichinomiya et al., 2002). Repression of A. fumigatus 
O-mannosyltransferase 2 (Afpmt2) caused growth retardation, abnormal cell polarity defects, and 
reduced conidium formation (Fang et al., 2010). Jiang et al (2008) created A. fumigatus strains 
conditionally expressing GDP mannose pyrophosphorylase. When GDP mannose 
pyrophosphorylase was repressed. these strains showed defective cell wall, impaired polarity 
maintenance, reduced conidiation and increased sensitivity to wall targeting chemicals. 
The alcA(p) was used also to study the roles of many genes from the cell wall integrity 
pathway. The Osherov group used alcA(p) to study the roles of protein kinase C (pkcA) as one of 
the cell wall integrity controllers. They found that repression of pkcA reduce germination, hyphal 
growth, conidiation and increase the cell wall thickness and sensitivity to wall targeting agents, 
however this alcA-pkcA strain was as sensitive as wild type to amphotericin B and voriconazole 
(Ronen et al., 2007). Osherov group also used the alcA-pkcA strain to identify new cell wall 
destabilizing compounds (Mircus et al., 2009). In another study the alcA-pkcA strain showed 
hypersensitivity to the antifungal protein PAF (Binder et al., 2010). Fortwendel et al (2009) used 
A. fumigatus strains defective in some cell wall integrity pathway genes (rasAΔ, cnaAΔ and 
crzAΔ strains), and found that these strains showed higher sensitivity to echinocandins.  
Schmalhorst et al (2008) used a gene deletion strategy to create an A. fumigatus strain 
defective in Galf biosynthesis (glfAΔ), This glfAΔ strain was more sensitive to many antifungal 
drugs including caspofungin and amphotericin B. Their result is consistent with our current result 
showing increased antifungal drugs sensitivity the Galf-defective strains alcA(p)-ugmA strain 
under repression condition and ugmAΔ strain towards caspofungin and amphotericin B. 
 
4.2. ugmA overexpression is not completely benign 
Our study showed that growing the alcA(p)-ugmA strain on threonine containing medium 
to overexpress ugmA resulted in wild type colony growth and sporulation. Similar results 
observed in case of induction of rpdA (histone deacetylase) in Aspergillus nidulans, using two 
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conditional promoters (alcA(p) and xylP(p), where threonine and xylose were used as inducers 
for alcA(p) and xylP(p) respectively (Tribus et al., 2010). In contrast, increasing FlbE activity, 
one of the conidiation activator in A. nidulans led to disrupted asexual development (Kwon et al., 
2010). Induction of ugmA expression resulted in slight decrease in sensitivity to terbinafine. 
Similarly, increasing mycobacterium UGM expression increased the resistance to isoniazid drug 
(Richards and Lowary, 2009). 
Unexpectedly, the hyphae of alcA(p)-ugmA strain grown on overexpression medium were 
wider with shorter basal cell and more branching. This phenotype waas similar to alcA(p)-ugmA 
strain under repression conditions and also to the ugmAΔ strain (El-Ganiny et al., 2008). we think 
that overexpression of ugmA will results in increased synthesis and deposition of Galf in fungal 
cell, perhaps at the expense of metabolites for hyphal growth. This will require further testing, 
since until now, only methods that reduced cell growth have been shown to affect cell wall 
composition and hyphal morphology. 
In conclusion we have shown that alcA(p) can be used to control the expression of ugmA 
in A. nidulans. Repression of ugmA increased sensitivity to caspofungin and amphotericin B, 
decreased sporulation, and disrupted normal hyphal growth. Overexpression of ugmA also results 
in abnormal hyphal morphology and in decrease in sensitivity to terbinafine. These results 
indicate that even increasing ugmA expression is not completely benign. Our data suggest that 
balanced expression of ugmA is required for wild type sporulation and hyphal morphology in A. 
nidulans, and we called this effect the Goldilocks effect. Deletion or repression of ugmA 
expression will affect the cell wall and hence the sensitivity to antifungal drugs. Further 
investigation is required to validate Galf as a virulence factor which will support the idea of 
targeting it by antifungal therapy; our future work will explore the roles of ugmA in Aspergillus 
pathogenicity using animal’s model systems. 
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Tables                 
Table 1: strains, primer and plasmids used in this study 
Strains 
Name  Description  Genotype  
A1149 a Wild type pyrG89; pyroA4; nkuA::argB 
AAE1 b Wild type pyrG89:N. crassa pyr4+; pyroA4; nkuA::argB 
AAE2 b ugmA∆ AN3112::AfpyrG; pyrG89; pyroA4; nkuA::argB 
AAE12 c AlcA(p)-ugmA ugmAp::pyrG:alcAp:ugmA; pyrG89; pyroA4; nkuA::argB 
Primers    Sequence 5`→3` 
Promoter exchange primers 
Ame115c ugmA F TCCTATCACCTCGCCTCAAAATGCTTAGTCTAGCTCGCAAGAC 
Ame 23 b ugmA R GCCTGCACCAGCTCCCTGCGCCTTATTCTTAGCAAA 
Ame 1 b Upstream F GACTCTTGAGATTTGCTTGGGTCTC 
Ame114c Upstream R TCAGTGCCTCCTCTCAGACAGAGAAGAGAGCGAAGCTGCAG 
Ame118 c Promoter F CTGTCTGAGAGGAGGCACTGA 
Ame119 c Promoter R TTTGAGGCGAGGTGATAGGA 
Ame116 c Fusion F GTAGTTGACAAGCATACGGAGTACTC 
Ame117 c Fusion R GGACCAGTAGGGACCTTCCT 
Ame134 c Midpromoter F GTGTTTGGTGTTGCCAAAGAC 
qRT-PCR  primers  
Ame 84 c ugm F CGTTCCCAGCTTTCAGGATA 
Ame 85 c ugm R CTTTGCAGCACCCAATCC 
Ame100 c act F T T C G G G T A T G T G C A A G G C 
Ame101 c act R T C G T G A C A A C A C C G T G C T 
plasmids 
palcA(p)  pGEM+ alcA(p)+ AfpyrG 
a Fungal Genetics Stock Center www.fgsc.net. 
b El-Ganiny et al. 2008. 
c This study.
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Table 2: Colony and hyphal characters of wild type (AAE1) and alcA(p)-ugmA (AAE12) strains 
grown under induction and repression conditions. Values presented as mean ± SE d 
 
Media Strain Colony 
diameter 
(mm) a 
Number of 
spores/ colony 
*106 b 
Hyphal width 
(µm) c 
Basal cell 
length (µm) c 
 
CMT 
wild type 22.5 ± 0.5  12.4 ± 1 2.5 ± 0.03 27.2 ± 1.3 
alcA(p)-ugmA 16.8 ± 0.6e 8.2 ± 1e 3 ± 0.04f 13.7 ± 0.6f 
      
 
CMFT 
wild type 18 ± 0.4  21 ± 5 2.6 ± 0.05 32.7 ± 2.9 
alcA(p)-ugmA 12 ± 0.7e 8.4 ± 3e 2.5 ± 0.05 17.9 ± 1.1f 
      
 
CM3G 
wild type 16 ± 0.4 38 ± 11 3.1 ± 0.05 30.3 ± 1.6 
alcA(p)-ugmA 3.6 ± 0.2f 0.6 ± 0.1f 3.7 ± 0.1f 17.2 ± 1f 
 
a  10 coloniess / strain  (from three biological replicates) 
b 3 colonies (each colony counted twice) from three different plates (biological replicates) 
c  50 measurements / strain, from two independent biological replicates. Hyphal width 
measured at septa, and basal cell length measured the distance between two subsequent 
septa. 
d  One-way ANOVA plus Tukey test  are used to compare wild type and alcA(p)-ugmA 
strains grown on the same media.  Values for alcA(p)-ugmA strains followed by letter if 
they are significantly different from wild typ, ‘e’ means significantly different at P<0.05 ; 
and ‘f’ means significantly different at P<0.001,  
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Table 3: Sensitivity of wild type, ugmAΔ, and alcA(p)-ugmA strains to antifungal drugs, assessed 
using disk diffusion method a, b. 
 
Media Strain Terbinafine Itraconazole Caspofungin Amphotericin B 
 
CMT 
wild type 
alcA(p)-ugmA 
16.1 ±0.2 
15 ± 0c 
8.3 ± 0.3 
8 ± 0.2 
4.3  ± 0.2 
4.5  ± 0.1 
1.5 ± 0.2 
1.6 ± 0.2 
      
 
CM3G 
wild type 
alcA(p)-ugmA 
18.3 ± 0.3 
18  ± 0.2 
7 ± 0.2 
7.6 ± 0.1 
3.4 ± 0.1 
6.8 ± 0.2d 
1.1 ± 0 
2.3 ± 0.1d 
      
 
CM 
wild type 
ugmA∆  
16 ± 0.5 
15 ± 0.8 
7 ± 0.3 
7.8 ± 0.2 
3.5 ± 0.05 
6.3 ± 0.2d 
1.7 ± 0.2 
2.5 ± 0.4d 
 
a   Drug sensitivity is measured as the radius (mm) of the clear zone with no visible growth. Data 
presented as mean ± SE (n = 4, four different biological replicates). 
b Statistical analysis used unpaired t-test to compare wildtype (AAE1) and Galf defective 
strains (AAE2 or AAE12) grown on the same media for each tested drug. 
c One-way ANOVA plus Tukey test was used to compare wild type and alcA(p)-ugmA strains 
grown on the same media.  Values for alcA(p)-ugmA strains followed by ‘c’ are 
significantly different from wild type at P<0.05, and values followed by ‘d’ are 
significantly different at P<0.001. 
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Figures 
 
   
 
Figure 1: representative gels of the qRT-PCR products, showing the change in ugmA expression 
after induction on CMT (A) and repression on CM3G (B). Actin was used as a reference gene.  
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Figure 2: Colony morphology of wild type and alcA(p)-ugmA strains grown on CM media with 
different carbon source. alcA(p)-ugmA strain has wild type colony and sporulation when grown 
on CMT and CMFT media, and resemble ugmA∆ phenotype when grown on CM3G media. 
            
                                            
  CM3G 
CMFT 
CMT 
wild	  type	   alcA(p)-­‐ugmA	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                                               A                                           B 
 
 
Figure 3: SEM micrographs showing: colony (A), and conidiophore (B) wild type and 
(alcA(p)-ugmA strains grown on CM with different carbon source. On CMT and CMFT media, 
alcA(p)-ugmA strain has abundant conidiophores with long chains of spores similar to wild type 
strain. On CM3G media, alcA(p)-ugmA produced very few conidiophores with short chains of 
spores. Scale bar is 100µm for A, and 10 µm for B. 
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Figure 4: Hyphal morphology wild type and alcA(p)-ugmA strains grown on CM with different 
carbon source and stained with Hoechst and Calcofluor. The alcA(p)-ugmA strain has wild type 
hyphae only on CMFT media and have wide, highly branched hyphae with shorter basal cells 
when grow on CMT (overexpression) and CM3G (high repression) media. Scale bar = 10 µm. 
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Figure 5: Sensitivity of wild type and alcAp-ugmA strains grown under induction (CMT) and 
repression (CM3G) conditions towards four antifungal drugs: caspofungin (Casp), itraconazole 
(Itrac), terbinafine (Terb) and amphotericin B (AmB). Arrows indicate the edge of the zone of 
inhibition (zone with no visible growth). 
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Supplemental materials 
a.  
 
b. 
                 1Kb  AAE1      AAE12                                      1Kb  AAE1     AAE12 
                                            
                  Ame1 & Ame23                                            Ame1 & Ame134 
c.              
Primer pair  AAE1  AAE12 
Ame1&Ame23 2.9 5.2 
Ame1 & Ame134 No band 2.8 
   
Supplemental figure A: Confirmatory PCR for promoter exchange. 
a) Diagram showing where the primers bind in the gDNA of wild type and alcA(p)-ugmA 
strains 
b) Electrophoresis gels for wild type (AAE1) and AlcAp-ugmA (AAE12) strains using two 
sets of primers. 
c) Expected amplicon size for both AAE1 and AAE12 with two primer pairs. 
 
5 KB 
3KB 
2KB 
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wild type                  alcA(p)-ugmA 
 
 
 
Supplemental Figure B: Colony morphology of wild type and alcA(p)-ugmA strains grown on 
CM (1% glucose) and YEPD media. Plates were incubated for 3 days at 28C.  
CM	  
	  	  	  YEPD	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Supplemental figure C: The growth of wild type (A) and ugmA∆ strain (B) in liquid CM* + 
nikkomycin Z (32 µg/ml).	  Strains are grown for 16 hr. at 28°C, then fixed and stained with 
Calcofluor and examined using confocal microscopy, Bar 10 µm. 
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Chapter 7 
General discussion 
Is the galactofuranose biosynthesis pathway in Aspergillus still a possible 
drug development target? 
 
Invasive fungal infections have increased dramatically since the mid-20th century, in 
parallel with the increased population of immunocompromised patients (Lass-Florl, 2009). 
Fungal infections are difficult to diagnose, and following diagnosis there are few therapeutic 
options, so they cause high morbidity and mortality (Chen et al., 2010; Denning and Hope, 
2010). Emerging antifungal resistance against current drugs makes treatment of fungal infections 
even more difficult (Carrillo-Muñoz et al., 2006). Taken together, there is considerable need to 
identify new antifungal targets for drug development (Ostrosky-Zeichner et al., 2010). 
Cell walls are essential for fungal survival and virulence, and since many of their 
polysaccharide components are not found in humans, so fungal walls are considered to be 
promising targets for drug development (Arana et al., 2009). Unfortunately, the fungal wall is 
composed of multiple interacting components , also the cell wall is produced and maintained by 
highly redundant suites of genes whose products have overlapping functions. Currently, there is 
only one class of antifungal drug in clinical use (echinocandins) that targets synthesis of the 
fungal wall polysaccharide, β-1,3-glucan (Denning, 2003). To date, inhibitors targeting other 
fungal wall structural components have not been effective in clinical use (Aimanianda and Latgé, 
2010). Other compounds which target fungal wall components (e.g. Calcofluor White and Congo 
Red) that are somewhat effective in vitro (Chapters 5) but are not useful clinically.  
Galactofuranose (Galf) is the 5-member ring isomer of galactose that forms short 
side-chains on galactomannans and other glycoconjugates (Latge, 2009). Galf is a cell wall 
component whose precise roles in cell wall architecture have not yet been well characterized,  
Galf is considered to be a fungal virulence factor in fungi as well as in pathogenic protozoa. In 
addition, Galf residues appear to form part of the secreted antigens in invasive aspergillosis 
infections (Leitao, 2003). However, this is still very preliminary. Loss of Galf in A. fumigatus 
strains has been associated with reduced virulence in one experimental study on a mouse model 
system (Schmalhorst et al 2008). In addition, Galf-containing glycoconjugates appear to have a 
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role in invasion of Trypanosoma cruzi into mammalian cells (De Arruda et al., 1989). Both being 
part of the cell wall and playing a role in virulence in at least some studies suggests that the 
Galf-biosynthesis pathway could be an excellent target for new antifungal drugs. Human serum 
Galf levels can be detected by the Platelia® monoclonal antibody (EBA2) that binds many forms 
of Galf epitope, and hence is used to monitor therapy progress in systemic aspergillosis patients 
(Wheat, 2003). However, Lamarre et al (2009) discussed evidence suggesting that EBA2, fails to 
recognize all forms of Galf conjugate as it binds only β 1,5 linked Galf residues. Engel et al. 
(2009) used the MEST-1 monoclonal antibody thoat detects the β 1,6 Galf residues. 
My Ph.D. research has explored the function of three enzymes that act sequentially in the 
Aspergillus nidulans Galf biosynthesis pathway: UgeA, UgmA and UgtA. Collectively these 
enzymes generate UDP-Galf from UDP-glucose in the cytoplasm, then transport it to the fungal 
Golgi equivalent for incorporation in cell wall Galf-containing glycoconjugates. The research I 
have described in Chapters 2-6 clearly shows that deletion or down-regulation of any of the three 
genes whose protein products mediate independent steps in wall Galf biosynthesis causes 
roughly comparably deficits in fungal growth, cell wall architecture, asexual sporulation, and 
response to antifungal drugs. Although deletion of any of these genes shows they are not 
essential, comparable to the effect of echinocandins on Aspergillus growth in vitro, there are 
reasons that support considering Galf biosynthesis as promising drug development target 
 
7.1. Each step in Galf biosynthesis controlled by single functional gene 
My research shows that the Galf biosynthesis pathway is a promising target for antifungal 
drug development. Although UgeA, UgmA, and UgtA are not essential for viability, single gene 
deletions have crippling effects on fungal growth and sporulation. Notably, the A. nidulans gene 
deletion strain phenotypes for UgmA and UgtA were fully complemented by their A. fumigatus 
orthologues (GlfA for UgmA, and GlfB for UgtA) showing that these enzumes are functionally 
homologous. This provides a substantial resource for future research: A. fumigatus is a Biosafety 
level 2 organism, whereas A. nidulans is Biosafety level 1. Thus it will be possible to study the 
structure and function of mutations in these A. fumigatus gene products when they are expressed 
in A. nidulans. Ultimately, these results must also be confirmed in A. fumigatus.   
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Both UDP-galactopyranose mutase (UgmA) and the UDP-Galf transporter (UgtA) are 
encoded by single gene sequences in A. nidulans, which makes targeting these genes an efficient 
strategy. Although there are two sequences (ugeA and ugeB) encoding putative 
UDP-glucose/galactose epimerases, only UgeA was demonstrated biochemically to have this 
epimerase function and ugeAΔ strains had a defective phenotype (chapter 4). In contrast, strains 
deleted for ugeB had wild type morphology, and the UgeB was detected only following 
overexpression and then only in conidiophores. In addition although UgeB consumes 
UDP-galactopyranose, it does not generate UDP-glucose (chapter 5). This is strong evidence that 
UgeA main functional enzyme that can convert UDP-glucose into UDP-galactose in A. nidulans. 
Similarly Damveld et al. (2008) showed that A. niger has two sequences encoding 
UDP-galactopyranose mutase (Ang-ugmA and Ang-ugeB). Deletion of Ang ugmA gave 
a defective phenotype, while deletion of ugmB had no effect on phenotype.  
 Enzymatic functions that are encoded by single genes cannot readily be compensated by 
genetic redundancy, and thus have higher likelihood of being drug targets. For example, 
synthesis of Aspergillus β-1,3-glucan is catalyzed by only one enzyme that is encoded by single 
gene, fksA (Kelly et al., 1996). In contrast chitin synthesis uses a suite of at least eight genes with 
overlapping functions (Mellado et al., 1995). Consistent with this, the echinocandins 
(β-1,3-glucan synthesis inhibitors) are clinically useful, whereas chitin synthase inhibitors have 
not proven to be effective drugs in clinical use (Latge, 2007). Consistent with this, nikkomycin Z 
(a chitin synthase inhibitor) caused morphological defects in wildtype A. nidulans hyphae, but 
was not able to inhibit the growth of either the wild type or the Galf-defective strains, when 
assessed using disc diffusion method (chapter 6).  
None of the Galf biosynthesis enzymes (UgeA [El-Ganiny et al., 2010], UgmA 
[El-Ganiny et al., 2008], and UgtA [Afroz et al., in press]) that I characterized during my 
research program is essential for viability of A. nidulans. However, each of these gene deletion 
strains has a similar phenotype and each is seriously compromised for growth in culture. These 
deletion strains have low growth rates with compact colonies and hyphal abnormalities, and 
severely decreased sporulation.  Schmalhorst et al. (2008) showed that an A. fumigatus strain 
deleted for its UgmA homologue had a similar phenotype to our strains and showed reduced 
pathogenicity in animal models. Although targeting Galf biosynthesis would not be fungicidal, 
reducing fungal capacity to invade and proliferate in host tissue would potentially slow disease 
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progress. Consistent with this, it has been shown previously that echinocandins including 
caspofungin do not kill Aspergillus (Denning, 2003) but in experimental animal studies these 
drugs induce morphological changes that decrease fungal pulmonary injury (Petraitiene et al., 
2002) and so they are clinically effective. Stated another way, fungicidal activity does not 
necessarily translate to improved drug efficacy in clinical use (Chapman et al., 2008). As a 
result, some recent antifungal therapeutic strategies are no longer trying to kill pathogens but 
rather to reduce its ability to cause disease (Gauwerky et al., 2009).  
 
7.2. Increased sensitivity of Galf-biosynthesis defective strains to antifungal drugs 
As one aspect of testing Galf biosynthesis enzyme pathway enzymes as potential targets for 
antifungal drug development, I compared Galf-biosynthesis defective strains (ugmAΔ or 
alcA(p)-ugmA repressed by growth on 3 % glucose) with wild type strains for their sensitivity 
towards four classes of commercially available antifungals. Galf-biosynthesis defective strains 
were more sensitive to caspofungin and amphotericin B than wild type strains. This is consistent 
with Schmalhorst et al. (2008) who showed that the AfglfAΔ strain was more sensitive to several 
antifungal drugs including caspofungin. When the alcA(p)-ugmA strain was grown on over-
expression medium, it was slightly less sensitive to terbinafine than wild type strain, consistent 
with increased resistance of Mycobacterium overexpressing UGM to the cell wall targeting drug 
isoniazid (Richards and Lowary, 2009). 
Also the sensitivity of the ugtAΔ strain was assayed using disc diffusion methods towards 
the fungal wall targeting agents Calcofluor White (CFW) and Congo Red (CR), both of which 
inhibit fungal growth, but are not clinically useful. The ugtAΔ strain showed slight increase in 
sensitivity to CFW. Both the A. nidulans ugmAΔ strain and the A. niger ugmAΔ strain were also 
more sensitive to high concentrations of CFW (30 µg/mL or more) than the wild type strains 
(Damveld et al., 2008; El-Ganiny et al., 2008). However, the CFW results must be interpreted 
with some caution, and possibly explored further, since El-Ganiny et al. (2008) also showed that 
low levels of CFW (10 µg/mL) partially remediated the ugmAΔ strain phenotype defects. 
The increased sensitivity of the Galf-biosynthesis defective strains to caspofungin is 
consistent with the importance of the cell wall in fungal growth. We indicated that the Galf-
defective strains had weaker cell wall than wild type strains (chapter 5). Attacking these strains 
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with wall targeting drugs was expected to cause easier damage to the already weakened wall, 
consistent with the increased sensitivity of cal mutants to wall targeting agents (Hill et al., 2006). 
Somewhat unexpectedly, these strains were also more sensitive to amphotericin B, which 
targets ergosterol in cell membranes. Similar increased sensitivity to amphotericin B was shown 
by Schmalhorst et al. (2008) for A. fumigatus glfA deletion strains. Szeghalmi et al (2007) and 
Gough and Kaminskyj (2010) showed that when hyphae from several fungal species including A. 
nidulans were grown under environmentally stressful conditions, they had increased hyphal 
protein levels that appeared to partially compensate for weaker cell walls. Consistent with this, 
preliminary evidence from spectroscopic analysis of A. nidulans wild type and Galf-defective 
strains showed that ugmAΔ hyphae had different carbohydrate and substantially higher protein 
content. The cytoskeleton/cell membrane and the cell wall form complementary support systems 
in fungal hyphae (Kaminskyj and Heath 1995, 1996). Reduced strength of the ugmAΔ cell wall 
(El-Ganiny et al., 2008; Paul et al., 2011) appears to increase dependence on the cell membrane-
cytoskeleton system for maintaining hyphal integrity. Notably, this effect was most strongly 
shown at the chemical level (increased amphotericin B sensitivity) rather than by inhibition of 
ergosterol biosynthesis (no significant change in sensitivity to azoles and allylamines 
 
7.3. Double mutant analysis reveals additional potential therapeutic targets 
In A. fumigatus, the hyphal wall surface appears to be enriched for Galf, which masks a 
layer enriched in mannosyl residues (Lamarre et al. 2009). El-Ganiny et al. (2008) created a 
double mutant [ugmAΔ swoA1] strain. The swoA1 mutation in a mannosyl transferase (Shaw and 
Momany, 2002), produced a strain with extremely diminished sporulation at 37 °C. A double 
mutant [ugmAΔ swoA1] strain had very small colonies and suffered from more severe growth 
defects than single ugmA or swoA strains. This suggests that treatments targeting both Galf and 
mannan biosynthesis could be promising for use in antifungal therapy. Similarly, S. cerevisiae 
fks1Δ strains (defective in β-1,3-glucan synthesis) are synthetically lethal with deletion of cnb1Δ 
(calcineurin catalytic subunit). The calcineurin pathway is required for compensation to cell wall 
defects that result from interference with β-1,3-glucan synthesis (Cowen and Steinbach, 2008).  
Paul et al. (2011) characterized and quantified the effect of several individual Galf 
biosynthesis gene deletion mutants, as well as two double deletion strains, [ugeA∆, ugeB∆] and 
[ugeA∆, ugmA∆] on hyphal wall structure. Use of atomic force microscopy, force compliance 
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analysis, and adhesion quantification showed that the UgmA and UgeA strain walls were 
substantially weaker and more hydrophilic than wild type strains. Notably, both [ugeA∆, ugeB∆] 
and [ugeA∆, ugmA∆] double deletion strains had substantially more severe defects than the 
single deletion strains, appearing to entirely lack the outer wall layer. Thus, as suggested by 
Costanzo et al. (2010) multiple gene deletion analysis can provide more insights into gene 
function. 
The UgmA and UgtA gene sequences are adjacent in the A. nidulans genome (ANID 
3112 and ANID 3113, respectively), which is consistent with other fungal systems (reviewed in 
Engel et al 2009). GFP tagging showed that UgmA is cytoplasmic protein (El-Ganiny et al., 
2010), whereas cellular distribution of UgtA-GFP has a strong tip-high gradient (Afroz et al, in 
press), consistent with fungal Golgi distribution (Breakspear et al., 2007; Hubbard and 
Kaminskyj, 2008) and with tip localized hyphal growth. UgtA is Golgi-localized, likely in the 
membrane rather than the lumen, because hydropathy analysis showed that it appeared to contain 
11 membrane-spanning alpha-helices. Loops including the N-terminus and other between 
alternate membrane-spanning regions are localized in the cytoplasm (chapter 4). This suggests 
the possibility that there could be an interaction between UgmA and cytoplasmic amino acids of 
UgtA related to production or transport of Galf residues for wall glycoconjugates. If this were so, 
then interfering with a putative UgmA-UgtA interaction might be deleterious to Galf deposition 
in the cell wall and could be an additional possible target for new antifungals. 
 
7.4. Combination antifungal therapy 
  The fungal cell wall is dynamic in its composition and architecture, changing in response 
to hyphal growth (Momany et al., 2004), to enviromental stresses (Szeghalmi et al 2007), and to 
planktonic versus biofilm growth (Loussert et al 2009). The relative inhibition of one type of cell 
wall polysaccharide can lead to compensatory increase in another component, typically mediated 
through the cell wall integrity pathway (Fujioka et al., 2007). For example, echinocandin 
treatment induces upregulation of chitin synthesis in the cell wall of C. albicans allowing the 
cells to escape lethality (Walker et al., 2008). Similarly, exposure of A. niger to CFW increases 
the expression of genes encoding α -glucan synthases (reviewed in Damveld et al., 2008). 
Inevitably, if a drug treatment is not 100 % lethal, this will result in development of resistance 
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(Sanguinetti et al., 2010). For antifungal agents that target gene products (unlike polyenes), the 
development of resistant strains is predictable (Anderson, 2005; Cowen, 2008).  
Combination antifungal therapies are a promising strategy for avoiding, or at least 
delaying, the development of resistance, that have already been used for new types of 
anti-bacterial treatment (Bassetti et al., 2008). Combination therapy has been used for treatment 
of cryptococcal infections (Van et al., 1997). Antifungal combination therapy can follow 
different strategies. For example it can target cell wall and cell membrane (Manavathu et al., 
2003); two cell wall components (Luque et al., 2003);  or a cell wall target plus cell wall integrity 
pathway target like calcineurin pathway (Fortwendel et al., 2009). Results presented in Chapter 6 
suggest that anti-Galf drugs (once developed) can be used in combination with echinocandins 
and/or with polyenes. Results presented in El-Ganiny et al (2008) and discussed in §7.3 suggest 
that targeting Galf and mannan synthesis could also be therapeutically useful.  
Ideally, we can predict how fungal cells can compensate for Galf loss using microarrays 
or PCR arrays. This will give a better idea about which drug combination would be more useful. 
Also it will be possible to detect and document synergistic drug interactions in animal models 
prior to testing in mammalian systems (currently under development by others in Kaminskyj 
research group). 
 
7.5. Future directions  
 Given that Galf residues have long been known or suspected to be important or essential 
for survival, growth, and pathogenicity of several microorganisms (reviewed in Beverley et al. 
2005), and since it is increasingly clear that new anti-fungal drug targets must now be selected 
amongst non-essential pathways for fungal metabolism, why has the Galf-biosynthesis pathway 
not received more widespread research attention for future drug development studies? Two 
factors have been extremely important.  
Unambiguous chemical analysis of Galf residues is expensive and extremely time 
consuming, compared to galactose. In solution, galactose is in equilibrium in the pyranose and 
furanose forms (95:5). These forms are stabilized by conjugation at carbon-1. Under appropriate 
conditions, purified AfglfA will convert UDP-Galp to UDP-Galf in vitro. However, there is no 
commercially available source of UDP-Galf. Also the EBA2 monoclonal antibody used clinically 
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in the Platelia kit is not readily available to researchers, and can only be purchased in a 96-well 
microtitre plate dish for ELISA assays.  
Until recently, the protein crystal structure of AfGlfA had not been solved at high 
resolution, despite ongoing and intense research effort. The structure of the prokaryotic UGM 
had been solved a decade previously (Sanders et al. 2001), but even for the prokaryote version 
the precise catalytic mechanism has not been completely clarified. As a result, it had not been 
possible to develop testable hypotheses about the catalytic mechanism of AfGlfA that could be 
used to predict and test a possible inhibitor compounds. Till now drugs that can target fungal 
Galf biosynthesis are not developed. 
Although Galf localization in the fungal wall remains incompletely characterized, the 
recent high spatial resolution crystal structure solutions of AfGlfA (van Straaten et al, in 
preparation), and A. nidulans UgeA (Dalrymple et al, submitted) now permit development and 
testing of specific hypothesis about amino acids that play important roles in these steps in Galf 
biosynthesis. With the crystal structures of AnUgeA and AfGlfA now available and building on 
the results presented from my thesis research, the following experimental directions are possible. 
1. Preliminary evidence suggests that like UgmA, both UgeA and UgtA deletion and conditional 
repression strains have increased sensitivity to antifungal drugs that are currently in clinical 
use. In addition to characterizing these drug sensitivities more fully, it will be useful to 
determine whether genes known to be involved in cell wall integrity are upregulated in 
response to perturbing the Galf biosynthesis pathway.  Cell wall integrity pathway genes 
have previously been characterized in Aspergillus nidulans (e.g. Fujioka et al., 2007).  If 
regulation of cell wall integrity pathway genes is altered in Galf-biosynthesis pathway 
deletion strains, they could be useful targets for combination therapy.  
2. Hydropathy analysis of UgtA has identified regions that are located on the cytoplasmic face of 
this transmembrane protein. Coupled with recent solutions for UgeA (Dalrymple et al, 
submitted) and UgmA structures (van Straaten et al, in preparation) this will allow for 
prediction of amino acid residues that could be involved in UgeA-UgmA and UgmA-UgtA 
interactions. If these interactions occur, blocking them might create a phenotype similar to a 
gene deletion. This suggestion can be tested with site-directed mutagenesis. 
3. This research used a suite of methods that can be adapted for rapid throughput analysis of 
chemical libraries that might potentially have antifungal activity. In particular, the disc 
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diffusion assay can be adapted to screen and compare the effect of candidate compounds for 
effect against wild type strains as well as those deleted for individual Galf biosynthesis 
genes. If the latter show increased effect compared to wild type, this will suggest potential 
synergies in combination with Galf-targeting compounds, assuming these are developed. 
4. The pathogenicity of different Galf-defective strains should be tested in tissue culture or 
animal model systems in comparison to wild type. There is controversy about the 
pathogenicity of ugmA∆ strains in animal models which needs to be resolved. Due to the cost 
and time involved in mouse model studies, a complementary strategy is to use animal tissue 
culture cells to study their response to wild type and Galf-biosynthesis defective strains. 
Preliminary results, through collaboration with our group, showed that ugmA∆ strains cannot 
grow in tissue culture plates although the wild type can, suggesting that ugmA∆ strains will 
be less able to cause disease. Future developments in this area will include development of 
new animal pathogenicity model systems. 
 
In summary, the research described in this thesis has presented a comprehensive study of 
three critical genes required for Galf biosynthesis in the model experimental fungal system 
Aspergillus nidulans. The results clearly show that Galf plays important roles in hyphal wall 
architecture, in cell growth, in surface-mediated interactions, and also in responses to currently 
available antifungal drugs. Although compounds that could inhibit function of these enzymes 
have yet to be generated, there is considerable reason for continuing to work in this area. In 
particular, the function of specific amino acids in the catalytic site of UgmA and UgeA will be 
assessed for function. This will be possible for two reasons. The deletion strain defects have been 
thoroughly described using cell morphometry and ultrastructure analysis, and their responses to 
antifungal drugs that are in clinical use. The A. fumigatus UgmA homologue GlfA and UgtA 
homologue GlfB were shown to functionally complement their respective A. nidulans deletion 
phenotypes. This will permit rapid characterization of the in vivo functions and interactions of 
these enzymes in a safe and environmentally tractable fungal model species. 
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Appendix: Molecular biology techniques used in the thesis 
1. DNA extraction and fusion PCR 
1.1. gDNA extraction protocol 
1. Inoculate 20 ml CM media in Petri plates with A. nidulans spores; incubate overnight at 
37ºC (until the mycelia fill the plate). 
2. Harvest mycelia by filtration through sterile paper towel, squeeze between several layers 
of paper towel to move extra water 
3. Transfer into sterile microfuge tube, freeze in -80 ºC for 30 min then lyophilize 
overnight. 
4. Break the lyophilized mycelia into fine powder using round toothpick 
5. Transfer 100 µl of fine powder into fresh microfuge tube 
6. Prepare fresh extraction buffer (pH 7.5-8) immediately before use as follow: 
500 mM EDTA  100 µl 
10% SDS  20 µl 
ddH2O  880 µl 
(This will be enough for 2 samples, make more buffer if you have more samples) 
7. Ad 500 µl extraction buffer per tube, Mix vigorously and transfer immediately to 
preheated 68ºC water bath. 
8. Incubate at 68ºC for 10 min meanwhile chill KOAc solution on ice (60 ml 5M KOAc, 
11.5 ml glacial acetic acid, 28.5 ml ddH2O). 
9. Vortex microfuge tubes briefly, centrifuge 5 min at maximum speed 
10. Transfer supernatant to fresh microfuge tube (using micropipette) 
11. Add 30 µl chilled KOAc solution, leave on ice for 5 min the centrifuge for 5 min 
12. Transfer supernatant into fresh microfuge tube 
13. Add equal volume of phenol:chloroform:isoamyl alcohol using Pasteur pipette 
14. Vortex 30s then microfuge for 2 min. 
15. Transfer the upper layer to a fresh microfuge tube (DO not transfer the material at the 
interface). 
16. Add equal volume of chloroform to the partially clean supernatant, vortex for 30s the 
centrifuge for 2 min 
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17. Transfer the upper layer to a fresh microfuge tube (DO not disturb the interface). 
18. Add 600 µl isopropanol, vortex well, centrifuge for 5 min. 
19. Pour off isopropanol then add 500 µl of 70% ethanol, vortex till the DNA pellet is not 
stuck, centrifuge for 5 min then decant supernatant and let the pellet dry. 
20. Resuspended in 100 µl (containing 5 µl RNAse). May require heating to dissolve 
21. Run agarose gel to check quality of DNA (sharp band) before proceeding into other steps. 
22.  The DNA should be cleaned using Qiagen columns before using it in PCR.  
 
1.2. Fusion PCR 
Fusion PCR is a technique that is used to fuse multiple DNA sequences together 
(typically three) to generate one construct that can be used for gene targeting (deletion, tagging 
and promoter exchange).  
         P1   P2         P3     P7                    P8    P4           P5   P6 
 
 
The fused sequences should have overlapping ends, so primers P3 and P4 are usually 
longer as they have tails (about 40 bases). P3 has a tail similar to reverse complement of P7 and 
P4 has a tail similar to the reverse complement of P8. The primers P2 and P5 are nested primers 
that are used in the fusion using Acuiprime high fidelity taq polymerase (Invitrogen) following 
manufacture instructions. 
In case of gene deletion, the construct consists of 1 Kb upstream of the target gene 
(sequence 1), 1Kb of the downstream (sequence 3) plus the sequence of the selectable nutritional 
marker (sequence 2).  In case of gene tagging with fluorescence protein (XFP), the construct 
consists of 1 Kb of your target gene, without the stop codon (sequence 1), 1 Kb of its 
downstream (sequence 3) and a sequence of 5GA-XFP + selectable marker (sequence 2), where 
5GA is 5 repeats of glycine and alanine that used as linker between the gene and the XFP. For 
promoter exchange the construct consists of 1 Kb of the upstream of the target gene (sequence 
1), 1 Kb of your target gene starting from ATG (sequence 3) and sequence 3 consists of 
selectable marker + conditional promoter (e.g. AfpyrG + alcAp). 
Sequence	  1	   Sequence	  2	   Sequence	  3	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When the fused constructs transformed into A. nidulans protoplasts, it is inserted in the 
genome by homologous recombination as sequence 1 & 3 were amplified from gDNA so they 
are identical to genomic sequences. Sequence 2 usually amplified from plasmid 
 
Recipe for fusion PCR 
DNA    1x3 µl 
Primers (10µm)  1x2 µl 
Taq polymerase  0.2 µl 
Buffer (10x)   5 µl 
Water      39.8 µl 
Total    50 µl 
 
2. RNA manipulation and qRT-PCR 
2.1. RNA extraction 
RNeasy plant kit (Qiagen) was used for RNA extraction from A. nidulans lyophilized 
mycelia, following the manufacturer instructions (everything should be RNase-free) 
1. Inoculate A. nidulans spores in liquid CM media (2x 105 spores/ mL media), incubate at 37°C 
with shacking for 16 hr 
2. Collect mycelia by centrifugation, remove supernatant and flash froze the pellet in liquid 
nitrogen. Lyophilize the mycelia overnight 
3. Transfer the lyophilized hyphae to RNase free centrifuge tube (start with similar weight for 
all samples).  
4. Broke the mycelia completely into fine powder using small pestle. 
5. Add 450 µl RLC buffer (to which β-Mercaptoethanol was added), vortex vigourously 
6. Transfer the lysate to QIAshredder spin column and centrifuge for 2 min at maximum speed. 
7.  transfer the supernatant to a new micro-centrifuge tube without disrupting the pellet 
8. Add 0.5 volume 100% ethanol and mix immediately by pipetting, transfer directly to RNeasy 
spin column, centrifuge for 15s at 8000xg, discard the flow-through 
9. Add 700 µl buffer RW1 to the column, close the lid gently and centrifuge for 15s at 8000xg, 
discard the flow-through. 
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10. Add 500 µl buffer RPE to the column, centrifuge for 15s at 8000xg, and discard the flow-
through. 
11. Add 500 µl buffer RPE to the column, centrifuge for 2 min at 8000xg, discard the flow-
through 
12. place the column in a new 2m collection tube, centrifuge for 1 min at maximum speed 
13. place the RNeasy column in a new 1.5 micro-centrifuge tube, add 50 µl RNase-free water 
directly to the membrane, centrifuge for 1 min at 8000 xg 
14. The eluted solution contains total RNA, measure the RNA concentration with Nanodrop and 
dilute to the appropriate concentration, aliquot and store in -20°C. 
 
2.2. gDNA elimination and cDNA  synthesis 
Quantitect reverse transcription kit (Qiagen) was used to remove gDNA contamination 
and synthesize DNA first strand. This protocol is optimized to be used for up to 1 µg RNA. RNA 
should be diluted up to 500 ng/ µl.  
For gDNA elimination follow the following steps 
1. Thaw template RNA, gDNA Wipeout buffer and RNase-free water on ice 
2. Prepare genomic DNA elimination reaction on ice as follow 
gDNA Wipeout buffer 7x   2 µl 
Template RNA (500 ng/µl)   2 µl 
RNase-free water    10µl 
Total      14 µl 
3. Incubate for 2-3 min at 42°C, then place immediately on ice 
For reverse transcription (cDNA synthesis) follow the following steps 
4. Thaw Quantiscript Reverse Transcriptase, Quantiscript RT buffer and RT primer Mix on 
ice. 
5. Prepare the reverse-transcription master mix as follow 
Quantiscript Reverse Transcriptase  1 µl  
Quantiscript RT buffer 5x   4 µl 
RT primer Mix    1 µl 
RNA from step 3    14 µl 
Total      20 µl 
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6. Incubate for 15-30 min at 42 °C. 
7. Incubate at 95°C for 3 min to inactivate the reverse transcriptase. 
8. Measure the cDNA concentration, dilute as required (e.g. 1:10), aliquot and store in -20 
°C, this cDNA can be used for qRT-PCR or cloning. 
 
2.3. qRT-PCR procedur 
QuantiTect SYBR Green kit (Qiagen) and IQ cycler (BioRad) were used for performing 
qRT-PCR.  We determined the relative expression of ugmA in alcA(p)-ugmA strain compared to 
wild type in case of induction (CMT), intermediate expression (CMFT) and maximum repression 
(CM3G) using actin as a reference gene and ΔΔct to calculate the fold change in ugmA 
expression.   
Procedure 
1) Thaw QuantiTect SYBR Green PCR Master Mix, template cDNA, primers and nuclease-free 
water on ice. 
2)  The following recipe is used for 1 reaction  
QuantiTect SYBR Green PCR Master Mix (2X)  10 µl 
Primers (10 µm)      2x0.3 
cDNA       3 µl 
Nuclease free-water     6.4 µl 
Total        20 µl    
3) For each gene (Actin or ugmA) multiply the above recipe by 10 to make a cocktail for 10 
reactions (3 technical replicates for wild type, 3 for mutant strain, 3 No template control 
(NTC) and 1 extra). 
4) Mix all the ingredients (except cDNA) and divide equally into 3 tubes (A, B, C). 
5) Add 10 µl cDNA to tube A (wild type) and B (mutant) and 10 µl water to tube C. 
6) Mix and dispense 20 µl in the bottom of each well (of the 96-well plate).   
7) Place the plastic film over the plate and carefully seal firmly, clean the surface with Kim 
wipes before putting in the IQ cycler. 
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3. DNA cloning 
3.1. Cloning using restriction digest and ligation  
1) The DNA fragment (insert) and the cloning plasmid (vector) should be cut using the same 
restriction enzymes to generate compatible ends.  
2) Set up the following reaction mixtures 
Test   Negative control 
Vector DNA  5 µl   5 µl 
Insert DNA  5 µl     - 
5X ligase buffer 4 µl   4 µl 
Water    5 µl   10 µl 
T4DNA ligase  1 µl   1 µl 
3) Leave at room temperature at least for 2 hours or ligate overnight 
4) Transform 10 µl of the rection mix into E. coli comptent cells, shake at 37°C for 1 hr 
5) Spread 50-100 µl on LB plates + suitable antibiotics, incubate overnight at 37°C 
6) Colonies on test plates can be used for plasmid extraction, negative control plates should 
have no colonies. 
 
3.2. Cloning using TA TOPO cloning kit (Invitrogen) 
TOPO cloning does not require restriction digest or ligation, the following steps are used 
(following the manufacturer’s instructions) 
1) Amplify the DNA fragment by PCR, end PCR reaction with a final 7-10 min extension 
step. 
2) Set up the following 2 reactions 
Test  Negative control 
Fresh PCR product  1 µl   - 
Salt solution   1 µl   1 µl  
Water     3 µl   4 µl 
TOPO Vector   1 µl   1 µl 
3) Mix gently and incubate both reactions for 5 min at room temperature 
4) Place tubes on ice, and thaw One Shot E. coli cells 
5) Add 2 µl of the TOPO cloning reaction to E. coli cells and mix gently 
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6) Incubate on ice for 30 min then heat-shoch the cells for 30 sec at 42°C 
7) Add 250 µl of room temperature SOC medium to the E. coli cell 
8) Cap the tubes and shake at 37°C for 1 h 
9) Spread 40 µl of 40 mg/ml X-gal onto LB/ampicillin plates and incubate at 37°C to dry 
10) Spread 50 µl transformed E. coli cells on the LB plates prepared in the previous step 
11) Incubate plates overnight at 37°C, in the next day transformed colonies (white colonies) 
can be used for plasmid extraction, negative control plates should have blue or no 
colonies.   
 
 
 
 
 
 
